New York University Report on Federal Awards In

Home , NYU Langone Health

New York University Report on Federal Awards in Accordance with the OMB Uniform Guidance August 31, 2018 Entity Identification Number: 13-5562308 New York University Index August 31, 2018

Page(s)

Part I – Financial Statements

Report of Independent Auditors ...... 1–2

Consolidated Financial Statements

Balance Sheets ...... 3

Statements of Activities ...... 4

Statements of Cash Flows ...... 5

Notes to Financial Statements ...... 6–44

Appendix A

Supplemental Schedules ...... 45–54

Notes to Consolidating Supplemental Information ...... 55

Part II – Supplemental Schedule of Expenditures of Federal Awards

Schedule of Expenditures of Federal Awards ...... 56–91

Notes to Schedule of Expenditures of Federal Awards ...... 92–93

Part III – Reports on Internal Control and Compliance

Report of Independent Auditors on Internal Control Over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance with Government Auditing Standards ...... 94–95

Report of Independent Auditors on Compliance with Requirements That Could Have a Direct and Material Effect on Each Major Program and on Internal Control Over Compliance in Accordance with the Uniform Guidance ...... 96–97

Part IV – Findings

Schedule of Findings and Questioned Costs ...... 98-101

Summary Schedule of Status of Prior Audit Findings ...... 102

Management’s Views and Corrective Action Plan ...... 103

Part I Financial Statement

Report of Independent Auditors

To the Board of Trustees of New York University

Report on the Consolidated Financial Statements We have audited the accompanying consolidated financial statements of New York University and its subsidiaries, which comprise the consolidated balance sheets as of August 31, 2018 and 2017, and the related consolidated statements of activities and of cash flows for the years then ended, and the related notes to the financial statements.

Management’s Responsibility for the Consolidated Financial Statements Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

Auditors’ Responsibility Our responsibility is to express an opinion on the consolidated financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to New York University and its subsidiaries’ preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of New York University and its subsidiaries’ internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of New York University and its subsidiaries as of August 31, 2018 and 2017, and the changes in their net assets and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.

PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, New York 10017 T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us

Other Matters Other Matter Our audit was conducted for the purpose of forming an opinion on the consolidated financial statements taken as a whole. The consolidating information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the consolidated financial statements. The consolidating information has been subjected to the auditing procedures applied in the audit of the consolidated financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the consolidated financial statements or to the consolidated financial statements themselves and other additional procedures, in accordance with auditing standards generally accepted in the United States of America. In our opinion, the consolidating information is fairly stated, in all material respects, in relation to the consolidated financial statements taken as a whole. The consolidating information is presented for purposes of additional analysis of the consolidated financial statements rather than to present the financial position, changes in net assets and cash flows of the individual companies and is not a required part of the consolidated financial statements. Accordingly, we do not express an opinion on the financial position, changes in net assets and cash flows of the individual companies.

Other Information Our audit was conducted for the purpose of forming an opinion on the consolidated financial statements taken as a whole. The accompanying schedule of expenditures of federal awards, for the year ended August 31, 2018, is presented for purposes of additional analysis as required by Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and is not a required part of the consolidated financial statements. Such information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the consolidated financial statements. The information has been subjected to the auditing procedures applied in the audit of the consolidated financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the consolidated financial statements or to the consolidated financial statements themselves, and other additional procedures in accordance with auditing standards generally accepted in the United States of America. In our opinion, the schedule of expenditures of federal awards is fairly stated, in all material respects, in relation to the consolidated financial statements as a whole.

Other Reporting Required by Government Auditing Standards In accordance with Government Auditing Standards, we have also issued our report dated December 7, 2018 on our consideration of New York University and its subsidiaries’ internal control over financial reporting and on our tests of their compliance with certain provisions of laws, regulations, contracts and grant agreements and other matters for the year ended August 31, 2018. The purpose of that report is solely to describe the scope of our testing of internal control over financial reporting and compliance and the results of that testing and not to provide an opinion on the effectiveness of internal control over financial reporting or on compliance. That report is an integral part of an audit performed in accordance with Government Auditing Standards in considering New York University and its subsidiaries’ internal control over financial reporting and compliance.

December 7, 2018, except for certain information in Note 16, for which the date is March 6, 2019 New York, New York

2 New York University Consolidated Balance Sheets August 31, 2018 and 2017

(in thousands of dollars) 2018 2017

Assets Cash and cash equivalents$ 1,487,070 $ 1,269,599 Short-term investments (Note 4) 1,870 1,989 Accounts and loans receivable, net (Note 5) 722,997 757,406 Patient accounts receivable, net (Note 3) 895,513 858,748 Contributions receivable, net (Note 6) 458,350 459,147 Other assets (Note 7) 949,778 867,288 Deposits with trustees (Note 2) 474,168 289,088 Long-term investments (Note 4) 4,881,342 4,875,687 Assets held for professional liabilities (Note 10) 525,834 503,328 Land, buildings, and equipment, net (Note 8) 10,931,180 9,962,531 Total assets$ 21,328,102 $ 19,844,811 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses$ 1,950,116 $ 1,696,552 Deferred revenue 973,655 1,021,079 Professional liabilities (Note 10) 640,722 629,810 Debt and other obligations (Note 9) 7,123,908 6,308,820 Funds held for others (Notes 5 and 7) 344,625 306,117 Accrued benefit obligation (Note 11) 452,487 567,558 Accrued postretirement obligation (Note 11) 541,949 569,448 Asset retirement obligation 256,318 235,362 Total liabilities 12,283,780 11,334,746 Net assets Unrestricted 5,414,491 4,800,589 Temporarily restricted (Note 14) 1,414,620 1,627,922 Permanently restricted (Note 14) 2,215,211 2,081,554 Total net assets 9,044,322 8,510,065 Total liabilities and net assets$ 21,328,102 $ 19,844,811

The accompanying notes are an integral part of these consolidated financial statements.

3 New York University Consolidated Statements of Activities Years Ended August 31, 2018 and 2017

(in thousands of dollars) 2018 2017

Changes in unrestricted net assets Operating revenues Tuition and fees (net of financial aid awards of $686,046 and $653,168)$ 1,851,954 $ 1,753,736 Grants and contracts (Note 2) 1,011,575 917,545 Patient care (net of provision for bad debt of $98,266 and $85,461) (Note 3) 6,981,943 5,571,455 Hospital affiliations (Note 12) 342,735 348,956 Insurance premiums earned 115,544 73,804 Contributions 168,192 183,505 Endowment distribution (Note 4) 169,149 162,214 Return on short-term investments (Note 4) 16,130 10,133 Auxiliary enterprises 505,317 513,259 Program fees and other 272,163 228,490 Net assets released from restrictions 121,469 123,365 Total operating revenues 11,556,171 9,886,462 Expenses (Note 13) Salaries and fringe 6,861,802 5,746,051 Medical and pharmaceutical costs 921,221 667,012 Professional services 682,020 619,620 Facilities cost 734,805 649,930 Supplies 208,506 193,006 Fees, insurance and taxes 327,901 254,630 Depreciation and amortization 718,309 574,824 Interest 248,197 222,055 Other 842,197 762,570 Total expenses 11,544,958 9,689,698 Excess of operating revenues over expenses 11,213 196,764 Nonoperating activities Investment return (Note 4) 157,692 209,366 Appropriation of endowment distribution (Note 4) (61,823) (59,375) Pension and postretirement nonservice costs (Note 11) (5,279) (31,640) Changes in pension and postretirement obligations (Note 11) 119,491 264,138 Net assets released from restrictions for capital purposes 347,319 109,242 Other 45,289 39,515 Loss on bond defeasance (Note 9) - (32,186) Acquisition of Winthrop-University Hospital Association (Note 1) - 274,927 Increase in unrestricted net assets 613,902 970,751 Changes in temporarily restricted net assets Contributions 172,193 134,106 Investment return (Note 4) 204,089 287,546 Appropriation of endowment distribution (Note 4) (107,326) (102,839) Other (13,470) 6,931 Net assets released from restrictions (468,788) (232,607) (Decrease) increase in temporarily restricted net assets (213,302) 93,137 Changes in permanently restricted net assets Contributions 140,531 154,663 Other (6,874) (2,305) Increase in permanently restricted net assets 133,657 152,358 Increase in net assets$ 534,257 $ 1,216,246

The accompanying notes are an integral part of these consolidated financial statements.

New York University Consolidated Statements of Cash Flows Years Ended August 31, 2018 and 2017

(in thousands of dollars) 2018 2017

Cash flows from operating activities Change in net assets $ 534,257 $ 1,216,246 Adjustments to reconcile change in net assets to net cash provided by operating activities Depreciation and amortization 718,309 574,825 Loss on sale or disposal of land, buildings and equipment and other adjustments 1,444 11,573 Noncash gain on extinguishment of debt - (3,651) Net gain on investments and deposits with trustees (294,202) (432,881) Bad debt expense 117,210 87,016 Pension and postretirement obligation change (119,491) (264,138) Contributions received for permanent investment and capital (143,364) (204,723) Acquisition of Winthrop-University Hospital Association - (295,427) Proceeds from insurance recovery for capital or FEMA award (6,742) (55,664) Changes in operating assets and liabilities Decrease in accounts and loans receivable, net 23,264 120,104 Increase in patient accounts receivable (135,031) (171,707) (Increase) decrease in nonendowment and noncapital contributions receivable (9,526) 54,894 Increase in other assets (9,286) (59,008) Decrease in asset retirement obligation (5,200) (5,646) Increase (decrease) in accounts payable and accrued expenses 253,660 (205,410) Increase in professional liabilities 10,912 80,909 Increase in deferred revenue 27,935 24,557 Decrease in accrued pension obligation (37,639) (46,636) Increase in accrued postretirement obligation 14,560 21,740 Net cash provided by operating activities 941,070 446,973 Cash flows from investing activities Purchases of investments (2,200,132) (1,537,038) Sales and maturities of investments 2,441,540 1,659,797 Increase in assets held for professional liabilities (17,672) (40,024) Drawdowns of unexpended bond proceeds 105,650 101,237 Additions to land, buildings, and equipment (1,638,933) (1,376,831) Proceeds from insurance recovery or FEMA award for capital 5,558 111,641 Cash acquired from acquisition of Winthrop-University Hospital Association - 68,736 Net cash used in investing activities (1,303,989) (1,012,482) Cash flows from financing activities Contributions received for permanent investment and capital 143,364 204,723 Proceeds from FEMA award for future mitigation 1,184 46,164 Proceeds from short-term borrowings 632,413 499,356 Proceeds from long-term borrowings 5,262 1,351,420 Principal payments on short-term borrowings (25,000) (529,370) Principal payments on long-term borrowings (174,983) (791,023) Payments of deferred financing costs (1,650) (5,922) (Decrease) increase in funds held for others (12,047) 4,216 Decrease in deposits with bond trustees 11,847 22,278 Net cash provided by financing activities 580,390 801,842 Net increase in cash 217,471 236,333 Cash Beginning of year 1,269,599 1,033,266 End of year $ 1,487,070 $ 1,269,599 Supplemental disclosure of cash flow information Bond proceeds $ 646,302 $ - Line of credit principal payments 341,685 - Interest paid 268,977 238,686 Change in noncash acquisitions of land, buildings, and equipment 24,829 90,946 Assets acquired under capital leases 113,153 258,481 Noncash acquisition of Winthrop-University Hospital Asociation net assets - 226,691

The accompanying notes are an integral part of these consolidated financial statements.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

1. Description of New York University

Founded in 1831, New York University (NYU) is a private institution of higher education, research, and patient care located primarily in New York City. NYU is recognized both nationally and internationally as a leader in scholarship and is a member of the distinguished Association of American Universities.

The consolidated reporting entities for NYU consist of the University and NYU Langone Health, which represents the operations of NYU Langone Health System (Health System) and NYU School of Medicine (NYUSoM).

The University The University includes nineteen colleges and divisions each with its own traditions, programs and faculty. The schools, in order of founding date, are the College of Arts and Science, School of Law, NYUSoM (reported as a part of NYU Langone Health), College of Dentistry, Graduate School of Arts and Science, Steinhardt School of Culture, Education and Human Development, Leonard N. Stern School of Business, Courant Institute of Mathematical Sciences, School of Professional Studies, Institute of Fine Arts, Robert F. Wagner Graduate School of Public Service, Post- Graduate Medical School, Silver School of Social Work, Tisch School of the Arts, Gallatin School of Individualized Study, Rory Meyers College of Nursing, Institute for the Study of the Ancient World, NYU Abu Dhabi, and Tandon School of Engineering (formerly Polytechnic University founded in 1854). The University also operates academic program sites and research programs in other parts of the United States and abroad.

In addition to the colleges and divisions, NYU operates NYU Shanghai, which grants NYU degrees, as a joint venture with East China Normal University. The New York based activities of NYU Shanghai are reported in the University’s consolidated balance sheets and consolidated statements of activities.

NYU Langone Health The Health System is the sole corporate member of NYU Langone Hospitals and, as of April 1, 2017, NYU Winthrop Hospital (Winthrop).

NYU Langone Hospitals operates the Kimmel Pavilion and Tisch Hospital, two acute care facilities which together consist of 844 beds, and are major centers for specialized procedures in cardiovascular services, neurosurgery, cancer treatment, reconstructive surgery, transplantation, psychiatric services and rehabilitation. NYU Langone Hospitals also operates NYU Langone Orthopedic Hospital, a 225-bed acute care facility specializing in orthopedic, neurologic, and rheumatologic services; NYU Langone Hospital-Brooklyn, a 450-bed acute care hospital; and several ambulatory facilities, including the Laura and Isaac Perlmutter Cancer Center, the Ambulatory Care Center, the Center for Musculoskeletal Care and Hassenfeld Children’s Center for Cancer and Blood Disorders.

In addition to NYU Langone Hospitals and Winthrop, the Health System’s wholly owned subsidiaries consist of: Lutheran Augustana Center for Extended Care and Rehabilitation, a 240- bed skilled nursing facility, Community Care Organization, Inc., a licensed home care agency; Shore Hill Housing, Sunset Gardens Housing and Harbor Hill Housing, which provide senior housing and rent subsidies for people meeting requirements defined by the US Department of Housing and Urban Development; and Sunset Bay Community Services, Inc., which provides

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

senior services and day care services. Lutheran Augustana Center for Extended Care and Rehabilitation received approval from New York State to discontinue operations, which was completed in April 2018. Additionally, effective August 2018, Lutheran CHHA, Inc., a certified home health agency, merged with NYU Winthrop and is no longer a separate wholly owned subsidiary of the Health System.

NYU Langone Hospitals is the sole corporate member of CCC550 Insurance, SCC. (CCC550), which provides the hospitals’ professional and general liability insurance, as well as insurance to physicians employed by the NYUSoM, and starting on July 1, 2017, Winthrop. CCC550 is subject to taxation in accordance with Section 29 of the Exempt Insurance Act in Barbados.

Affiliation with NYU Winthrop On April 1, 2017, the Health System completed an affiliation agreement (Affiliation) in which it became the sole corporate member of Winthrop (formerly Winthrop-University Hospital Association) and its subsidiary entities, Winthrop University Hospital Service Corporation and Winthrop Clinical Partners, Inc. Winthrop-University Hospital Association subsequently changed its name to NYU Winthrop Hospital. Winthrop is a 591-bed adult Level 1 trauma center and teaching hospital in Mineola, New York.

The Affiliation and subsequent change in control of Winthrop was accounted for as a business combination in accordance with Accounting Standards Codification (ASC), Topic 805, Business Combinations, and ASC 958-805-05, Acquisition by a Not-for-Profit Entity. NYU recorded $274,927 of unrestricted non-operating income in the 2017 consolidated statement of activities which represents Winthrop’s net assets at March 31, 2017 and the excess of the fair value of assets acquired over the fair value of liabilities assumed. No consideration was exchanged for the acquisition.

In 2017, Winthrop changed its fiscal year end from December 31 to August 31 to conform to NYU’s year end. As a result of this change, obtaining revenues and changes in net assets as though the acquisition occurred at the beginning of fiscal year 2017 was impracticable.

The following is a summary of the Winthrop activity included in the 2017 consolidated statements of activities:

Net assets as of March 31, 2017$ 176,444 Excess of the fair value of assets acquired over liabilities 98,483 Acquisition of Winthrop-University Hospital Association 274,927 Operating revenues 649,478 Operating expenses 630,016 19,462 Nonoperating activities 25,839 Change in unrestricted net assets 320,228 Change in temporarily restricted net assets 12,750 Change in permanently restricted net assets 8,820 Total change in net assets as a result of the acquisition$ 341,798

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The following is a summary of the Winthrop amounts included in the consolidated balance sheet as of August 31, 2017:

Assets $ 1,231,969 Liabilities 890,171 Unrestricted net assets 320,228 Temporarily restricted net assets 12,750 Permanently restricted net assets 8,820

2. Summary of Significant Accounting Policies

Basis of Presentation The consolidated financial statements of NYU have, in all material respects, been prepared on an accrual basis in accordance with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements include the accounts of NYU, as well as its separately incorporated affiliates. NYU and, generally, all of its affiliates are exempt from federal income taxes under the provisions of Section 501(c)(3) of the Internal Revenue Code.

NYU prepares its consolidated financial statements in accordance with the provisions of ASC Topic 958, Not for Profit Entities. This standard focuses on the entity as a whole and requires classification of net assets as unrestricted, temporarily restricted or permanently restricted, as determined by the existence or absence of restrictions placed on the assets’ uses by donors or by provision of law. A description of the net asset classifications follows:

Permanently Restricted net assets include gifts, pledges, trusts, and gains explicitly required by donors to be retained in perpetuity, while allowing the use of the investment return for general or specific purposes, in accordance with donor provisions.

Temporarily Restricted net assets include contributions and investment return that can be expended when donor or legal restrictions have been met. Contributions receivable that do not carry a purpose restriction are deemed to be time restricted. Temporary restrictions are removed either through the passage of time or because certain actions are taken by NYU that fulfill the restrictions or both.

Unrestricted net assets are the remaining net assets of NYU that are used to carry out its missions of education, research and patient care which are not subject to donor restrictions.

Operations Revenues and expenses related to conducting programmatic activities and provision of services by NYU are classified as operating in the consolidated statement of activities. Tuition and fees are derived from degree programs as well as executive and continuing education programs. Tuition and fee revenue is recognized as operating income in the period in which it is earned. Tuition and fee receipts received in advance are recorded as deferred revenue. Net tuition and fees are computed after deducting certain scholarships and fellowships awarded to students. Investment return relating to management-designated endowment funds and the related endowment appropriation, as well as changes in pension and postretirement obligations and unusual or nonrecurring activity, are classified as nonoperating in the consolidated statement of activities.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Grants and Contracts Grant and contract revenues represent reimbursements of costs incurred in direct support of research and other sponsored activities. Such sponsored grants and contracts generally provide for the recovery of indirect costs supporting these activities. Indirect costs, included in grant and contract revenues, are recovered at rates established in advance by NYU through negotiations with the federal government and other private sponsors and amount to $163,509 and $150,927 for the years ended August 31, 2018 and 2017, respectively.

In 2014, NYU Langone Health was awarded a $982,400 multi-year fixed capped public assistance grant from the Federal Emergency Management Agency (FEMA) for both repair and replacement of damages and hazard mitigation projects as a result of Superstorm Sandy. As allowable repairs and replacement costs are incurred, revenues are recognized within the consolidated statements of activities based on the nature of the expenditure, as either operating or capital. Cash received in advance of spending is recorded as deferred revenue with a corresponding assets limited as to use within other assets on the consolidated balance sheet (Note 7). The hazard mitigation project portion of the award was recognized as a temporarily restricted contribution (Note 14), with a corresponding FEMA receivable (Note 5). The net assets are released from restriction as the costs are incurred, and totaled $84,007 and $82,851 for the years ending August 31, 2018 and 2017, respectively.

Contributions Contributions, including unconditional promises to give, are recognized as revenue in the period received at their fair value. Contributions receivable are reported at their discounted present value, using an estimated interest rate for the year in which the promise was received and considering market and credit risk as applicable (3.6% in 2018 and 2.9% in 2017). Amortization of the discount is recorded as additional contribution revenue. Conditional promises to give are not recognized as revenue until the conditions on which they depend are substantially met. Allowances are recorded for estimated uncollectible contributions based upon management’s judgment and analysis of the creditworthiness of the donors, past collection experience and other relevant factors.

Cash and Cash Equivalents Cash and cash equivalents include cash and all highly-liquid debt instruments with original maturities of three months or less when purchased. This does not include pooled investments with less than three months to maturity held within the long-term investment portfolio. The carrying amount of cash and cash equivalents approximates fair value due to the short-term maturity of the instruments. NYU maintains its deposits with high credit quality financial institutions, with balances that exceed federal depository insurance limits. Management does not believe the credit risk related to these deposits is significant.

Deposits with Trustees Deposits with trustees consist of unexpended bond proceeds (to fund various construction projects) held by the trustee, the Dormitory Authority of the State of New York (DASNY), of $412,289 and $256,542 as well as debt service reserve funds held by NYU of $61,879 and $32,546 at August 31, 2018 and 2017, respectively.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Land, Buildings, and Equipment Land, buildings, and equipment are carried at their acquisition or construction cost. If donated, these assets are recorded at their fair value on the date of the gift. Buildings and equipment are depreciated over their estimated useful lives (buildings and building improvements 10-60 years, equipment 3-10 years) using the straight-line method.

Collections The University does not assign a value to collection items. Collection items are generally held for educational purposes and are not disposed of for financial gain or otherwise encumbered in any manner.

Asset Retirement Obligation NYU recognizes asset retirement obligations on future events, such as the abatement of asbestos and removal of lead-based paint and petroleum bulk storage tanks from buildings. The fair value of the liability for a conditional asset retirement obligation is recognized in the period in which it occurred, provided that it can be reasonably estimated. Corresponding asset retirement costs (net of accumulated depreciation) have been included in land, buildings, and equipment.

Funds Held for Others Funds held for others consist of the University’s federal grants refundable and deferred compensation plan liabilities (for NYU’s (457(b) plans). Corresponding assets are included within accounts receivable (Note 5) and other assets (Note 7), respectively.

Accounting Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingencies at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Reclassifications Certain amounts in the 2017 consolidated financial statements have been reclassified to conform to the current year’s presentation.

New Authoritative Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. This standard implements a single framework for recognition of all revenue earned from customers. This framework ensures that entities appropriately reflect the consideration to which they expect to be entitled in exchange for goods and services by allocating transaction price to identified performance obligations and recognizing revenue as performance obligations are satisfied. Qualitative and quantitative disclosures are required to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The standard is effective for fiscal years beginning after December 15, 2017. NYU has implemented this standard using a modified retrospective approach in fiscal year 2019 and concluded there will be no opening net asset impact.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

In February 2016, the FASB issued ASU 2016-02, Leases. Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of leases with a term of twelve months or less) at the commencement date: (a) a lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and (b) a right-of-use asset, representing the lessee’s right to use, or control the use of, a specified asset for the lease term. The guidance requires a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, to provide an additional transition method to adopt the guidance by allowing entities to initially apply the new leases standard at the adoption date and recognize a cumulative effect to the opening balance of net assets. The standard is effective for fiscal years beginning after December 15, 2018. NYU is currently evaluating the impact this standard will have on the 2020 consolidated financial statements.

In August 2016, the FASB issued ASU 2016-14, Presentation of Financial Statements for Not-for- Profit Entities. This standard marks the completion of the first phase of a larger project aimed at improving not-for-profit financial reporting. Under the new guidance, the existing three categories of net assets will be replaced with a simplified model that combines temporarily restricted and permanently restricted net assets into a single category called “net assets with donor restrictions” and renames unrestricted net assets as “net assets without donor restrictions.” There will be new reporting requirements for expenses and additional disclosures to describe an organization’s liquidity. The standard is effective for fiscal years beginning after December 15, 2017. NYU has implemented this standard using a retrospective approach in fiscal year 2019 and concluded there will be no opening net asset impact.

In June 2018, the FASB issued ASU 2018-08, Not-for-Profit Entites, Clarifying the Scope and the Accounting Guidance for Contributions Received and Contributions Made. This standard provides a framework for evaluating whether grants should be accounted for as exchange transactions or as nonexchange transactions. For nonexchange transactions, the new guidance clarifies whether arrangements are conditional or unconditional. The standard is effective for fiscal years beginning after June 15, 2018. NYU has implemented this standard using a modified prospective approach in fiscal year 2019 and concluded there will be no opening net asset impact.

3. Patient Care Revenue and Receivables

NYU Langone Health has agreements with third party payors that provide for payments at amounts different from its established rates (i.e. gross charges). Payment arrangements include prospective determined rates per discharge, reimbursed costs, discounted charges and per diem payments.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Patient care services rendered are recorded in the period in which the service is performed, net of contractual and other allowances that represent differences between gross charges and the estimated receipts under such programs. Patient care revenue for NYU Langone Health is reported at the estimated net realizable amounts due from patients, third-party payors and others for services rendered and includes estimated retroactive revenue adjustments due to ongoing and future audits, reviews and investigations. Retroactive adjustments are accrued on an estimated basis in the period the related services are rendered and adjusted in future periods as final settlements are determined. Patient service revenues are also reduced for allowances for uncollectible accounts. Patient service revenue for NYU Langone Health, net of contractual allowances and discounts, is as follows for the years ended August 31, 2018 and 2017:

2018 2017

Gross charges$ 32,151,225 $ 22,743,511 Allowances (25,126,972) (17,141,474) Patient service revenue, net of contractual allowances 7,024,253 5,602,037 Bad debt expense (98,266) (85,461) Total net patient service revenue$ 6,925,987 $ 5,516,576

NYU Langone Health’s patient accounts receivable, after contractual allowances but before allowances for bad debts is $1,079,842 and $1,042,953 at August 31, 2018 and 2017, respectively. The process for estimating the ultimate collection of receivables involves significant assumptions and judgments. NYU Langone Health implemented a quarterly standardized approach to estimate and review the collectability of receivables based on the payor classification and the period for which the receivables have been outstanding. Past due balances over 90 days from the date of billing and in excess of a specified amount are considered delinquent and are reviewed for collectability. Account balances are written off against the allowance when management feels it is probable the receivable will not be recovered. Historical collection and payor reimbursement experience is an integral part of the estimation process related to reserves for doubtful accounts. In addition, NYU Langone Health assesses the current state of its billing functions in order to identify any known collection or reimbursement issues and assess the impact, if any, on reserve estimates. NYU Langone Health believes that the collectability of its receivables is directly linked to the quality of its billing processes, most notably those related to obtaining the correct information in order to bill effectively for the services it provides. Revisions in reserve for doubtful accounts estimates are recorded as an adjustment to bad debt expense. NYU Langone Health’s allowance for uncollectible accounts are $193,502 and $190,681 at August 31, 2018 and 2017, respectively, and have remained consistent as a percentage of accounts receivables net of contractual allowances. NYU Langone Health’s patient accounts receivable, net, is $886,340 and $852,272 at August 31, 2018 and 2017, respectively.

NYU Langone Health has established estimates, based on information presently available, of amounts due to or from Medicare and non-Medicare payors for adjustments to current and prior years’ payment rates, based on industry-wide and NYU Langone Health-specific data. The amounts due to third party payors at August 31, 2018 and 2017 are $96,693 and $76,661, respectively, and are included in accounts payable and accrued expenses on the consolidated balance sheets. Additionally, certain payors’ payment rates for various years have been appealed by NYU Langone Health. If the appeals are successful, additional income applicable to those years may be realized.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

NYU Langone Hospitals’ cost reports have been audited by the Medicare fiscal intermediary through December 31, 2014; however, final settlements are pending for 2003 and 2004. NYU Langone Hospital-Brooklyn cost reports have been audited by the Medicare fiscal intermediary through December 31, 2015; however, final settlements are pending for the years 2008 to 2015. Winthrop’s cost reports have been audited by the Medicare fiscal intermediary through December 31, 2015.

NYU Langone Health grants credit without collateral to its patients, most of whom are local residents and are insured under third-party payor arrangements. The mix of net patient service revenue for the years ended August 31, 2018 and 2017 are as follows:

2018 2017 Health System NYUSoM Health System NYUSoM

Medicare 18 % 16 % 17 % 17 % Medicaid 2 1 2 1 Medicare and Medicaid managed care 17 16 17 13 Blue Cross 24 16 24 17 Managed care and other 39 51 40 52 100 % 100 % 100 % 100 %

The mix of net patient receivables from patients and third party payors at August 31, 2018 and 2017 are as follows:

2018 2017 Health System NYUSoM Health System NYUSoM

Medicare 11 % 11 % 11 % 11 % Medicaid 2 1 2 1 Medicare and Medicaid managed care 20 18 23 17 Blue Cross 19 14 19 15 Managed care and other 48 56 45 56 100 % 100 % 100 % 100 %

The Health System provides significant amounts of partially or totally uncompensated patient care. For accounting purposes, such uncompensated care is treated either as charity care or bad debt expense.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The Health System’s charity care policy, in accordance with the New York State Department of Health’s guidelines, ensures the provision of quality health care to the community served while carefully considering the ability of the patient to pay. The policy has sliding fee schedules for inpatient, ambulatory and emergency services provided to the uninsured and under-insured patients that qualify. Patients are eligible for the charity care fee schedule if they meet certain income and liquid asset tests. Since payment of the difference between NYU Langone Hospitals’ standard charges and the charity care fee schedules is not sought, these forgone charges for charity care are not reported as revenue. Total forgone charges for charity care totaled $94,726 and $55,775 for fiscal year 2018 and 2017, respectively. This equated to an approximate cost of $20,586 and $13,192 for the years ended August 31, 2018 and 2017, respectively which is based on a ratio of cost to charges during the respective years.

New York State regulations provide for the distribution of funds from an indigent care pool, which is intended to partially offset the cost of bad debts and services provided to the uninsured. The funds are distributed based on each hospital’s level of bad debt and charity care in relation to all other hospitals. Subsidy payments recognized as revenue amounted to approximately $59,315 and $51,307 for 2018 and 2017, respectively, and are included in net patient service revenue in the accompanying consolidated statement of activities.

Patients who do not qualify for sliding scale fees and all uninsured inpatients who do not qualify for Medicaid assistance are billed at the Health System’s rates. Uncollected balances for these patients are categorized as bad debts. Similarly, at NYUSoM, those balances which are deemed uncollectible based on an inability or unwillingness to pay are written off. Uncollected balances for these patients are categorized as bad debts and totaled $98,266 and $85,461 for the years ended August 31, 2018 and 2017, respectively.

4. Investments

Fair Value Measurements Authoritative guidance of fair value measurements, ASC Topic 820, Fair Value Measurements and Disclosures, Fair Value Measurements, establishes a hierarchy of valuation methodologies based on the extent to which asset valuations are observable in the marketplace.

The following describes the hierarchy of methodologies used to measure fair value of investments:

Fair value for Level 1 is based on unadjusted quoted prices in actively traded markets that NYU has the ability to access for identical assets and liabilities. Market price data is generally obtained from exchange or dealer markets.

Fair value for Level 2 is based on quoted prices for instruments similar to those held by NYU in actively traded markets, quoted prices for identical instruments held by NYU in markets that are not actively traded and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data. Inputs are obtained from various sources including market participants, dealers and brokers.

Fair value for Level 3 is based on valuation techniques used to assess prices that are unobservable as the assets trade infrequently or not at all.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Investments for which fair value is measured at net asset value (NAV) per share as a practical expedient consist primarily of NYU’s ownership in alternative investments (principally limited partnership interests in public equity, hedge funds, credit, real assets, private equity, real estate, and other similar funds). The NAV of the securities held by limited partnerships that do not have readily determinable fair values are determined by the general partner and are based on appraisals or other estimates that require varying degrees of judgment. If no public market exists for the investment securities, the fair value is determined by the general partner taking into consideration, among other things, the cost of the securities, prices of recent significant placements of securities of the same issuer and subsequent developments concerning the companies to which the securities relate. NYU has performed due diligence on these investments and believes the reported NAV as a practical expedient is an appropriate measure of fair value as of August 31, 2018 and 2017. ASU 2015-07 removed the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the NAV per share as a practical expedient. As such, alternative investments measured using a NAV that is not publicly available are excluded from the fair value hierarchy disclosures and reported separately in the fair value hierarchy tables.

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while NYU believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

Asset Classes NYU invests across a broad range of asset classes, including public equity, fixed income, hedge funds, credit, real assets, private equity, real estate, and cash and other. NYU may invest directly in the securities of these asset classes, or indirectly through interests in funds and limited partnerships. Securities held directly by NYU are valued at their observable market prices. The value of holdings in funds and limited partnerships are in accordance with the valuations provided by their investment managers. Funds and limited partnerships may make investments in securities that are publicly traded, which are generally valued based on observable market prices. Managers of investment funds and limited partnerships value those investments based upon the best information available for a given circumstance and may incorporate assumptions that are the investment manager’s best estimates after consideration of a variety of internal and external factors.

Investments held by NYU’s investment pool are categorized as follows:

Public Equity Public equity consists of publicly-traded equity, mutual funds, and other commingled funds (which may include passive index exposure).

Fixed Income Fixed income includes investments in securities such as U.S. government securities, non-U.S. sovereign bonds, and corporate and asset-backed securities.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Hedge Funds Hedge funds include investments with managers who invest across different strategies such as long and short equity, multi-strategy, event driven and relative value funds. These managers typically employ some leverage.

Credit Credit includes public and private investments in strategies including distressed debt and special situations.

Real Assets Real assets includes public and private investments in real assets.

Private Equity Private equity investments include limited partnership investments in funds pursuing strategies in corporate buyouts, growth equity, and venture capital.

Real Estate Real estate includes public and private investments in real estate.

Cash and Other Cash and other predominantly includes cash and cash equivalents.

NYU invests in various retirement plan assets as part of the deferred compensation plans. In addition to the asset categories described above, investments held by the deferred compensation plans (Note 7) are categorized as follows:

Variable Annuity Variable annuity contracts invest in a variety of public equity securities to generate varying rates of return based on the underlying public equities.

Fixed Income Annuity Fixed income annuities are used to purchase a guaranteed amount of future retirement benefits.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The following tables summarize the fair value of financial instruments at August 31, 2018 and 2017:

2018 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Long-term investments-investment pool Public equity$ 940,925 $ - $ - $ 940,925 Fixed income - 355,149 - 355,149 Real assets 17,083 - - 17,083 Cash and other 261,153 - - 261,153 1,219,161 355,149 - 1,574,310 Alternative investments measured at NAV as a practical expedient 2,675,188 Subtotal investment pool 4,249,498 Other long-term investments Public equity 197,058 2,960 - 200,018 Fixed income 407,431 10,191 - 417,622 Cash and other 11,399 - 2,805 14,204 Subtotal other long-term investments 615,888 13,151 2,805 631,844 Total long-term investments 1,835,049 368,300 2,805 4,881,342 Short-term investments Cash and other 1,870 - - 1,870 Total short-term investments 1,870 - - 1,870 Other financial instruments Split-interest agreements and interest in perpetual trust (Note 7) - - 37,299 37,299 Deposits with trustees (Note 2) Fixed income 71,181 402,987 - 474,168 Total deposits with trustees 71,181 402,987 - 474,168 Deferred compensation plan held for others (Note 7) Variable annuities 85,975 37,239 - 123,214 Pooled separate account - 2,764 - 2,764 Fixed income annuity 14,746 4,626 22,420 41,792 Public equity 103,831 7,132 - 110,963 Total deferred compensation plan held for others 204,552 51,761 22,420 278,733 Assets held for professional liabilities (Note 10) Cash and other 25,889 - - 25,889 Public equity 43,559 - - 43,559 Fixed income 10,187 446,199 - 456,386 Total assets held for professional liabilities 79,635 446,199 - 525,834 $ 2,192,287 $ 1,269,247 $ 62,524 $ 6,199,246

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Long-term investments-investment pool Public equity$ 865,299 $ - $ - $ 865,299 Fixed income - 183,147 - 183,147 Real assets 16,535 - - 16,535 Cash and other 406,230 - 43,980 450,210 1,288,064 183,147 43,980 1,515,191 Alternative investments measured at NAV as a practical expedient 2,585,944 Subtotal investment pool 4,101,135 Other long-term investments Public equity 256,233 2,794 - 259,027 Fixed income 434,014 10,200 - 444,214 Cash and other 68,007 29 3,275 71,311 Subtotal other long-term investments 758,254 13,023 3,275 774,552 Total long-term investments 2,046,318 196,170 47,255 4,875,687 Short-term investments Cash and other 1,989 - - 1,989 Total short-term investments 1,989 - - 1,989 Other financial instruments Split-interest agreements and interest in perpetual trust (Note 7) - - 35,508 35,508 Deposits with trustees (Note 2) Fixed income 65,446 223,642 - 289,088 Total deposits with trustees 65,446 223,642 - 289,088 Deferred compensation plan held for others (Note 7) Variable annuities 67,053 30,585 - 97,638 Pooled separate account - 2,417 - 2,417 Fixed income annuity 12,731 3,971 19,057 35,759 Public equity 86,093 6,270 - 92,363 Total deferred compensation plan held for others 165,877 43,243 19,057 228,177 Assets held for professional liabilities (Note 10) Cash and other 18,150 - - 18,150 Public equity 40,066 - - 40,066 Fixed income 9,039 436,073 - 445,112 Total assets held for professional liabilities 67,255 436,073 - 503,328 $ 2,346,885 $ 899,128 $ 101,820 $ 5,933,777

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The following tables represent NYU’s investments measured at NAV as a practical expedient by asset class and the respective liquidity terms as of August 31, 2018 and 2017:

2018 Asset category Redemption Frequency Redemption Redeemable alternative investments (if currently eligible) Notice Period Fair Value

Public equity Daily, Weekly, Monthly, Quarterly Daily to 90 days$ 1,305,436 Hedge funds Quarterly, Semi-Annual, Annual, Bi-Annual 45-90 days 697,303 Credit Quarterly 60 days 12,970 $ 2,015,709 Remaining Time to draw Unfunded Nonredeemable alternative investments Life Commitment Commitments Fair Value

Private equity Up to 9 years 7-14 days$ 152,419 $ 263,307 Credit Up to 8 years 7-14 days 47,819 154,187 Real assets Up to 15 years 7-14 days 40,883 72,748 Real estate Up to 13 years 7-14 days 103,363 169,237 $ 344,484 659,479 Alternative investments measured at NAV as a practical expedient $ 2,675,188

2017 Asset category Redemption Frequency Redemption Redeemable alternative investments (if currently eligible) Notice Period Fair Value

Public equity Daily, Weekly, Monthly, Quarterly Daily to 90 days$ 1,338,387 Hedge funds Quarterly, Semi-Annual, Annual, Bi-Annual 45-90 days 676,698 $ 2,015,085 Remaining Time to draw Unfunded Nonredeemable alternative investments Life Commitment Commitments Fair Value

Private equity Up to 9 years 7-14 days$ 148,373 $ 219,924 Credit Up to 9 years 7-14 days 69,034 128,464 Real assets Up to 8 years 7-14 days 22,057 69,763 Real estate Up to 13 years 7-14 days 108,792 152,708 $ 348,256 570,859 Alternative investments measured at NAV as a practical expedient $ 2,585,944

The following table provides the changes for financial instruments classified within Level 3 of the fair value hierarchy as defined above:

2018 Deferred Split-interest and Compensation Perpetual Trust Cash and Other Plan Assets Total

Fair value at August 31, 2017 $ 35,508 $ 47,255 $ 19,057 $ 101,820 Unrealized gains 1,791 - 931 2,722 Sales - (44,450) (700) (45,150) Transfers in - - 3,132 3,132 Fair value at August 31, 2018 $ 37,299 $ 2,805 $ 22,420 $ 62,524

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Deferred Split-interest and Compensation Perpetual Trust Cash and Other Plan Assets Total

Fair value at August 31, 2016 $ 33,875 $ 47,742 $ - $ 81,617 Unrealized gains (losses) 1,633 (487) - 1,146 Transfers in - - 19,057 19,057 Fair value at August 31, 2017 $ 35,508 $ 47,255 $ 19,057 $ 101,820

Total investment return for the years ended August 31, 2018 and 2017 is as follows:

2018 2017

Dividends and interest$ 84,775 $ 73,977 Realized and unrealized gains, net 301,561 437,612 Investment expenses (8,425) (4,544) Total investment return, net$ 377,911 $ 507,045 Endowment distribution approved for spending $ 169,149 $ 162,214 Return on short-term investments 16,130 10,133 Unrestricted investment return, net of spending 95,869 149,991 Temporarily restricted investment return, net of spending 96,763 184,707 Total investment return, net$ 377,911 $ 507,045

NYU maintains an investment pool for its long-term investments which include its endowment and similar funds. The pool is managed to achieve the maximum long-term return given prudent risk parameters. NYU relies on a total return strategy, the objective of which is to achieve a long-term rate of return consisting of a combination of current income and capital appreciation, recognizing that changes in market conditions and interest rates will result in varying strategies in an attempt to optimize results. Investment return (realized and unrealized net gains or losses, interest and dividends) and the appropriation for the approved endowment distribution for board-designated endowment funds are reported as nonoperating activities in the consolidated statement of activities. Investment return and the appropriation for the approved endowment distribution for true endowment funds are reported as temporarily restricted activities in the consolidated statement of activities.

NYU’s Board of Trustees has authorized a spending policy designed to allow asset growth while providing a predictable flow of return to support operations. Distributions from the endowment to support operations (approximately 4.5% in 2018 and 2017) are calculated using the prior year distribution adjusted for the change in the New York Metro Area Consumer Price Index (CPI). To preserve the endowment’s purchasing power, caps may further limit spending as follows: 1) the distribution of endowment return to support operations may not exceed the prior year’s distribution by more than 10%, unless the increase was the result of new gifts to the endowment, and 2) if the results of using only the average market value of either the final four quarters alone or the final eight quarters alone would be a decline in the distribution from the prior year’s distribution, then the distribution may not exceed the previous year’s level.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

5. Accounts and Loans Receivable, net

Accounts and loans receivable, net of allowances for uncollectable amounts consist of the following at August 31, 2018 and 2017:

2018 2017

Students and other$ 159,078 $ 147,571 Grants and contracts 114,856 93,302 Student loans 110,182 113,074 FEMA award receivable 101,592 167,984 Housing loans and other loans to employees 65,567 64,202 Insurance premiums and recoveries (Note 10) 218,286 214,087 769,561 800,220 Allowance for uncollectible amounts (46,564) (42,814) Accounts and loans receivable, net$ 722,997 $ 757,406

A reasonable estimate of the fair value of loans receivable from students under government loan programs could not be made because the notes cannot be sold and can only be assigned to the U.S. government or its designees. The fair value of loans receivable from students under NYU’s loan programs approximates carrying value.

Student loans consist primarily of Federal advances to the University under Perkins and other Federal loan programs which totaled $67,857 and $77,940 at August 31, 2018 and 2017, respectively. NYU records a liability on its consolidated balance sheet for these advances within funds held for others.

Housing loans and other loans to employees are secured by an interest in the underlying property or continued employment.

Management regularly assesses the adequacy of the allowance for credit losses by performing ongoing evaluation of the accounts and loans receivable portfolios.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

6. Contributions Receivable

Contributions receivable consist of the following at August 31, 2018 and 2017:

2018 2017

Amounts expected to be collected in Less than one year$ 269,603 $ 205,967 One to five years 222,414 281,638 More than five years 66,509 71,834 558,526 559,439 Discount (31,313) (36,397) Allowance for uncollectible amounts (68,863) (63,895) Contributions receivable, net$ 458,350 $ 459,147

Contributions receivable activity for the years ended August 31, 2018 and 2017 is as follows:

2018 2017

Contributions receivable, gross, beginning of year$ 559,439 $ 639,639 New pledges received 168,777 175,448 Adjustments and write-offs (8,870) (21,989) Pledge payments received (160,820) (233,659) Contributions receivable, gross, end of year 558,526 559,439 Discount and allowance for uncollectible amounts (100,176) (100,292) Contributions receivable, net, end of year$ 458,350 $ 459,147

Conditional promises to give, bequests, and intentions to give not included in the consolidated financial statements, are $952,420 and $847,131 at August 31, 2018 and 2017, respectively.

Expenses related to fundraising activities are $48,699 and $49,220 for the years ended August 31, 2018 and 2017, respectively.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

7. Other Assets

Other assets consist of the following at August 31, 2018 and 2017:

2018 2017

Deferred compensation plan assets held for others$ 278,733 $ 228,177 Prepaid expenses and deferred charges 161,290 167,100 Inventory 100,305 78,512 Intangible assets and goodwill 87,897 40,686 Assets held for sale 73,461 - Third-party payor receivables 72,775 61,202 Split-interest agreements 37,299 35,508 Assets limited as to use - FEMA award 14,904 90,263 Tenant improvement allowance 7,553 66,934 Other 115,561 98,906 Other assets$ 949,778 $ 867,288

Deferred compensation plan assets held for others represents employee contributions and investment income for NYU’s 457(b) plans. A corresponding obligation is recorded within funds held for others on the consolidated balance sheets.

Assets held for sale represent certain assets of the Health System that meet the requirements to be classified as held for sale and are presented at the lower of cost of fair value, less cost to sell. The assets include the land and buildings of Shore Hill Housing, Sunset Gardens Housing and Harbor Hill Housing. The determination of fair value involves judgement and assumptions including the nature of the potential sales transaction, composition of assets and negotiations with third party purchasers. The carrying amounts of the assets held for sale were reviewed to determine whether the carrying amounts are fully recoverable in comparison to estimated fair values and an impairment of $22,670 was recorded within depreciation and amortization in the consolidated statement of activities for the year ended August 31, 2018.

8. Land, Buildings, and Equipment

Land, buildings, and equipment consist of the following at August 31, 2018 and 2017:

2018 2017

Land$ 363,955 $ 431,078 Buildings and building improvements 11,957,137 9,802,512 Equipment 2,176,047 1,868,040 Capital leases 562,360 474,811 Construction in progress 1,149,131 2,266,669 16,208,630 14,843,110 Less: Accumulated depreciation (5,277,450) (4,880,579) Land, buildings, and equipment, net$ 10,931,180 $ 9,962,531

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Depreciation expense is $685,905 and $581,335 for the years ended August 31, 2018 and 2017, respectively.

9. Debt and Other Obligations

NYU has various bond issues outstanding, primarily issued through The Dormitory Authority of the State of New York (DASNY). The University and NYUSoM are considered the legally obligated group for certain borrowings presented below as the “Total Obligated Group”.

Debt and other obligations consists of the following at August 31, 2018 and 2017:

2018 Total Obligated Health Consolidated University NYUSoM Group System NYU

Issuer Dormitory Authority of the State of New York (DASNY)$ 3,059,068 $ 705,053 $ 3,764,121 $ 366,830 $ 4,130,951 New York University 287,285 72,895 360,180 - 360,180 NYU Langone Hospitals - - - 1,490,662 1,490,662 Nassau County Local Economic Assistance Corporation - - - 156,365 156,365 Other obligations 51,058 432,852 483,910 501,840 985,750 Debt and other obligations$ 3,397,411 $ 1,210,800 $ 4,608,211 $ 2,515,697 $ 7,123,908

2017 Total Obligated Health Consolidated University NYUSoM Group System NYU

Issuer Dormitory Authority of the State of New York (DASNY)$ 2,666,619 $ 522,869 $ 3,189,488 $ 387,264 $ 3,576,752 New York University 296,581 76,359 372,940 - 372,940 NYU Langone Hospitals - - - 1,490,325 1,490,325 Nassau County Local Economic Assistance Corporation - - - 160,925 160,925 Other obligations 101,477 384,748 486,225 221,653 707,878 Debt and other obligations$ 3,064,677 $ 983,976 $ 4,048,653 $ 2,260,167 $ 6,308,820

In May 2018, DASNY issued $348,880 of revenue bonds (Series 2018A) on behalf of the Obligated Group with interest rates ranging from 3.25% to 5.00%. The Series 2018A bonds mature serially from July 2019 through July 2042. The Series 2018A bonds maturing in July 2048 are payable in annual sinking fund installments from July 2043 to maturity.

In May 2018, DASNY issued $243,705 of taxable bonds (Series 2018B) on behalf of the Obligated Group, with interest rates ranging from 2.27% to 4.85%. The Series 2018B bonds mature serially from July 2019 through July 2035. The Series 2018B bonds maturing in July 2040 are payable in annual sinking fund installments from July 2036 to maturity. The Series 2018B bonds maturing in July 2048 are payable in annual sinking fund installments from July 2041 to maturity.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The proceeds from the DASNY Series 2018A and Series 2018B were used to fund improvements on the Manhattan and Brooklyn campuses and repay certain lines of credit.

In June 2017, DASNY issued $450,170 of revenue bonds (Series 2017A) on behalf of the Obligated Group with interest rates ranging from 3.00% to 5.00%. The Series 2017A bonds mature serially from July 2019 through July 2040, as well as July 2043. The Series 2017A bonds maturing in July 2043 are payable in annual sinking fund installments from July 2041 to maturity.

In June 2017, DASNY issued $227,836 of taxable bonds (Series 2017B), with interest rates ranging from 1.60% to 4.15%. The Series 2017B bonds mature serially from July 2019 through July 2032, as well as in July 2034, July 2039, and July 2047. The Series 2017B bonds maturing in July 2034 are payable in annual sinking fund installments from July 2033 to maturity. The Series 2017B bonds maturing in July 2039 are payable in annual sinking fund installments from July 2035 to maturity. The Series 2017B bonds maturing in July 2047 are payable in annual sinking fund installments from July 2043 to maturity.

The proceeds from the DASNY Series 2017A and Series 2017B were used, in part, to advance refund portions of the DASNY Series 2009A and Series 2009B bonds as well as the NYCIDA 2007 Polytechnic University Project bonds. The remainder of the proceeds were used to fund improvements on the Manhattan and Brooklyn campuses and repay certain lines of credit. In connection with the transaction, the Obligated Group recorded a loss on bond defeasance of $32,186.

In May 2017, NYU Langone Hospitals issued Series 2017A Taxable Bonds totaling $600,000. The Series 2017A Taxable Bonds require annual interest payments through August 2047 at rates varying from 4.17% to 4.37%. The proceeds of the Series 2017A bonds were used to repay a bank loan and certain outstanding lines of credit, pay the costs of various construction, renovation and equipment projects, and for working capital and other eligible corporate purposes.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The principal amounts outstanding for debt and other obligations consist of the following at August 31, 2018 and 2017:

2018 Total Obligated Health Consolidated University NYUSoM Group System NYU

DASNY Series 1998A bonds, with interest rates ranging from 5.75% to 6.00%, maturing serially through July 2020, payable thereafter in annual sinking fund installments to maturity in 2027 (including premium of $3,174)$ 129,104 $ - $ 129,104 $ - $ 129,104 2001 Series 1 bonds, with an interest rate of 5.50%, maturing serially from July 2011, through July 2025, payable thereafter in annual sinking fund installments to maturities in July 2031 and July 2040 (including premiums of $2,136 and $2,327) 59,265 49,069 108,334 - 108,334 Series 2009A bonds, with interest rates ranging from 4.00% to 5.00%, maturing serially through July 2019 (including net premiums of $142 and $16) 9,443 887 10,330 - 10,330 Series 2011A bonds, with interest rates ranging from 2.00% to 6.00%, maturing serially through July 2020, payable thereafter in annual sinking fund installments - - - 8,240 8,240 Series 2012A bonds, with interest rates ranging from 3.00% to 5.00%, maturing serially through July 2032, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2042 (including net premiums of $11,811 and $4,233) 144,326 44,113 188,439 - 188,439 Series 2012B bonds, with interest rates ranging from 4.00% to 5.00%, maturing serially through July 2032, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2042 (including premium of $3,900) 58,936 - 58,936 - 58,936

Series 2012C taxable bonds, with interest rates ranging from 1.93% to 3.62%, maturing serially through July 2027 19,715 - 19,715 - 19,715 Series 2013A bonds, with interest rates ranging from 2.00% to 5.00%, maturing serially through July 2033, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2043 (including net premiums of $6,900) 123,150 - 123,150 - 123,150 Series 2013B taxable bonds, with interest rates ranging from 2.33% to 5.25%, maturing serially through July 2028, payable thereafter in annual sinking fund installments to maturities in July 2033 and July 2043 26,680 - 26,680 - 26,680

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2018 Total Obligated Health Consolidated University NYUSoM Group System NYU

Series 2014 bonds, with interest rate ranging from 2.00% to 5.00%, maturing serially through July 2032 and July 2036 (including premium of $7,958) - - - 80,233 80,233 Series 2014 S2 bonds, with interest rate ranging from 3.75% to 4.95%, maturing serially through July 2034 and July 2035 (including premium of $15,236) - - - 118,241 118,241 Series 2014A taxable bonds, with an interest rate of 2.59% maturing in July 2034, payable in annual sinking fund installments through July 2034 53,350 - 53,350 - 53,350 Series 2015 bonds, with interest rates ranging from 2.00% to 5.50%, maturing serially through July 2035, payable in annual sinking fund installments from July 2036 to July 2048 (including premium of $77,046) 758,581 - 758,581 - 758,581 Series 2016A bonds, with interest rates ranging from 2.00% to 5.00%, maturing serially through July 2036 payable thereafter in annual sinking fund installments until July 2043 (including premiums of $71,777 and $22,067) 518,432 158,287 676,719 - 676,719 Series 2016B taxable bonds, with interest rates ranging from 1.20% to 5.00%, maturing serially through July 2022 payable thereafter in annual sinking fund installments until July 2046 192,420 37,255 229,675 - 229,675 Series 2016A bonds, with interest rates ranging from 3.53% to 4.77%, maturing serially to maturity in July 2040 and payable thereafter in annual sinking fund installments until July 2043 (including premium of $21,513) - - - 164,083 164,083 Series 2017A bonds, with interest rates ranging from 3.25% to 5.00%, maturing serially to maturity in July 2040 and payable thereafter in annual sinking fund installments until July 2047 (including premium of $44,704 and $21,306) 340,698 175,482 516,180 - 516,180 Series 2017B taxable bonds, with interest rates ranging from 1.60% to 4.15%, maturing serially to maturity in July 2032 177,430 50,406 227,836 - 227,836 Series 2018A bonds, with interest rates ranging from 3.25% to 5.00%, maturing serially through July 2048 payable thereafter in annual sinking fund installments (including premiums of $38,921 and $9,766) 313,336 84,231 397,567 - 397,567 Series 2018B taxable bonds, with interest rates ranging from 2.27% to 4.85%, maturing serially through July 2048 payable thereafter in annual sinking fund installments (including premiums of $7,114 and $2,919) 147,254 106,484 253,738 - 253,738 Deferred financing costs (13,052) (1,161) (14,213) (3,967) (18,180) Subtotal of DASNY bonds 3,059,068 705,053 3,764,121 366,830 4,130,951

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2018 Total Obligated Health Consolidated University NYUSoM Group System NYU NYU Series 2009 taxable bonds, with an interest rate of 5.24%, maturing in July 2032, payable in annual sinking fund installments from July 2018 through July 2032 14,075 73,430 87,505 - 87,505 Series 2010 taxable bonds, with an interest rate of 4.96%, maturing in July 2032, payable in annual sinking fund installments from July 2018 through July 2032 21,495 - 21,495 - 21,495 Series 2015 taxable bonds, with interest rates ranging from 1.32% to 4.14%, maturing serially through July 2028, payable in annual sinking fund installments from July 2029 to July 2048 252,800 - 252,800 - 252,800 Deferred financing costs (1,085) (535) (1,620) - (1,620) Subtotal of NYU bonds 287,285 72,895 360,180 - 360,180 NYU Langone Hospitals Series 2012 taxable bonds, with an interest rate of 4.40%, maturing in July 2042 (including discount of $828) - - - 249,172 249,172 Series 2013 taxable bonds, with an interest rate of 5.75%, maturing in July 2043 (including discount of $1,195) - - - 348,805 348,805 Series 2014 taxable bonds, with an interest rate of 4.78%, maturing in July 2044 (including discount of $1,088) - - - 298,912 298,912 Series 2017A taxable bonds, with an interest rate ranging from 4.17% to 4.37%, maturing in August 2047 - - - 600,000 600,000 Deferred financing costs - - - (6,227) (6,227) Subtotal of NYU Langone Hospitals bonds - - - 1,490,662 1,490,662 Nassau County Local Economic Assistance Corporation Series 2012 taxable bonds with varying interest rates of 3.00% to 5.00%, maturing in July 2042 (including premium of $7,803) - - - 122,033 122,033 Series 2014 taxable bonds, with an interest rate of 2.99%, maturing in July 2036 - - - 34,332 34,332 Subtotal of Nassau County Local Economic Assistance Corporation bonds - - - 156,365 156,365 Other obligations Various at fixed and variable interest rates - - - 19,113 19,113 Mortgage loans - 42,000 42,000 41,837 83,837 Lines of credit 45,000 138,700 183,700 311,519 495,219 Capital leases 6,058 252,152 258,210 129,371 387,581 Subtotal of other obligations 51,058 432,852 483,910 501,840 985,750 Total amounts outstanding$ 3,397,411 $ 1,210,800 $ 4,608,211 $ 2,515,697 $ 7,123,908

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Total Obligated Health Consolidated University NYUSoM Group System NYU

DASNY Series 1998A bonds, with interest rates ranging from 5.75% to 6.00%, maturing serially through July 2020, payable thereafter in annual sinking fund installments to maturity in 2027 (including premium of $3,814)$ 140,159 $ - $ 140,159 $ - $ 140,159 2001 Series 1 bonds, with an interest rate of 5.50%, maturing serially through July 2025, payable thereafter in annual sinking fund installments to maturities in July 2031 and July 2040 (including premiums of $2,297 and $2,433) 60,751 50,260 111,011 - 111,011 Series 2008A bonds, with an interest rate of 4.00% maturing serially through the call date in July 2018 (including premium of $20) 3,795 - 3,795 - 3,795 Series 2008B bonds, with an interest rate of 4.00% maturing serially through the call date in July 2018 (including premium of $17) 3,097 - 3,097 - 3,097 Series 2008C bonds, with an interest rate of 4.00% maturing serially through the call date in July 2018 (including premium of $7) 2,412 - 2,412 - 2,412 Series 2009A bonds, with an interest rate of 5.00%, maturing serially through the call date in July 2019 (including net premiums of $442 and discounts of $13) 9,744 890 10,634 - 10,634 Series 2011A bonds, with interest rates ranging from 2.00% to 6.00%, maturing serially through July 2026, payable thereafter in annual sinking fund installments to maturities in July 2031 and July 2040 - - - 12,075 12,075 Series 2012A bonds, with interest rates ranging from 3.00% to 5.00%, maturing serially through July 2032, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2042 (including net premiums of $12,671 and $4,410) 150,323 45,823 196,146 - 196,146 Series 2012B bonds, with interest rates ranging from 4.00% to 5.00%, maturing serially through July 2032, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2042 (including premium of $4,199) 59,234 - 59,234 - 59,234

Series 2012C taxable bonds, with interest rates ranging from 1.93% to 3.62%, maturing serially through July 2027 21,670 - 21,670 - 21,670 Series 2013A bonds, with interest rates ranging from 4.00% to 5.00%, maturing serially through July 2033, payable thereafter in annual sinking fund installments to maturities in July 2037 and July 2043 (including net premiums of $7,380) 125,965 - 125,965 - 125,965 Series 2013B taxable bonds, with interest rates ranging from 2.33% to 5.25%, maturing serially through July 2028, payable thereafter in annual sinking fund installments to maturities in July 2033 and July 2043 27,895 - 27,895 - 27,895

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Total Obligated Health Consolidated University NYUSoM Group System NYU

Series 2014 bonds, with interest rate ranging from 2.00% to 5.00%, maturing serially through July 2032 and July 2036 (including premium of $8,402) - - - 83,442 83,442 Series 2014 S2 bonds, with interest rate ranging from 3.75% to 4.95%, maturing serially through July 2034 and July 2035 (including premium of $16,132) - - - 123,347 123,347 Series 2014A bonds, with an interest rate of 2.59% maturing in July 2034, payable in annual sinking fund installments from July 2018 through July 2034 54,250 - 54,250 - 54,250 Series 2015A bonds, with interest rates ranging from 2.00% to 5.50%, maturing serially through July 2035, payable in annual sinking fund installments from July 2036 to July 2048 (including premium of $81,733) 769,207 - 769,207 - 769,207 Series 2016A bonds, with interest rates ranging from 2.00% to 5.00%, maturing serially through July 2036 payable thereafter in annual sinking fund installments until July 2043 (including premium of $76,037 and $22,861) 522,692 159,080 681,772 - 681,772 Series 2016B taxable bonds, with interest rates ranging from 1.20% to 3.88%, maturing serially through July 2022 payable thereafter in annual sinking fund installments until July 2046 205,535 40,700 246,235 - 246,235 Series 2016A bonds, with interest rates ranging from 3.53% to 4.77%, maturing serially to maturity in July 2040 and payable thereafter in annual sinking fund installments until July 2043 (including premium of $22,502) - - - 172,573 172,573 Series 2017A bonds, with interest rates ranging from 3.00% to 5.00%, maturing serially to maturity in July 2040 and payable thereafter in annual sinking fund installments until July 2047 (including premium of $48,894 and $22,082) 344,889 176,258 521,147 - 521,147 Series 2017B taxable bonds, with interest rates ranging from 1.60% to 4.15%, maturing serially to maturity in July 2032 177,429 50,406 227,835 - 227,835 Deferred financing costs (12,428) (548) (12,976) (4,173) (17,149) Subtotal of DASNY bonds 2,666,619 522,869 3,189,488 387,264 3,576,752

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Total Obligated Health Consolidated University NYUSoM Group System NYU

NYU Series 2009 taxable bonds, with an interest rate of 5.24%, maturing in July 2032, payable in annual sinking fund installments from July 2018 through July 2032 14,747 76,933 91,680 - 91,680 Series 2010 taxable bonds, with an interest rate of 4.96%, maturing in July 2032, payable in annual sinking fund installments from July 2018 through July 2032 22,520 - 22,520 - 22,520 Series 2015 taxable bonds, with interest rates ranging from 1.32% to 4.14%, maturing serially through July 2028, payable in annual sinking fund installments from July 2029 to July 2048 260,490 - 260,490 - 260,490 Deferred financing costs (1,176) (574) (1,750) - (1,750) Subtotal of NYU bonds 296,581 76,359 372,940 - 372,940 NYU Langone Hospitals Series 2012 taxable bonds, with an interest rate of 4.40%, maturing in July 2042 (including discount of $863) - - - 249,137 249,137 Series 2013 taxable bonds, with an interest rate of 5.75%, maturing in July 2043 (including discount of $1,243) - - - 348,758 348,758 Series 2014 taxable bonds, with an interest rate of 4.78%, maturing in July 2044 (including discount of $1,130) - - - 298,870 298,870 Series 2017A taxable bonds, with an interest rate ranging from 4.17% to 4.37%, maturing in August 2047 - - - 600,000 600,000 Deferred financing costs -(6,440)(6,440) Subtotal of NYU Langone Hospitals bonds - - - 1,490,325 1,490,325 Nassau County Local Economic Assistance Corporation Series 2012 taxable bonds with varying interest rates of 3.00% to 5.00%, maturing in July 2042 (including premium of $8,262) - - - 125,177 125,177 Series 2014 taxable bonds, with an interest rate of 2.99%, maturing in July 2036 - - - 35,748 35,748 Subtotal of Nassau County Local Economic Assistance Corporation bonds - - - 160,925 160,925 Other obligations Various at fixed and variable interest rates - - - 21,139 21,139 Mortgage loans - 42,000 42,000 80,429 122,429 Lines of credit 95,335 79,156 174,491 55,000 229,491 Capital leases 6,142 263,592 269,734 65,085 334,819 Subtotal of other obligations 101,477 384,748 486,225 221,653 707,878 Total amounts outstanding$ 3,064,677 $ 983,976 $ 4,048,653 $ 2,260,167 $ 6,308,820

Interest expense on debt and other obligations totaled $248,197 and $222,055 for the years ended August 31, 2018 and 2017, respectively. This excludes $28,776 and $21,083 of interest capitalized (net of income earned on deposits with bond trustees) for the years ended August 31, 2018 and 2017, respectively, which is included in land, buildings, and equipment, net.

NYU enters into various debt and other loan agreements that are secured by specific revenue streams, collateral and other real property or improvements, in addition to issuing debt supported by a general obligation of the University, any of which may constrain the use of certain assets.

Other agreements include covenants requiring that NYU Langone Hospitals and Winthrop maintain certain financial ratios. At August 31, 2018 and 2017, NYU is compliant with all financial and administrative covenants.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Obligations with Financial Institutions At August 31, 2018, the Obligated Group has four contractually committed bank credit agreements which total $800,000 and expire from December 2018 to June 2020. The interest is accrued at rates based on LIBOR. The amounts outstanding under these agreements are $183,700 and $174,491 as of August 31, 2018 and 2017, respectively.

At August 31, 2018, The Health System has four unsecured lines of credit which total $425,000 and expire from November 2018 to May 2021. The interest is accrued at rates based on LIBOR. The amounts outstanding under these agreements are $311,519 and $55,000 as of August 31, 2018 and 2017, respectively.

Future Principal Payments The aggregate required principal payments on all debt and other obligations, including capital leases, for each of the next five fiscal years, and thereafter to maturity, are as follows:

Debt and Other Year Ending August 31, Obligations Capital Leases Total

2019$ 328,964 $ 69,113 $ 398,077 2020 192,722 59,916 252,638 2021 361,205 51,496 412,701 2022 142,785 44,125 186,910 2023 145,471 33,290 178,761 Thereafter 5,211,621 328,208 5,539,829 6,382,768 586,148 6,968,916 Unamortized premiums and discounts, net 379,586 - 379,586 Unamortized deferred financing costs (26,027) - (26,027) Less: Imputed interest - (198,567) (198,567) $ 6,736,327 $ 387,581 $ 7,123,908

10. Professional Liabilities

NYU Langone Health’s professional liabilities are reported on a discounted basis and comprise estimates for known reported losses and loss expenses plus a provision for losses incurred but not reported. Losses are actuarially determined and are based on the loss experience of the insured. In management’s opinion, recorded reserves for both self-insured and commercially insured exposures are adequate to cover the ultimate net cost of losses incurred to date; however, the provision is based on estimates and may ultimately be settled for a significantly greater or lesser amount. Professional liabilities recorded on the consolidated balance sheets as of August 31 are as follows:

2018 2017

CCC550 professional liabilities$ 453,472 $ 417,576 Winthrop self-insured liabilities 70,201 87,365 Commercially insured liabilities 117,049 124,869 Professional liabilities$ 640,722 $ 629,810

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

NYU Langone Hospitals is self-insured for professional and general liabilities on an occurrence basis through CC550. Beginning July 1, 2017, Winthrop and certain of its physicians are also self- insured through CCC550. Prior to July 1, 2017, Winthrop was self-insured for professional liabilities and designated funds in a revocable trust for satisfaction of claims and expenses.

CCC550 provides insurance coverage to certain voluntary attending physicians (VAPs) serving NYUSoM and NYU Langone Hospitals. The cost of this insurance coverage is the responsibility of such physicians.

At August 31, 2018 and 2017, assets held for professional liabilities of $525,834 and $503,328, respectively, on the consolidated balance sheet includes funds held by CCC550 of $467,206 and $448,815, respectively, and funds held in Winthrop’s self-insurance trust of $58,628 and $54,513, respectively.

Commercial insurance policies are purchased by Winthrop for certain physicians on both a claims made and occurrence basis. NYU Langone Health recorded a corresponding insurance recovery receivable for claims covered by these policies within accounts and loans receivable, net on the consolidated balance sheet (Note 5).

11. Pension Plans and Other Postretirement Benefits

Pension Plans Substantially all NYU employees are covered by retirement plans including various defined contribution plans, multi-employer defined benefit plans, and five NYU-sponsored benefit plans.

Defined contribution plans Contributions to the defined contribution plans are based on rates required by union contracts or other contractual arrangements. Contributions of $210,328 and $185,097 in 2018 and 2017, respectively, are reported as expenses in the consolidated statements of activities. There is no obligation on the consolidated balance sheets for these plans.

Multi-employer defined benefit plans Contributions to the multi-employer defined benefit plans are based on rates required by union contracts and other contractual arrangements. Contributions of $204,646 and $182,675 in 2018 and 2017, respectively, are reported as expenses in the consolidated statements of activities. There is no obligation on the consolidated balance sheets for these plans.

Defined benefit plans Contributions to the five defined benefit plans are intended to provide benefits attributed to service to date, as well as for those expected to be earned in the future. Contributions are made in amounts sufficient to meet the minimum funding requirements set forth in the Employee Retirement Income Security Act of 1974 as amended under the Pension Protection Act of 2006 (ERISA), plus such additional amounts as the sponsors may deem appropriate. Pension benefits under these defined benefit plans are based on participants’ final average compensation levels and years of service and are accrued during the period the employees provide service to NYU. Contributions of $58,003 and $78,901 in 2018 and 2017, respectively, are reported as a reduction in the accrued benefit obligation on the consolidated balance sheets for these plans.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Postretirement Benefits NYU has five health and welfare plans that provide certain health care and life insurance benefits for eligible retired employees. NYU employees may become eligible for these benefits if they reach the age and service requirements of the plan while working for NYU. The costs related to these plans are accrued during the period the employees provide service to NYU. Contributions of $24,624 and $19,075 in 2018 and 2017, respectively, are reported as a reduction in the accrued postretirement obligation on the consolidated balance sheets for these plans.

The following tables provide information with respect to the defined benefit and other postretirement benefit plans for the years ended August 31:

Plans’ Funded Status Defined benefit pension plans Postretirement benefit plans 2018 2017 2018 2017 Change in benefit obligation Benefit obligation, beginning of year$ 2,214,679 $ 1,511,162 $ 695,568 $ 740,308 Acquisition of Winthrop retirement plan - 751,673 - - Service cost 50,447 40,052 18,979 20,063 Interest cost 77,972 60,433 25,124 24,413 Actuarial gain (53,585) (89,728) (33,286) (75,047) Benefits paid (73,445) (58,348) (24,423) (20,474) Benefits paid from Plan related to Lump Sum Window (15,182) - - - Participant contributions - - 5,225 4,727 Retiree drug subsidy receipts - - 1,419 1,576 Administrative expenses (850) (565) - - Benefit obligation, end of year 2,200,036 2,214,679 688,606 695,566 Change in fair value of plan assets Fair value of plan assets, beginning of year 1,647,121 949,959 126,118 109,309 Acquisition of Winthrop retirement plan - 537,026 - - Actual return on plan assets 116,720 140,148 13,694 11,905 Employer contributions 58,003 78,901 24,624 19,075 Employer contributions to Plan related to Lump Sum Window 15,182 --- Benefits paid (73,445) (58,348) (24,423) (20,474) Benefits paid from Plan related to Lump Sum Window (15,182) - - - Participant contributions - - 5,225 4,727 Retiree drug subsidy receipts - - 1,419 1,576 Administrative expenses (850) (565) - - Fair value of plan assets, end of year 1,747,549 1,647,121 146,657 126,118 Accrued benefit obligation$ 452,487 $ 567,558 $ 541,949 $ 569,448

Benefit obligation range of assumptions as of August 31 Discount rate 3.96% - 4.34% 3.85% - 4.15% 4.15% - 4.30% 3.85% - 4.03% Rate of increase in compensation levels 2.92% - 4.00% 3.00% - 4.00% - -

In 2018, the University offered terminated vested participants in its defined benefit pension plan the opportunity to have their pension benefit distributed as a lump sum. The University contributed an additional $15,182 to the plan to fund the lump sum payments.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Net Periodic Benefit Cost

Defined benefit pension plans Postretirement benefit plans 2018 2017 2018 2017

Components of net periodic benefit cost Operating expense - Service cost$ 50,447 $ 40,052 $ 18,979 $ 20,063 Nonoperating expense: Interest cost 77,972 60,433 25,124 24,413 Expected return on plan assets (115,222) (83,887) (7,633) (6,659) Amortization of prior service cost (credit) 2 2 (1,322) (5,111) Amortization of actuarial loss 22,322 34,315 4,036 8,134 Total non-service costs (14,926) 10,863 20,205 20,777 Net periodic benefit cost$ 35,521 $ 50,915 $ 39,184 $ 40,840 Other changes recognized in unrestricted net assets Actuarial net gain arising during period$ (55,075) $ (146,530) $ (39,378) $ (80,268) Amortization of prior service (cost) credit (2) (2) 1,322 5,111 Amortization of actuarial loss (22,322) (34,315) (4,036) (8,134) Total recognized in nonoperating activities$ (77,399) $ (180,847) $ (42,092) $ (83,291) Net periodic benefit cost range of assumptions Discount rate 3.37 %-4.15 % 3.07 %-4.31% 3.61 %-4.03 % 3.85 %-4.03% Rate of increase in compensation levels 3.00 %-4.00 % 2.00 %-4.00%-- Expected long-term rate of return on plan assets 6.00%-7.75 % 6.00 %-7.75% 6.00 %-7.00 % 6.00 %-7.00% Ultimate retiree health-care cost trend - - 4.50% 4.50% Year ultimate trend rate is achieved - - 2024-2038 2023-2038

The accumulated benefit obligation for the defined benefit pension plans is $2,065,215 and $2,059,069 at August 31, 2018 and 2017, respectively.

Amounts not yet reflected in net periodic benefit cost and included in unrestricted assets for the defined benefit pension plans totaled $234,380 and $311,239 for the years ended August 31, 2018 and 2017, respectively. Amounts not yet reflected in net periodic benefit cost and included in unrestricted assets for the postretirement benefit plans totaled $78,874 and $120,935 for the years ended August 31, 2018 and 2017, respectively.

Amounts in unrestricted net assets expected to be recognized in net periodic benefit cost in the next fiscal year for the defined benefit pension plans totaled $14,234 and $22,325 for the years ended August 31, 2018 and 2017, respectively. Amounts in unrestricted net assets expected to be recognized in net periodic benefit cost in the next fiscal year for the postretirement benefits plans totaled $525 and $3,413 for the years ended August 31, 2018 and 2017, respectively.

In 2018 and 2017, the effect of a 1% change in the health care cost trend rate is as follows:

2018 2017 1% Increase 1% Decrease 1% Increase 1% Decrease

Effect on net periodic benefit cost$ 5,742 $ (4,556) $ 9,551 $ (7,361) Effect on postretirement benefit obligation 92,078 (75,241) 118,780 (93,477)

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Plan Assets The following table presents the fair value of the defined benefit plan investments (according to the fair value hierarchy defined in Note 4) at August 31:

2018 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Cash equivalents$ 11,934 $ - $ - $ 11,934 Fixed income 335,081 - - 335,081 Public equity 861,441 - - 861,441 Real estate 212,153 478 - 212,631 Private equity 130,810 101,952 - 232,762 $ 1,551,419 $ 102,430 $ - $ 1,653,849 Alternative investments measured at NAV as a practical expedient 93,700 Total $ 1,747,549

2017 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Cash equivalents$ 15,436 $ - $ - $ 15,436 Fixed income 374,446 89,420 - 463,866 Public equity 1,047,503 - - 1,047,503 Real estate - 24,549 - 24,549 Private equity - 10,904 - 10,904 $ 1,437,385 $ 124,873 $ - $ 1,562,258 Alternative investments measured at NAV as a practical expedient 84,863 Total $ 1,647,121

The defined benefit pension assets seek to: (1) provide retirement benefits to its participants and beneficiaries; and (2) achieve full funding of the pension liability, while incurring an acceptable level of risk manageable for the sponsor. The pension liability growth rate together with the objective to achieve and maintain a fully-funded 100% level over a reasonable timeline implies a minimum absolute rate of return to be met through either: (1) annual budgeted contributions, (2) pension assets growth, (3) plan de-risking improvements, or (4) a combination thereof.

The strategy for achieving and maintaining a fully funded pension liability may vary with the prevailing funded level and other parameters related to the overall goal. The asset allocation process is designed to be dynamic and employ a liability-driven, glide path investment strategy, which reframes risk and performance relative to the pension liability. This approach is expected to enable pension assets to more reliably track the value of the pension liability, with less funded level volatility, than a static total-return investment. Target allocations at the funded level are 55-75% Equity and 25-45% Fixed Income. The expected long-term rate of return assumption is determined

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

by adding expected inflation to expected long-term real returns of various asset classes, weighing the asset class returns by the plans’ investment in each class, and taking into account expected volatility and correlation between the returns of various asset classes. NYU management believes 6.0% - 7.75% is a reasonable estimate of long-term rates of return on plan assets for 2018 and will continue to evaluate the actuarial assumptions, and adjust them as necessary.

The following table presents the fair value of the postretirement benefit plan investments (according to the fair value hierarchy defined in Note 4) at August 31:

2018 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Cash equivalents$ 133 $ - $ - $ 133 Fixed income 37,458 21,872 - 59,330 Public equity 87,194 - - 87,194 Total$ 124,785 $ 21,872 $ - $ 146,657

2017 Active Observable Unobservable Markets Inputs Inputs (Level 1) (Level 2) (Level 3) Total

Public equity$ 73,396 $ - $ - $ 73,396 Fixed income 31,341 21,381 - 52,722 Total $ 104,737 $ 21,381 $ - $ 126,118

The plans’ investment objectives seek a long-term total rate of return to meet NYU’s current and future plan obligations.

The Post-Retirement Benefit Plan target asset allocation mix is 70% equity and 30% fixed income and cash, for which each asset class has a permitted range of +/- 10%.

The expected long-term rate of return assumption is determined by adding expected inflation to expected long-term real returns of various asset classes, taking into account expected volatility and correlation between the returns of various asset classes. NYU management believes that 6.0%- 7.0% is a reasonable range of long-term rates of return on plan assets for 2018 and will continue to evaluate the actuarial assumptions, and adjust them as necessary.

Contributions Annual contributions to the plans are determined by NYU based upon calculations prepared by the plans’ actuaries. Total expected contributions for the defined benefit pension plans and other postretirement benefit plans in fiscal year 2019 are $44,209 and $27,023, respectively.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Benefit Payments The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid in the following years:

Defined benefit Postretirement Year Ending August 31, pension plans benefit plans

2019 $ 82,034 $ 24,175 2020 86,570 26,087 2021 92,474 27,880 2022 97,588 29,898 2023 103,282 32,007 2024-2028 598,350 191,470

Multi-Employer Benefit Plans NYU participates in multi-employer defined benefit pension plans. NYU makes cash contributions to these plans under the terms of collective-bargaining agreements that cover its union employees based on a fixed rate and hours worked per week by the covered employees. The risks of participating in these multi-employer plans are different from other single-employer plans in the following aspects: (1) assets contributed to the multi-employer plan by one employer may be used to provide benefits to employees of other participating employers; (2) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (3) if NYU chooses to stop participating in some of its multi-employer plans, NYU may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability.

NYU’s contributions are reported as expenses in the consolidated statements of activities for the following multi-employer defined benefit pension and postretirement plans for the years ended August 31, 2018 and 2017:

2018 2017

1199 SEIU Health Care Employees Health & Welfare Fund$ 135,902 $ 121,785 1199 SEIU Health Care Employees Pension Fund 44,776 40,240 United Federation of Teachers Welfare Fund 15,980 14,355 Local 810 United Wire, Metal & Machine Health & Welfare Fund 4,344 3,309 Local 810 United Wire, Metal & Machine Pension Fund 3,317 2,665 Local 153 Pension Fund 273 265 Local 30 Pension Fund 54 56 $ 204,646 $ 182,675

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The Pension Protection Act (PPA) zone status indicates the plan’s funded status of either at least 80% funded (green) or less than 80% funded (yellow or red). A zone status of red requires the plan sponsor to implement a Funding Improvement Plan (FIP) or Rehabilitation Plan (RP). The following table includes information for related pension funds:

Expiration Date of Pension Protection FIP/RP Status Collective- EIN/PensionAct Zone Status Pending/ Surcharge Bargaining Pension Plan Name Plan Number 2018 2017 Implemented Imposed Agreement

1199 Pension Fund 13-3604862 Green Green N/A No September 2018 Local 810 United Wire Pension Fund 13-6596940 Red Red Yes Yes June 2019 Local 153 Pension Fund 13-2864289 Red Red Yes No N/A

NYU’s contributions to the Local 810 United Wire Pension Fund represent approximately 58% of total plan contributions. NYU is in withdrawal status for the Local 153 Pension Fund with quarterly withdrawal payments continuing through 2036.

12. Hospital Affiliations

NYUSoM has three affiliation agreements with the New York City Health and Hospitals Corporation to provide general care and mental health services. The three agreements are with Woodhull Medical and Mental Health Center and Cumberland Diagnostic and Treatment Center, Bellevue Hospital Center and Gouverneur Healthcare Services; and Coler Rehabilitation and Nursing Care Center and Henry J Carter Specialty Hospital and Nursing Facility and are effective from July 1, 2015 through June 30, 2020. NYUSoM recognized revenues from these affiliation agreements of $314,345 and $319,377 for the years ended August 31, 2018 and 2017, respectively.

NYU Langone Hospitals has several clinical affiliation agreements with New York City area hospitals where physicians provide patient care and supervision of residents at affiliated organizations. NYU Langone Hospitals also maintains an affiliation agreement with Sunset Park Health Council, Inc., a New York not-for-profit corporation, d/b/a Family Health Centers at NYU Langone (FHC). NYU Langone Hospitals recognized revenue from these affiliation agreements of $28,390 and $29,579 for the years ended August 31, 2018 and 2017, respectively.

13. Functional Classification of Expenses

NYU’s primary program services are instruction, research and patient care. Expenses reported as hospital affiliation, libraries support, student services, auxiliary enterprises and institutional services are incurred in support of these primary program activities. Natural expenses attributed to more than one functional expense category are allocated using a variety of cost allocation techniques such as square footage and time and effort.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Expenses by function classification for the years ended August 31, 2018 and 2017 consist of the following:

2018 Instruction and Research and other academic other sponsored Hospital Libraries Student Auxiliary Institutional programs programs Patient care affiliation support services enterprises services Total

Salary and fringe$ 1,209,507 $ 486,422 $ 3,867,388 $ 289,225 $ 41,181 $ 88,792 $ 118,570 $ 760,717 $ 6,861,802 Medical and pharamaceutical costs 55 1,565 913,669 3 - 13 248 5,668 921,221 Professional services 107,035 30,587 210,002 3,324 3,665 18,354 70,690 238,363 682,020 Facilities costs 103,488 143,805 127,406 13 4,553 11,926 188,328 155,286 734,805 Supplies 42,586 40,973 62,909 24 28,928 4,362 1,932 26,792 208,506 Fees, insurance and taxes 5,523 575 165,449 10 191 1,491 15,897 138,765 327,901 Depreciation and amortization expense 64,024 35,757 272,340 - 6,601 14,841 145,397 179,349 718,309 Interest expense 67,774 11,371 82,803 - 859 3,444 49,111 32,835 248,197 Other 172,853 120,529 247,715 1,363 7,581 24,162 28,482 239,512 842,197 $ 1,772,845 $ 871,584 $ 5,949,681 $ 293,962 $ 93,559 $ 167,385 $ 618,655 $ 1,777,287 $ 11,544,958 University $ 1,717,992 $ 247,303 $ 69,712 $ - $ 84,872 $ 157,609 $ 464,123 $ 545,845 $ 3,287,456 NYU Langone Heatlh 54,853 624,281 5,879,969 293,962 8,687 9,776 159,642 1,236,627 8,267,797 1,772,845 871,584 5,949,681 293,962 93,559 167,385 623,765 1,782,472 11,555,253 Eliminations (10,295) $ 11,544,958 2017 Instruction and Research and other academic other sponsored Hospital Libraries Student Auxiliary Institutional programs programs Patient care affiliation support services enterprises services Total

Salary and fringe$ 1,142,272 $ 472,547 $ 3,070,559 $ 288,017 $ 41,325 $ 83,724 $ 74,904 $ 572,703 $ 5,746,051 Medical and pharamaceutical costs 103 4,293 617,337 4 - 13 85 45,177 667,012 Professional services 87,988 30,750 226,203 5,639 4,113 17,311 70,754 176,862 619,620 Facilities costs 103,508 70,136 103,009 9 6,000 9,727 161,056 196,485 649,930 Supplies 43,379 41,906 54,551 22 27,901 4,179 1,551 19,517 193,006 Fees, insurance and taxes 4,181 587 134,229 10 152 2,704 15,491 97,276 254,630 Depreciation expense 65,818 55,684 216,153 - 7,539 13,890 107,619 108,121 574,824 Interest expense 64,773 15,441 70,095 - 1,531 3,672 50,229 16,314 222,055 Other 156,269 140,861 243,413 1,471 5,561 22,571 58,551 133,873 762,570 $ 1,668,291 $ 832,205 $ 4,735,549 $ 295,172 $ 94,122 $ 157,791 $ 540,240 $ 1,366,328 $ 9,689,698 University $ 1,611,411 $ 230,371 $ 59,551 $ - $ 83,540 $ 147,370 $ 464,414 $ 521,775 $ 3,118,432 NYU Langone Heatlh 56,880 601,834 4,675,998 295,172 10,582 10,421 80,651 852,003 6,583,541 1,668,291 832,205 4,735,549 295,172 94,122 157,791 545,065 1,373,778 9,701,973 Eliminations (12,275) $ 9,689,698

14. Components of Temporarily and Permanently Restricted Net Assets

Temporarily restricted net assets are available for the following purposes at August 31, 2018 and 2017:

2018 2017

Contributions and earnings for operating purposes$ 976,956 $ 965,956 Contributions for buildings and equipment 24,086 247,947 FEMA award for mitigation 117,247 201,254 Scholarships and fellowships 259,268 176,719 Annuity trust agreements 37,063 36,046 $ 1,414,620 $ 1,627,922

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

Permanently restricted net assets at August 31, 2018 and 2017 are retained in perpetuity to support the following activities:

2018 2017

Program support$ 491,314 $ 476,110 Faculty and staff salaries 828,999 792,684 Scholarships and fellowships 810,344 733,810 Research and sponsored programs 52,195 55,763 Library books 24,274 15,621 Buildings and equipment 5,208 4,811 Student loans 2,877 2,755 $ 2,215,211 $ 2,081,554

NYU’s investment pools include individual endowed funds established for a variety of purposes. Pooled assets include both donor restricted endowment funds and funds designated by the Board of Trustees to function as endowments.

NYU classifies as permanently restricted net assets: (a) the original value of gifts donated to the permanent endowment, (b) the original value of subsequent gifts to the permanent endowment, and (c) accumulations to the permanent endowment required by the applicable donor gift instrument. Accumulated unspent earnings from the permanently restricted endowments are classified as temporarily restricted net assets. Board-designated endowments, as well as any accumulated losses on any individual permanently restricted endowment (underwater endowment), are classified as unrestricted net assets.

NYU defines the appropriation of endowment net assets for expenditure as the authorization of its investment spending rate as approved annually by the Board of Trustees (Note 4). However, when donors have expressly stipulated the payout percentage of earnings on endowments that differs from NYU policies, the donors’ intent prevails. In making a determination to appropriate or accumulate, NYU adheres to the standard of prudence prescribed by New York Prudent Management of Institutional Funds Act (NYPMIFA) and considers the following factors: the duration and preservation of the endowment fund; NYU’s mission and the purpose of the endowment fund; general economic conditions; the possible effect of inflation or deflation; the expected total return from income and the appreciation of investments; other resources of NYU; where appropriate and circumstances would otherwise warrant, alternatives to expenditures of the endowment fund giving due consideration to the effect that such alternatives may have on NYU; and the investment policy of NYU.

From time to time, the fair value of assets associated with individual donor-restricted endowment funds may fall below the original value of the gift donated to the permanent endowment (underwater endowment). Deficits of this nature are reported as a reduction of unrestricted net assets. These deficits resulted from unfavorable market fluctuations that eroded accumulated gains for the permanently restricted endowments as well as the continued appropriation of certain programs which was deemed prudent by the University’s Board of Trustees. Current and future gains will be classified as increases in unrestricted net assets until the shortfalls previously charged to unrestricted net assets have been eliminated and the individual endowment funds are returned to their required levels as stipulated by donors.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

The following table represents the net asset classes of NYU’s endowment funds as of August 31:

2018 Temporarily Permanently Unrestricted Restricted Restricted Total

Donor-restricted endowment$ - $ 690,229 $ 2,097,385 $ 2,787,614 Board-designated endowment 1,462,105 - - 1,462,105 Underwater endowment (13 funds) (221) - - (221) $ 1,461,884 $ 690,229 $ 2,097,385 $ 4,249,498

2017 Temporarily Permanently Unrestricted Restricted Restricted Total

Donor-restricted endowment$ - $ 600,870 $ 1,993,398 $ 2,594,268 Board-designated endowment 1,507,136 - - 1,507,136 Underwater endowment (14 funds) (269) - - (269) $ 1,506,867 $ 600,870 $ 1,993,398 $ 4,101,135

The following table provides the changes in the net asset classes of NYU’s endowment funds at August 31:

2018 Temporarily Permanently Unrestricted Restricted Restricted Total

Investment pool net assets, beginning of year $ 1,506,867 $ 600,870 $ 1,993,398 $ 4,101,135 Contributions 50,725 - 129,030 179,755 Investment pool return 108,893 202,157 - 311,050 Endowment distribution (62,110) (107,039) - (169,149) Liquidations (151,183) - - (151,183) Reclassification of net assets 8,692 (5,759) (25,043) (22,110) Investment pool net assets, end of year $ 1,461,884 $ 690,229 $ 2,097,385 $ 4,249,498

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

2017 Temporarily Permanently Unrestricted Restricted Restricted Total

Investment pool net assets, beginning of year $ 1,344,766 $ 420,162 $ 1,848,638 $ 3,613,566 Contributions 84,617 - 147,108 231,725 Investment pool return 170,445 286,428 - 456,873 Endowment distribution (59,375) (102,839) - (162,214) Liquidations (30,877) - - (30,877) Reclassification of net assets (2,709) (2,881) (2,348) (7,938) Investment pool net assets, end of year $ 1,506,867 $ 600,870 $ 1,993,398 $ 4,101,135

15. Commitments and Contingencies

In the normal course of business, NYU leases facilities under operating leases. Minimum rental payments under these agreements over the next five years and thereafter are as follows:

Year Ending August 31, 2019 $ 322,377 2020 293,113 2021 277,214 2022 255,635 2023 241,827 Thereafter 2,893,517

Rent expense is $315,055 and $260,211 for the years ended August 31, 2018 and 2017, respectively.

The University entered into a capital lease for a four story office building, with a 32 year term, which is effective November 2019. Future lease payments under this capital lease total $285,596.

NYU, with the exception of Winthrop, which is fully insured, is self-insured for workers’ compensation. The University purchases an excess workers’ compensation insurance policy with a retention of $500 per claim. In connection with being self-insured, the University has maintained a surety bond in the amount of $11,749 at August 31, 2018 and 2017. Additionally, NYU Langone Health has maintained stand-by letters of credit aggregating approximately $46,247 and $35,306 at August 31, 2018 and 2017, respectively. Cash and marketable securities collateralize the letters of credit.

NYU is a defendant in various legal actions arising from the normal course of its operations and amounts expended under government grants and contracts are subject to audit by governmental agencies. In addition, amounts received for patient care from Medicare and Medicaid are subject to audit. Although the final outcome of such actions and audits cannot be determined, management believes that eventual liability, if any, will not have a material effect on NYU’s consolidated balance sheet.

New York University Notes to Consolidated Financial Statements August 31, 2018 and 2017

(in thousands of dollars)

16. Subsequent Events

NYU performed an evaluation of subsequent events through December 7, 2018, which is the date the consolidated financial statements were issued, and updated as of March 6, 2019.

In October 2018, National Indemnity Company, a subsidiary of Berkshire Hathaway, closed on the purchase of Medical Liability Mutual Insurance Company (“MLMIC”) as a Mutual Company. MLMIC was previously owned by its policyholders, and in order to complete the demutualization, policyholders would receive payouts of approximately 1.9 times the amount in premiums paid during the three-year period leading up to July 2016, when the MLMIC board approved the sale. The Health System was a holder of various professional liability insurance policies from MLMIC (Note 10), and a result of the October 2018 closing of the sale, received total demutualization payments of $97,800 which will be recognized as income in fiscal year 2019.

In October 2018, the Health System amended an existing line of credit which increased the borrowing capacity from $100,000 to $200,000, and entered into a new line of credit in the amount of $50,000. The interest rates on both lines are based on LIBOR.

In November 2018, the Health System extended another existing line of credit through August 2019 and increased the borrowing capactiy from $25,000 to $50,000. The interest rate is based on LIBOR.

In February 2019, DASNY issued $862,755 of revenue bonds (Series 2019 A&B) on behalf of the Obligated Group. The 2019 A&B revenue bonds will be used to fund construction, renovation and equipment projects, including projects identified as promoting environmental sustainability purposes. Some proceeds will be used to repay a portion of the outstanding balance on lines of credit.

Appendix A Supplemental Schedules to the Consolidated Financial Statements

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Balance Sheet for NYU - Summary) August 31, 2018

(in thousands of dollars) 2018 NYU Consolidated University Langone Health Eliminations NYU

Assets Cash and cash equivalents$ 1,008,398 $ 478,672 $ - $ 1,487,070 Short-term investments (Note 4) 1,870 - - 1,870 Accounts and loans receivable, net (Note 5) 399,694 432,547 (109,244) 722,997 Patient accounts receivable, net (Note 3) 9,173 886,340 - 895,513 Contributions receivable, net (Note 6) 275,513 182,837 - 458,350 Other assets (Note 7) 235,688 714,090 - 949,778 Deposits with trustees (Note 2) 463,832 10,336 - 474,168 Long-term investments (Note 4) 3,273,725 1,607,617 - 4,881,342 Assets held for professional liabilities (Note 10) - 525,834 - 525,834 Land, buildings, and equipment, net (Note 8) 3,880,529 7,050,651 - 10,931,180 Total assets$ 9,548,422 $ 11,888,924 $ (109,244) $ 21,328,102 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses$ 328,044 $ 1,731,316 $ (109,244) $ 1,950,116 Deferred revenue 840,531 133,124 - 973,655 Professional liabilities (Note 10) - 640,722 - 640,722 Debt and other obligations (Note 9) 3,397,411 3,726,497 - 7,123,908 Funds held for others (Notes 5 and 7) 147,306 197,319 - 344,625 Accrued benefit obligation (Note 11) 36,267 416,220 - 452,487 Accrued postretirement obligation (Note 11) 359,923 182,026 - 541,949 Asset retirement obligation 174,588 81,730 - 256,318 Total liabilities 5,284,070 7,108,954 (109,244) 12,283,780 Net assets Unrestricted 1,798,901 3,615,590 - 5,414,491 Temporarily restricted (Note 14) 832,562 582,058 - 1,414,620 Permanently restricted (Note 14) 1,632,889 582,322 - 2,215,211 Total net assets 4,264,352 4,779,970 - 9,044,322 Total liabilities and net assets$ 9,548,422 $ 11,888,924 $ (109,244) $ 21,328,102

The accompanying note is an integral part of these consolidating financial statements 45

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Balance Sheet for NYU - Summary) August 31, 2017

(in thousands of dollars) 2017 NYU Consolidated University Langone Health Eliminations NYU

Assets Cash and cash equivalents$ 889,802 $ 379,797 $ - $ 1,269,599 Short-term investments (Note 4) 1,989 - - 1,989 Accounts and loans receivable, net (Note 5) 425,471 463,779 (131,844) 757,406 Patient accounts receivable, net (Note 3) 6,476 852,272 - 858,748 Contributions receivable, net (Note 6) 315,413 143,734 - 459,147 Other assets (Note 7) 214,223 653,065 - 867,288 Deposits with trustees (Note 2) 272,803 16,285 - 289,088 Long-term investments (Note 4) 3,129,709 1,745,978 - 4,875,687 Assets held for professional liabilities (Note 10) - 503,328 - 503,328 Land, buildings, and equipment, net (Note 8) 3,796,033 6,166,498 - 9,962,531 Total assets$ 9,051,919 $ 10,924,736 $ (131,844) $ 19,844,811 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses$ 326,807 $ 1,501,589 $ (131,844) $ 1,696,552 Deferred revenue 797,619 223,460 - 1,021,079 Professional liabilities (Note 10) - 629,810 - 629,810 Debt and other obligations (Note 9) 3,064,677 3,244,143 - 6,308,820 Funds held for others (Notes 5 and 7) 150,001 156,116 - 306,117 Accrued benefit obligation (Note 11) 100,955 466,603 - 567,558 Accrued postretirement obligation (Note 11) 385,009 184,439 - 569,448 Asset retirement obligation 179,036 56,326 - 235,362 Total liabilities 5,004,104 6,462,486 (131,844) 11,334,746 Net assets Unrestricted 1,695,986 3,104,603 - 4,800,589 Temporarily restricted (Note 14) 764,745 863,177 - 1,627,922 Permanently restricted (Note 14) 1,587,084 494,470 - 2,081,554 Total net assets 4,047,815 4,462,250 - 8,510,065 Total liabilities and net assets$ 9,051,919 $ 10,924,736 $ (131,844) $ 19,844,811

The accompanying note is an integral part of these consolidating financial statements 46

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Balance Sheet for NYU - Detail) August 31, 2018

(in thousands of dollars) 2018 Total Health Consolidated University NYUSoM Eliminations Subtotal System Eliminations NYU

Assets Cash and cash equivalents$ 1,008,398 $ 68,643 $ - $ 1,077,041 $ 410,029 $ - $ 1,487,070 Short-term investments (Note 4) 1,870 - - 1,870 - - 1,870 Accounts and loans receivable, net (Note 5) 399,694 222,917 (101,241) 521,370 241,493 (39,866) 722,997 Patient accounts receivable, net (Note 3) 9,173 120,436 - 129,609 765,904 - 895,513 Contributions receivable, net (Note 6) 275,513 101,964 - 377,477 80,873 - 458,350 Other assets (Note 7) 235,688 234,584 - 470,272 479,506 - 949,778 Deposits with trustees (Note 2) 463,832 - - 463,832 10,336 - 474,168 Long-term investments (Note 4) 3,273,725 977,525 - 4,251,250 630,092 - 4,881,342 Assets held for professional liabilities (Note 10) - - - - 525,834 - 525,834 Land, buildings, and equipment, net (Note 8) 3,880,529 2,490,158 - 6,370,687 4,560,493 - 10,931,180 Total assets$ 9,548,422 $ 4,216,227 $ (101,241) $ 13,663,408 $ 7,704,560 $ (39,866) $ 21,328,102 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses$ 328,044 $ 769,409 $ (101,241) $ 996,212 $ 993,770 $ (39,866) $ 1,950,116 Deferred revenue 840,531 32,462 - 872,993 100,662 - 973,655 Professional liabilities (Note 10) - - - - 640,722 - 640,722 Debt and other obligations (Note 9) 3,397,411 1,210,800 - 4,608,211 2,515,697 - 7,123,908 Funds held for others (Notes 5 and 7) 147,306 147,938 - 295,244 49,381 - 344,625 Accrued benefit obligation (Note 11) 36,267 31,716 - 67,983 384,504 - 452,487 Accrued postretirement obligation (Note 11) 359,923 100,211 - 460,134 81,815 - 541,949 Asset retirement obligation 174,588 39,228 - 213,816 42,502 - 256,318 Total liabilities 5,284,070 2,331,764 (101,241) 7,514,593 4,809,053 (39,866) 12,283,780 Net assets Unrestricted 1,798,901 864,810 - 2,663,711 2,750,780 - 5,414,491 Temporarily restricted (Note 14) 832,562 458,227 - 1,290,789 123,831 - 1,414,620 Permanently restricted (Note 14) 1,632,889 561,426 - 2,194,315 20,896 - 2,215,211 Total net assets 4,264,352 1,884,463 - 6,148,815 2,895,507 - 9,044,322 Total liabilities and net assets$ 9,548,422 $ 4,216,227 $ (101,241) $ 13,663,408 $ 7,704,560 $ (39,866) $ 21,328,102

The accompanying note is an integral part of these consolidating financial statements 47

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Balance Sheet for NYU - Detail) August 31, 2017

(in thousands of dollars) 2017 Total Health Consolidated University NYUSoM Eliminations Subtotal System Eliminations NYU

Assets Cash and cash equivalents$ 889,802 $ 12,639 $ - $ 902,441 $ 367,158 $ - $ 1,269,599 Short-term investments (Note 4) 1,989 - - 1,989 - - 1,989 Accounts and loans receivable, net (Note 5) 425,471 237,170 (131,703) 530,938 311,908 (85,440) 757,406 Patient accounts receivable, net (Note 3) 6,476 111,398 - 117,874 740,874 - 858,748 Contributions receivable, net (Note 6) 315,413 54,650 - 370,063 89,084 - 459,147 Other assets (Note 7) 214,223 282,547 - 496,770 370,518 - 867,288 Deposits with trustees (Note 2) 272,803 - - 272,803 16,285 - 289,088 Long-term investments (Note 4) 3,129,709 974,872 - 4,104,581 771,106 - 4,875,687 Assets held for professional liabilities (Note 10) - - - - 503,328 - 503,328 Land, buildings, and equipment, net (Note 8) 3,796,033 2,033,403 - 5,829,436 4,133,095 - 9,962,531 Total assets$ 9,051,919 $ 3,706,679 $ (131,703) $ 12,626,895 $ 7,303,356 $ (85,440) $ 19,844,811 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses$ 326,807 $ 691,158 $ (131,703) $ 886,262 $ 895,730 $ (85,440) $ 1,696,552 Deferred revenue 797,619 89,506 - 887,125 133,954 - 1,021,079 Professional liabilities (Note 10) - - - - 629,810 - 629,810 Debt and other obligations (Note 9) 3,064,677 983,976 - 4,048,653 2,260,167 - 6,308,820 Funds held for others (Notes 5 and 7) 150,001 119,588 - 269,589 36,528 - 306,117 Accrued benefit obligation (Note 11) 100,955 46,868 - 147,823 419,735 - 567,558 Accrued postretirement obligation (Note 11) 385,009 101,961 - 486,970 82,478 - 569,448 Asset retirement obligation 179,036 29,236 - 208,272 27,090 - 235,362 Total liabilities 5,004,104 2,062,293 (131,703) 6,934,694 4,485,492 (85,440) 11,334,746 Net assets Unrestricted 1,695,986 676,635 - 2,372,621 2,427,968 - 4,800,589 Temporarily restricted (Note 14) 764,745 495,363 - 1,260,108 367,814 - 1,627,922 Permanently restricted (Note 14) 1,587,084 472,388 - 2,059,472 22,082 - 2,081,554 Total net assets 4,047,815 1,644,386 - 5,692,201 2,817,864 - 8,510,065 Total liabilities and net assets$ 9,051,919 $ 3,706,679 $ (131,703) $ 12,626,895 $ 7,303,356 $ (85,440) $ 19,844,811

The accompanying note is an integral part of these consolidating financial statements 48

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Activities for NYU - Summary) Year Ended August 31, 2018

(in thousands of dollars) 2018 NYU Consolidated University Langone Health Eliminations NYU

Changes in unrestricted net assets Operating revenues Tuition and fees (net of financial aid awards of $675,222 University; $10,824 NYU Langone Health)$ 1,803,767 $ 48,187 $ - $ 1,851,954 Grants and contracts (Note 2) 545,688 465,887 - 1,011,575 Patient care (net of provision for bad debts of $98,266 NYU Langone Health) (Note 3) 55,956 6,925,987 - 6,981,943 Hospital affiliations (Note 13) - 342,735 - 342,735 Insurance premiums earned - 115,544 - 115,544 Contributions 118,659 49,533 - 168,192 Endowment distribution (Note 4) 128,868 40,281 - 169,149 Return on short-term investments (Note 4) 16,072 58 - 16,130 Auxiliary enterprises 439,915 70,512 (5,110) 505,317 Program fees and other 106,620 170,728 (5,185) 272,163 Net assets released from restrictions 52,149 69,320 - 121,469 Total operating revenues 3,267,694 8,298,772 (10,295) 11,556,171 Expenses (Note 13) Salaries and fringe 1,829,414 5,032,388 - 6,861,802 Medical and pharmaceutical costs - 921,221 - 921,221 Professional services 269,470 412,550 - 682,020 Facilities cost 351,547 388,368 (5,110) 734,805 Supplies 93,492 115,014 - 208,506 Fees, insurance and taxes 51,535 276,366 - 327,901 Depreciation and amortization 261,918 456,391 - 718,309 Interest 122,761 125,436 - 248,197 Other 307,319 540,063 (5,185) 842,197 Total expenses 3,287,456 8,267,797 (10,295) 11,544,958 (Deficency) excess of operating revenues over expenses (19,762) 30,975 - 11,213 Nonoperating activities Investment return (Note 4) 89,826 67,866 - 157,692 Appropriation of endowment distribution (Note 4) (47,610) (14,213) - (61,823) Pension and postretirement nonservice costs (Note 11) (17,150) 11,871 - (5,279) Changes in pension and postretirement obligations (Note 11) 83,325 36,166 - 119,491 Net assets released from restrictions for capital purposes 20,725 326,594 - 347,319 Other (6,439) 51,728 - 45,289 Increase in unrestricted net assets 102,915 510,987 - 613,902 Changes in temporarily restricted net assets Contributions 74,218 97,975 - 172,193 Investment return (Note 4) 151,910 52,179 - 204,089 Appropriation of endowment distribution (Note 4) (81,258) (26,068)-(107,326) Other (4,179) (9,291) - (13,470) Net assets released from restrictions (72,874) (395,914) - (468,788) Increase (decrease) in temporarily restricted net assets 67,817 (281,119) - (213,302) Changes in permanently restricted net assets Contributions 49,758 90,773 - 140,531 Other (3,953) (2,921) - (6,874) Increase in permanently restricted net assets 45,805 87,852 - 133,657 Increase in net assets$ 216,537 $ 317,720 $ - $ 534,257

The accompanying note is an integral part of these consolidating financial statements 49

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Activities for NYU - Summary) Year Ended August 31, 2017

(in thousands of dollars) 2017 NYU Consolidated University Langone Health Eliminations NYU

Changes in unrestricted net assets Operating revenues Tuition and fees (net of financial aid awards of $643,034 University; $10,134 NYU Langone Health)$ 1,704,645 $ 49,091 $ - $ 1,753,736 Grants and contracts (Note 2) 509,030 408,515 - 917,545 Patient care (net of provision for bad debts of $85,461 NYU Langone Health) (Note 3) 54,879 5,516,576 - 5,571,455 Hospital affiliations (Note 13) - 348,956 - 348,956 Insurance premiums earned - 73,804 - 73,804 Contributions 134,390 49,115 - 183,505 Endowment distribution (Note 4) 123,800 38,414 - 162,214 Return on short-term investments (Note 4) 10,152 (19) - 10,133 Auxiliary enterprises 447,659 70,425 (4,825) 513,259 Program fees and other 107,690 128,250 (7,450) 228,490 Net assets released from restrictions 26,405 96,960 - 123,365 Total operating revenues 3,118,650 6,780,087 (12,275) 9,886,462 Expenses (Note 14) Salaries and fringe 1,719,591 4,026,460 - 5,746,051 Medical and pharmaceutical costs - 667,012 - 667,012 Professional services 247,501 372,119 - 619,620 Facilities cost 335,965 318,790 (4,825) 649,930 Supplies 91,666 101,340 - 193,006 Fees, insurance and taxes 42,992 211,638 - 254,630 Depreciation and amortization 259,490 315,334 - 574,824 Interest 119,297 102,758 - 222,055 Other 301,930 468,090 (7,450) 762,570 Total expenses 3,118,432 6,583,541 (12,275) 9,689,698 Excess of operating revenues over expenses 218 196,546 - 196,764 Nonoperating activities Investment return (Note 4) 132,932 76,434 - 209,366 Appropriation of endowment distribution (Note 4) (45,616) (13,759) - (59,375) Pension and postretirement nonservice costs (Note 11) (22,429) (9,211) - (31,640) Changes in pension and postretirement obligations (Note 11) 117,453 146,685 - 264,138 Net assets released from restrictions for capital purposes 21,074 88,168 - 109,242 Other 24,565 14,950 - 39,515 Loss on bond defeasance (Note 9) (24,124) (8,062) - (32,186) Acquisition of Winthrop-University Hospital Association (Note 1) - 274,927 - 274,927 Increase in unrestricted net assets 204,073 766,678 - 970,751 Changes in temporarily restricted net assets Contributions 57,715 76,391 - 134,106 Investment return (Note 4) 217,178 70,368 - 287,546 Appropriation of endowment distribution (Note 4) (78,184) (24,655)-(102,839) Other 9,334 (2,403) - 6,931 Net assets released from restrictions (47,479) (185,128) - (232,607) Increase (decrease) in temporarily restricted net assets 158,564 (65,427) - 93,137 Changes in permanently restricted net assets Contributions 81,500 73,163 - 154,663 Other (2,093) (212) - (2,305) Increase in permanently restricted net assets 79,407 72,951 - 152,358 Increase in net assets$ 442,044 $ 774,202 $ - $ 1,216,246

The accompanying note is an integral part of these consolidating financial statements 50

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Activities for NYU - Detail) Year Ended August 31, 2018

(in thousands of dollars) 2018 Total Health Consolidated University NYUSoM Eliminations Subtotal System Eliminations NYU

Changes in unrestricted net assets Operating revenues Tuition and fees (net of financial aid awards of $675,222 University; and $10,824 NYU Langone Health)$ 1,803,767 $ 48,187 $ - $ 1,851,954 $ - $ - $ 1,851,954 Grants and contracts (Note 2) 545,688 423,150 - 968,838 42,737 - 1,011,575 Patient care (net of provision for bad debts of $98,266 NYU Langone Health) (Note 3) 55,956 1,788,996 - 1,844,952 5,654,643 (517,652) 6,981,943 Hospital affiliations (Note 13) - 314,345 - 314,345 28,390 - 342,735 Insurance premiums earned - - - - 115,544 - 115,544 Contributions 118,659 40,204 - 158,863 9,329 - 168,192 Endowment distribution (Note 4) 128,868 38,715 - 167,583 1,566 - 169,149 Return on short-term investments (Note 4) 16,072 58 - 16,130 - - 16,130 Auxiliary enterprises 439,915 20,901 (5,110) 455,706 49,611 - 505,317 Program fees and other 106,620 288,308 (5,185) 389,743 149,520 (267,100) 272,163 Net assets released from restrictions 52,149 56,342 - 108,491 12,978 - 121,469 Total operating revenues 3,267,694 3,019,206 (10,295) 6,276,605 6,064,318 (784,752) 11,556,171 Expenses (Note 14) Salaries and fringe 1,829,414 2,176,255 - 4,005,669 2,856,133 - 6,861,802 Medical and pharmaceutical costs - 42,706 - 42,706 878,515 - 921,221 Professional services 269,470 162,333 - 431,803 777,032 (526,815) 682,020 Facilities cost 351,547 179,604 (5,110) 526,041 208,764 - 734,805 Supplies 93,492 53,462 - 146,954 61,552 - 208,506 Fees, insurance and taxes 51,535 132,222 - 183,757 144,144 - 327,901 Depreciation and amortization 261,918 109,292 - 371,210 347,099 - 718,309 Interest 122,761 37,203 - 159,964 88,233 - 248,197 Other 307,319 221,072 (5,185) 523,206 576,928 (257,937) 842,197 Total expenses 3,287,456 3,114,149 (10,295) 6,391,310 5,938,400 (784,752) 11,544,958 (Deficency) excess of operating revenues over expenses (19,762) (94,943) - (114,705) 125,918 - 11,213 Nonoperating activities Investment return (Note 4) 89,826 24,605 - 114,431 43,261 - 157,692 Appropriation of endowment distribution (Note 4) (47,610) (14,050) - (61,660) (163) - (61,823) Pension and postretirement nonservice costs (Note 11) (17,150) (2,427) - (19,577) 14,298 - (5,279) Changes in pension and postretirement obligations (Note 11) 83,325 22,016 - 105,341 14,150 - 119,491 Net assets released from restrictions for capital purposes 20,725 54,028 - 74,753 272,566 - 347,319 Other (6,439) 148,946 - 142,507 (97,218) - 45,289 Mission based payment - 50,000 - 50,000 (50,000) - - Increase in unrestricted net assets 102,915 188,175 - 291,090 322,812-613,902 Changes in temporarily restricted net assets Contributions 74,218 72,498 - 146,716 25,477 - 172,193 Investment return (Note 4) 151,910 48,804 - 200,714 3,375 - 204,089 Appropriation of endowment distribution (Note 4) (81,258) (24,665) - (105,923) (1,403) - (107,326) Other (4,179) (23,403) - (27,582) 14,112 - (13,470) Net assets released from restrictions (72,874) (110,370) - (183,244) (285,544) - (468,788) Increase (decrease) in temporarily restricted net assets 67,817 (37,136) - 30,681 (243,983) - (213,302) Changes in permanently restricted net assets Contributions 49,758 89,038 - 138,796 1,735 - 140,531 Other (3,953) - - (3,953) (2,921) - (6,874) Increase (decrease) in permanently restricted net assets 45,805 89,038 - 134,843 (1,186) - 133,657 Increase in net assets$ 216,537 $ 240,077 $ - $ 456,614 $ 77,643 $ - $ 534,257

The accompanying note is an integral part of these consolidating financial statements 51

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Activities for NYU - Detail) Year Ended August 31, 2017

(in thousands of dollars) 2017 Total Health Consolidated University NYUSoM Eliminations Subtotal System Eliminations NYU

Changes in unrestricted net assets Operating revenues Tuition and fees (net of financial aid awards of $643,034 University; and $10,134 NYU Langone Health)$ 1,704,645 $ 49,091 $ - $ 1,753,736 $ - $ - $ 1,753,736 Grants and contracts (Note 2) 509,030 403,641 - 912,671 4,874 - 917,545 Patient care (net of provision for bad debts of $85,461 NYU Langone Health) (Note 3) 54,879 1,523,560 - 1,578,439 4,406,146 (413,130) 5,571,455 Hospital affiliations (Note 13) - 319,377 - 319,377 29,579 - 348,956 Insurance premiums earned - - - - 73,804 - 73,804 Contributions 134,390 42,185 - 176,575 6,930 - 183,505 Endowment distribution (Note 4) 123,800 36,910 - 160,710 1,504 - 162,214 Return on short-term investments (Note 4) 10,152 (19) - 10,133 - - 10,133 Auxiliary enterprises 447,659 23,015 (4,825) 465,849 47,410 - 513,259 Program fees and other 107,690 218,478 (7,450) 318,718 100,274 (190,502) 228,490 Net assets released from restrictions 26,405 52,119 - 78,524 44,841 - 123,365 Total operating revenues 3,118,650 2,668,357 (12,275) 5,774,732 4,715,362 (603,632) 9,886,462 Expenses (Note 14) Salaries and fringe 1,719,591 1,901,793 - 3,621,384 2,124,667 - 5,746,051 Medical and pharmaceutical costs - 47,548 - 47,548 619,464 - 667,012 Professional services 247,501 160,675 - 408,176 635,379 (423,935) 619,620 Facilities cost 335,965 125,822 (4,825) 456,962 192,968 - 649,930 Supplies 91,666 50,443 - 142,109 50,897 - 193,006 Fees, insurance and taxes 42,992 117,227 - 160,219 94,411 - 254,630 Depreciation and amortization 259,490 91,654 - 351,144 223,680 - 574,824 Interest 119,297 31,836 - 151,133 70,922 - 222,055 Other 301,930 229,965 (7,450) 524,445 417,822 (179,697) 762,570 Total expenses 3,118,432 2,756,963 (12,275) 5,863,120 4,430,210 (603,632) 9,689,698 Excess (deficiency) of operating revenues over expenses 218 (88,606) - (88,388) 285,152 - 196,764 Nonoperating activities Investment return (Note 4) 132,932 37,089 - 170,021 39,345 - 209,366 Appropriation of endowment distribution (Note 4) (45,616) (13,601) - (59,217) (158) - (59,375) Pension and postretirement nonservice costs (Note 11 ) (22,429) (4,755) - (27,184) (4,456) - (31,640) Changes in pension and postretirement obligations (Note 11) 117,453 31,055 - 148,508 115,630 - 264,138 Net assets released from restrictions for capital purposes 21,074 62,585 - 83,659 25,583 - 109,242 Other 24,565 32,900 - 57,465 (17,950) - 39,515 Mission based payment - 50,000 - 50,000 (50,000) - - Loss on bond defeasance (Note 9) (24,124) (8,062) - (32,186) - - (32,186) Acquisition of Winthrop-University Hospital Association (Note 1) - - - - 274,927 - 274,927 Increase in unrestricted net assets 204,073 98,605 - 302,678 668,073 - 970,751 Changes in temporarily restricted net assets Contributions 57,715 26,731 - 84,446 49,660 - 134,106 Investment return (Note 4) 217,178 66,902 - 284,080 3,466 - 287,546 Appropriation of endowment distribution (Note 4) (78,184) (23,309) - (101,493) (1,346) - (102,839) Other 9,334 (2,403) - 6,931 - - 6,931 Net assets released from restrictions (47,479) (114,704) - (162,183) (70,424) - (232,607) Increase (decrease) in temporarily restricted net assets 158,564 (46,783) - 111,781 (18,644) - 93,137 Changes in permanently restricted net assets Contributions 81,500 64,318 - 145,818 8,845 - 154,663 Other (2,093) (200) - (2,293) (12) - (2,305) Increase in permanently restricted net assets 79,407 64,118 - 143,525 8,833 - 152,358 Increase in net assets$ 442,044 $ 115,940 $ - $ 557,984 $ 658,262 $ - $ 1,216,246

The accompanying note is an integral part of these consolidating financial statements 52

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Cash Flows for NYU – Summary) Year Ended August 31, 2018

(in thousands of dollars) 2018 NYU Consolidated University Langone Health Eliminations NYU Cash flows from operating activities Change in net assets $ 216,537 $ 317,720 $ - $ 534,257 Adjustments to reconcile change in net assets to net cash provided by operating activities Depreciation and amortization 261,918 456,391 - 718,309 (Gain) loss on sale or disposal of land, buildings and equipment and other adjustments (5,387) 6,831 - 1,444 Net gain on investments and deposits with trustees (206,653) (87,549) - (294,202) Bad debt expense 15,807 101,403 - 117,210 Pension and postretirement obligation change (83,325) (36,166) - (119,491) Contributions received for permanent investment and capital (61,318) (82,046) - (143,364) Proceeds from insurance recovery for capital and FEMA award for future mitigation - (6,742) - (6,742) Changes in operating assets and liabilities Decrease in accounts and loans receivable, net 17,156 28,679 (22,571) 23,264 Increase in patient accounts receivable (2,697) (132,334) - (135,031) Decrease (Increase) in nonendowment and noncapital contributions receivable 32,714 (42,240) - (9,526) (Increase) decrease in other assets (13,812) 4,526 - (9,286) Decrease in asset retirement obligation - (5,200) - (5,200) Increase in accounts payable and accrued expenses 8,163 222,926 22,571 253,660 Increase in professional liabilities - 10,912 - 10,912 Increase (decrease) in deferred revenue 42,912 (14,977) - 27,935 Decrease in accrued pension obligation (13,190) (24,449) - (37,639) Increase in accrued postretirement obligation 6,741 7,819 - 14,560 Net cash provided by operating activities 215,566 725,504 - 941,070 Cash flows from investing activities Purchases of investments (1,622,856) (577,276) - (2,200,132) Sales and maturities of investments 1,687,651 753,889 - 2,441,540 Increase in assets held for professional liabilities - (17,672) - (17,672) Drawdowns of unexpended bond proceeds 105,650 - - 105,650 Additions to land, buildings, and equipment (367,803) (1,271,130) - (1,638,933) Proceeds from insurance recovery for capital - 5,558 - 5,558 Net cash used in investing activities (197,358) (1,106,631) - (1,303,989) Cash flows from financing activities Contributions restricted for permanent investment and capital 61,318 82,046 - 143,364 Proceeds from FEMA award for future mitigation - 1,184 - 1,184 Proceeds from short-term borrowings 106,500 525,913 - 632,413 Proceeds from long-term borrowings - 5,262 - 5,262 Principal payments on short-term borrowings - (25,000) - (25,000) Principal payments on long-term borrowings (61,029) (113,954) - (174,983) Payments of deferred financing costs (1,650) - - (1,650) Decrease in funds held for others (10,649) (1,398) - (12,047) Increase in deposits with bond trustees 5,898 5,949 - 11,847 Net cash provided by financing activities 100,388 480,002 - 580,390 Net increase in cash 118,596 98,875 - 217,471 Cash Beginning of year 889,802 379,797 - 1,269,599 End of year $ 1,008,398 $ 478,672 $ - $ 1,487,070 Supplemental disclosure of cash flow information Bond proceeds (non-cash) $ 461,452 $ 184,850 $ - $ 646,302 Line of credit repayments (non-cash) 156,835 184,850 - 341,685 Interest paid 121,602 147,375 - 268,977 Change in noncash acquisitions of land, buildings, and equipment (14,416) 39,245 - 24,829 Assets acquired under capital leases - 113,153 - 113,153

The accompanying note is an integral part of these consolidating financial statements 53

New York University Supplemental Schedule to the Consolidated Financial Statements (Consolidating Statement of Cash Flows for NYU – Summary) Year Ended August 31, 2017

(in thousands of dollars) 2017 NYU Consolidated University Langone Health Eliminations NYU Cash flows from operating activities Change in net assets $ 442,044 $ 774,202 $ - $ 1,216,246 Adjustments to reconcile change in net assets to net cash provided by operating activities Depreciation and amortization 259,490 315,335 - 574,825 (Gain) loss on sale or disposal of land, buildings and equipment and other adjustments (4,789) 16,362 - 11,573 Gain on extinguishment of debt (2,530) (1,121) - (3,651) Net gain on investments and deposits with trustees (313,300) (119,581) - (432,881) Bad debt (recovery) expense (3,725) 90,741 - 87,016 Pension and postretirement obligation change (117,453) (146,685) - (264,138) Contributions received for permanent investment and capital (78,257) (126,466) - (204,723) Acquisition of Winthrop-University Hospital Association - (295,427) - (295,427) Proceeds from insurance recovery for capital or FEMA award - (55,664) - (55,664) Changes in operating assets and liabilities Decrease in accounts and loans receivable, net 15,165 142,554 (37,615) 120,104 Increase in patient accounts receivable (3,274) (168,433) - (171,707) Decrease in nonendowment and noncapital contributions receivable 8,558 46,336 - 54,894 Increase in other assets (20,988) (38,020) - (59,008) Decrease in asset retirement obligation - (5,646) - (5,646) Decrease in accounts payable and accrued expenses (28,090) (214,935) 37,615 (205,410) Increase in professional liabilities - 80,909 - 80,909 Increase (decrease) in deferred revenue 48,714 (24,157) - 24,557 Increase (decrease) in accrued pension obligation 7,325 (53,961) - (46,636) Increase in accrued postretirement obligation 12,674 9,066 - 21,740 Net cash provided by operating activities 221,564 225,409 - 446,973 Cash flows from investing activities Purchases of investments (1,126,788) (410,250) - (1,537,038) Sales and maturities of investments 1,085,387 574,410 - 1,659,797 Increase in assets held for professional liabilities - (40,024) - (40,024) Drawdowns of unexpended bond proceeds 101,033 204 - 101,237 Additions to land, buildings, and equipment (331,526) (1,045,305) - (1,376,831) Proceeds from insurance recovery or FEMA award for capital - 111,641 - 111,641 Cash acquired from Winthrop-University Hospital Association - 68,736 - 68,736 Net cash used in investing activities (271,894) (740,588) - (1,012,482) Cash flows from financing activities Contributions restricted for permanent investment and capital 78,257 126,466 - 204,723 Proceeds from FEMA award for future mitigation - 46,164 - 46,164 Proceeds from short-term borrowings 82,500 416,856 - 499,356 Proceeds from long-term borrowings 523,366 828,054 - 1,351,420 Principal payments on short-term borrowings (75,469) (453,901) - (529,370) Principal payments on long-term borrowings (479,995) (311,028) - (791,023) Payments of deferred financing costs (1,922) (4,000) - (5,922) Increase (decrease) in funds held for others 5,767 (1,551) - 4,216 Decrease in deposits with bond trustees 21,907 371 - 22,278 Net cash provided by financing activities 154,411 647,431 - 801,842 Net increase in cash 104,081 132,252 - 236,333 Cash Beginning of year 785,721 247,545 - 1,033,266 End of year $ 889,802 $ 379,797 $ - $ 1,269,599 Supplemental disclosure of cash flow information Interest paid $ 125,488 $ 113,198 $ - $ 238,686 Change in noncash acquisitions of land, buildings, and equipment 1,384 89,562 - 90,946 Assets acquired under capital leases - 258,481 - 258,481 Noncash acquisition of Winthrop-Hospital University Association - 226,691 - 226,691

The accompanying note is an integral part of these consolidating financial statements 54

New York University Notes to Consolidating Supplemental Schedules August 31, 2018 and 2017

1. Basis of Presentation – Consolidating Supplemental Schedules

The consolidating supplemental schedules (consolidating information) presented on pages 45-54 was derived from and relates directly to the underlying accounting and other records used to prepare the consolidated financial statements. The consolidating information is presented for purposes of additional analysis of the consolidated financial statements rather than to present the financial position, changes in net assets and cash flows of the individual companies within NYU and is not a required part of the consolidated financial statements. The individual reporting entities within NYU as presented within the consolidating information are disclosed within Note 1 to the consolidated financial statements.

The consolidating financial statements were prepared on an accrual basis of accounting, consistent with the consolidated financial statements (Note 2). All transactions between and amounts due to (from) the reporting entities within NYU have been eliminated within the consolidating supplemental schedules.

Part II Supplemental Schedule of Expenditures of Federal Awards

New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Department of Agriculture Food and Nutrition Service KSU/USAF 2012 FAP Research Project 10.200$ - $ (4,260) Kansas State University S13114 $ (4,260) $ - Phase II Expansion and Phase III: Caseload Management Model Project 10.200 - 149,913 Kansas State University Requested 2018-06-27 149,913 - US Air Force Family Advocacy Research Project: Program Implementation Evaluation 10.200 - 221 Pennsylvania State University 5508-NYU-USDA-0264 221 - - 145,874 145,874 - Assessing Intermediated Marketing Channels for Beginning Farmers and Ranchers to Enhance Farm Viability 10.310 - 40,181 Syracuse University 28361-04254-S02 Amd 2 40,181 - Assessing the Outputs of Government-Funded University Research: The Case of Food Safety and Security 10.310 - 663 Syracuse University 28361-04254-S02 Amd 2 663 - Building Capacity to Control Foodborne Disease: A Transitional Multidisciplinary Approach 10.310 - 135 Georgia Institute of Technology RF468-G2 (Amd 1) 135 - Agriculture and Food Research Initiative (AFRI) 10.310 119,063 - 119,063 - Agriculture and Food Research Initiative (AFRI) 10.310 760,136 - North Carolina State University 2011-0494-25 Amd No. 1 760,136 88,862 879,199 40,979 920,178 88,862 Cooperative Extension Service 10.500 2,251,103 - 2,251,103 - Developing FAP Maltreatment Trainings 10.500 - 1,148 Kansas State University S14013 1,148 - 2,251,103 1,148 2,252,251 - Total U.S. Department of Agriculture Food and Nutrition Service 3,130,302 188,001 3,318,303 88,862 U.S. Department of Commerce Marine Debris Program 11.RD 205,801 - 205,801 - 205,801 - 205,801 - Research and Evaluation Program 11.312 116,935 - 116,935 138,324 116,935 - 116,935 138,324 National Oceanic and Atmospheric Administration (NOAA) Cooperative Institutes 11.432 - 42,277 University of Georgia RR272-718/S001505 42,277 - National Oceanic and Atmospheric Administration (NOAA) Cooperative Institutes 11.432 - 38,831 Cornell University 16-A0-00-005828 38,831 - - 81,108 81,108 - Unallied Science Program 11.472 - 1,293 University of Georgia RR272-465/5054016 1,293 - - 1,293 1,293 - Comparative Environmental DNA Analysis of Hawaiian Coral Reef Fishes 11.482 - 33,359 National Fish and Wildlife Foundation(nfwf) 0302.16.053131 33,359 18,823 - 33,359 33,359 18,823 Standard Reference Materials 11.604 185 - 185 - 185 - 185 - Measurement and Engineering Research and Standards 11.609 725,574 - 725,574 100,695 725,574 - 725,574 100,695 Total U.S. Department of Commerce 1,048,495 115,760 1,164,255 257,842 U.S. Department of Defense Department of Defense 12.RD - 7,864 State University of New York Upstate Med Engineering T Cells Again 7,864 - Department of Defense 12.RD (3,837) - W81XWH-14-1-0043 (3,837) - 2017-2018 Interpersonnel Agreement for Adam Jay Harrison for MD5/NSTA 12.RD 141,689 - 2017-2018 Interpersonnel Agreement 141,689 - Innovative Transformative Applications Program (ITAP) MD5 12.RD - 16,191 Gxm Consulting, LLC Modification No. 2 16,191 - MD5/National Security Technology Accelerator (NSTA) 12.RD - 260,817 Civil-military Innovation Institute, Inc. CMI2-NYU-1801-001 260,817 - Accessing Urban Physiology : Development of methodologies for accessing urban patterns of activity. 12.RD - 1,308 North Carolina State University 2017-1532-14 1,308 - Cyber Security via Signaling Games (MBMC) Phase II 12.RD - 24 Carnegie Mellon University 15-00314-SUB-002 24 - ENSURE: An ENd-to-End SecURE Obfuscation for HLS 12.RD - 128,971 The Boeing Company Purchase Contract No. 1445821 Item 0002 128,971 - Foresight and Understanding from Scientific Exposition (FUSE) 12.RD - 6 Bae Systems 770966 6 - Millimeter Wave adaptive Beamforming Algorithms and Prototyping 12.RD (652) - (652) - Multi-Resolution Utility Discovery and Maximization 12.RD - 39,613 Bae Systems 1006435-2 39,613 - MD5/NSTA 12.RD - 420,376 Civil-military Innovation Institute, Inc. 1803-001 420,376 - Prospective Longitudinal Study of Mild Traumatic Brain Injury (mTBI) and Post Concussion Syndrome (OCS) - Analysis Us 12.RD - (9,961) Hackensack University Medical Center PO#MM01B-0000110817 (9,961) - 137,200 865,209 1,002,409 - A Game-Theoretic Approach to Optimizing Behaviors in Acquisition 12.300 - 44,398 Carnegie Mellon University 17-00356-SUB-000 Amd 1 44,398 - Basic and Applied Scientific Research 12.300 - (159) University of California, San Diego 87048634 (159) - Basic and Applied Scientific Research 12.300 - 108,483 University of California, Davis A17-0260-S003 108,483 - Basic and Applied Scientific Research 12.300 7,911 - 7,911 - Basic and Applied Scientific Research 12.300 (1) - (1) - Basic and Applied Scientific Research 12.300 (64,218) - (64,218) (61,119) Basic and Applied Scientific Research 12.300 165,899 - 165,899 - Basic and Applied Scientific Research 12.300 184,262 - 184,262 - Basic and Applied Scientific Research 12.300 46,360 - 46,360 - Basic and Applied Scientific Research 12.300 166,623 - 166,623 - Basic and Applied Scientific Research 12.300 323 - 323 - Basic and Applied Scientific Research 12.300 670,109 - 670,109 84,220 Basic and Applied Scientific Research 12.300 119,993 - 119,993 - Basic and Applied Scientific Research 12.300 57,714 - 57,714 -

The accompanying notes are an integral part of this schedule. 56 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Department of Defense (continued) Basic and Applied Scientific Research 12.300 422,332 - 422,332 - Basic and Applied Scientific Research 12.300 416,188 - 416,188 245,390 Basic and Applied Scientific Research 12.300 3,357 - 3,357 - Basic and Applied Scientific Research 12.300 8,237 - 8,237 - Basic and Applied Scientific Research 12.300 131,001 - 131,001 - Basic and Applied Scientific Research 12.300 18,270 - 18,270 - Basic and Applied Scientific Research 12.300 30,934 - 30,934 - Basic and Applied Scientific Research 12.300 79,990 - 79,990 - Basic and Applied Scientific Research 12.300 103,926 - 103,926 - Causal inference using hierarchical and nonparametric Bayesian interaction models 12.300 - 26,881 Columbia University A(GG012619) Amd 2 26,881 - Cooperative Multicast and Broadcast at the Tactical Edge (COMBAT) 12.300 - 37,274 University of Southern California 73098281 Amd No. 5 37,274 - Embedasploit: A "Pen-Test in a Box" for Industrial Control System 12.300 - 162,189 Georgia Institute of Technology RF823-G1 Amd 2 162,189 - Media Forensics Integrity Analytics 12.300 - 173,086 Purdue University 4104-75026 Amd. No. 4 173,086 - Towards verification-guided hardware synthesis for security 12.300 - 1,091 Texas A&M Engineering Experiment Station M1801652 Amd 001 1,091 - 2,569,210 553,243 3,122,453 268,491 Military Medical Research and Development 12.420 5,028 - 5,028 - Military Medical Research and Development 12.420 530,337 - 530,337 - Military Medical Research and Development 12.420 313,412 - 313,412 - Military Medical Research and Development 12.420 808,458 - 808,458 - Military Medical Research and Development 12.420 - 13,005 University of Pittsburgh Medical Center 0053521(412472-4) 13,005 - Military Medical Research and Development 12.420 - 47,006 Columbia University 1(GG012666) 47,006 - Military Medical Research and Development 12.420 - 143,249 Johns Hopkins University 2003475766 143,249 - Military Medical Research and Development 12.420 - 50,590 Henry M. Jackson Foundation (HJF) 3591 50,590 - Military Medical Research and Development 12.420 - 2,532 University of Delaware 42272 2,532 - Military Medical Research and Development 12.420 - 7,177 Research Foundation of SUNY 68864 7,177 - Military Medical Research and Development 12.420 72,702 - 72,702 24,322 Military Medical Research and Development 12.420 (48) - (48) - Military Medical Research and Development 12.420 231,582 - 231,582 - Military Medical Research and Development 12.420 233,970 - 233,970 - Military Medical Research and Development 12.420 128,724 - 128,724 - Military Medical Research and Development 12.420 474,040 - 474,040 146,627 Military Medical Research and Development 12.420 511 - 511 - Military Medical Research and Development 12.420 226,635 - 226,635 - Military Medical Research and Development 12.420 489,223 - 489,223 - Military Medical Research and Development 12.420 310,810 - 310,810 - Military Medical Research and Development 12.420 139,012 - 139,012 - Military Medical Research and Development 12.420 407,504 - 407,504 - Military Medical Research and Development 12.420 285,824 - 285,824 - Military Medical Research and Development 12.420 89,795 - 89,795 - Military Medical Research and Development 12.420 200,800 - 200,800 - Military Medical Research and Development 12.420 31,673 - 31,673 - Military Medical Research and Development 12.420 503,105 - 503,105 - Military Medical Research and Development 12.420 (3,197) - (3,197) - Military Medical Research and Development 12.420 244,510 - 244,510 - Military Medical Research and Development 12.420 744,438 - 744,438 5,501 Military Medical Research and Development 12.420 785,081 - 785,081 103,825 Military Medical Research and Development 12.420 275,419 - 275,419 - Military Medical Research and Development 12.420 197,571 - 197,571 - Military Medical Research and Development 12.420 123,635 - 123,635 - Military Medical Research and Development 12.420 264,150 - 264,150 7,850 Military Medical Research and Development 12.420 365,880 - 365,880 - Military Medical Research and Development 12.420 124,009 - 124,009 - Military Medical Research and Development 12.420 389,838 - 389,838 - Military Medical Research and Development 12.420 84,891 - 84,891 27,732 Military Medical Research and Development 12.420 280,282 - 280,282 - Military Medical Research and Development 12.420 206,323 - 206,323 - Military Medical Research and Development 12.420 - 509 Wake Forest University WFUHS 441038 CTA-08 509 - 9,565,927 264,068 9,829,995 315,857 Basic Scientific Research 12.431 (26) - (26) - Basic Scientific Research 12.431 1,004 - 1,004 - Basic Scientific Research 12.431 194,296 - 194,296 - Basic Scientific Research 12.431 152,330 - 152,330 - Basic Scientific Research 12.431 217,963 - 217,963 110,464 Basic Scientific Research 12.431 72,956 - 72,956 - Basic Scientific Research 12.431 28,641 - 28,641 - Basic Scientific Research 12.431 132,513 - 132,513 - Basic Scientific Research 12.431 86,937 - 86,937 - Basic Scientific Research 12.431 259,763 - 259,763 - Basic Scientific Research 12.431 - 122,561 Luna, Inc. 16-A0-00-007052 122,561 -

The accompanying notes are an integral part of this schedule. 57 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Department of Defense (continued) Closed-Loop Multisensory Brain-Computer Interface for Enhanced Decision Accuracy 12.431 - 137,917 University of Southern California 79573913 A03 137,917 - Dynamics and Control of Switching Complex Networks - Proposal No. 63928-NS-H 12.431 - 54,886 Georgia State University SP00012020-01 Amd No. 3 54,886 - Geometric and Graph Structures in Information Characterization and Extraction 12.431 - 31,573 University of Pennsylvania 572558 31,573 - Hybrid Epitaxial Semiconductor-Superconductor Qubits 12.431 - 48,859 University of Maryland 60590-Z8078201 48,859 - Lateral Stirring by Internal Waves in the LatMix Campaign 12.431 - 2,356 Northwest Research Associates, Inc. NWRA-15-S-183 2,356 - Near and Far-Field Interfaces to DNA-Guided Nanostructures from RF to Lightwave: Exploiting the Spectrum 12.431 - 525 University of California, Irvine 2010-2515 A10 525 - Reconfigurable Matter from Programmable colloids 12.431 - 1,584 University of Michigan 3001750680 1,584 - Theory and Experiment of Cocrystals: Principles Synthesis and Properties 12.431 - 134,527 University of Michigan 3002780205 A07 134,527 - Unlearning Neural Systems Dysfunction in Neuropsychiatric Disorders 12.431 - 162,699 The Regents of the University of California 8180sc A05 162,699 - 1,146,377 697,487 1,843,864 110,464 STTR Phase II: Field Drug Identification Kit 12.630 - 206,359 Sensodx, LLC STTR Phase II - 1004 Amendment 1 206,359 - - 206,359 206,359 - Uniformed Services University Medical Research Projects 12.750 - 25,014 Henry M. Jackson Foundation (HJF) 904872 25,014 - - 25,014 25,014 - (YIP) Epitaxial superconductor-semiconductor materials systems for quantum computation 12.800 - 110,894 City College (CUNY) CM00001924-00 A01 110,894 - A Compressed Sensing Approach to Signal Fragmentation 12.800 - 67,886 University of California, Los Angeles 1010 GVA 387 Amendment 1 67,886 - Air Force Defense Research Sciences Program 12.800 100,259 - 100,259 - Air Force Defense Research Sciences Program 12.800 235,016 - 235,016 127,158 Air Force Defense Research Sciences Program 12.800 115,772 - 115,772 - Domain Vocabulary Extraction and Tranduction and Auto-Induction of Layout (DOVETAIL) PHASE 2 12.800 - 3 Sri International 27-001373 3 - Kinetic Simulation of Non-Equilibrium Plasmas 12.800 - 86,250 University of California, Los Angeles 1010 G VA386 86,250 - Lifted Inference for Probabilistic Programming 12.800 - 7,540 Sri International 19-000249 MOD NO. 8 7,540 - 451,047 272,573 723,620 127,158 Mathematical Sciences Grants 12.901 125 - 125 - 125 - 125 - A Data-Driven,Operator-Theoretic Framework for Space-time Analysis of Process Dynamics 12.910 - 104,444 Aimdyn, Inc 25-74200-S3946 Year 2 104,444 - A Synthetic Immune System based on Peptoid NanoSwatches 12.910 - 62,896 Lawrence Berkeley National Laboratory 7114069 MOD 9 62,896 - Continual Learning Across Synapses Circuits and Brain Areas 12.910 - 75,974 Baylor College of Medicine PO 7000000604 75,974 - Engineering Therapies that Evolve to Autonomously Control Epidemics 12.910 - 69,904 The J David Gladstone Institutes R2451-C 69,904 - MediFor Technical Area (TA) 2 - Integrity Reasoning Engine and MedifFor Console Development 12.910 - 17,846 Sri International PO 1811 MOD 3 17,846 - MEGA: BISC: Bioelectronic Interfacing to Sensory Cortex using massive fully implanted flexible wireless CMOS surface re 12.910 - 194,250 Columbia University 6(GG012664) A03 194,250 - Multi-terminal hybrid InAs/superconductor Josephson junctions 12.910 - 42,352 University of Maryland, College Park 52225-Z9032201 Amd A 42,352 - Network Back-haul Layered Architecture (NEBULA) NYU Statement of Work: High Variability Congestion Control 12.910 - 137,519 Bae Systems 964185-4 137,519 - RAPID ATTACK DETECTION ISOLATION AND CHARACTERIZATION SYSTEMS (RADICS) 12.910 - 321,888 Sri International PO4814 Mod 6 321,888 - Research and Technology Development 12.910 - (12,662) Columbia University 1(GG009414) (12,662) - Research and Technology Development 12.910 - 274,207 Columbia University 2(GG008460-01) 274,207 - Research and Technology Development 12.910 - 369,563 University of Wisconsin 738K065 369,563 - Research and Technology Development 12.910 134,867 - 134,867 - Research and Technology Development 12.910 393,279 - 393,279 121,156 Research and Technology Development 12.910 - 532,400 Evocative Design HR001117C0068 532,400 - Research and Technology Development 12.910 - 64,723 J. David Gladstone Institute R2451-B 64,723 - Research and Technology Development 12.910 - 188,257 Columbia University RES511430 188,257 - Research and Technology Development 12.910 180,648 - 180,648 - Research and Technology Development 12.910 35,428 - 35,428 - Research and Technology Development 12.910 89,671 - 89,671 - Research and Technology Development 12.910 200,739 - 200,739 47,505 Research and Technology Development 12.910 62,492 - 62,492 - Research and Technology Development 12.910 82,649 - 82,649 - Research and Technology Development 12.910 52,718 - 52,718 - Research and Technology Development 12.910 809,105 - 809,105 - Research and Technology Development 12.910 12,494 - 12,494 - Research and Technology Development 12.910 647,714 - 647,714 14,709 Securely Updating Automobiles 12.910 482,773 - 482,773 - 3,184,577 2,443,561 5,628,138 183,370 Total U.S. Department of Defense 17,054,463 5,327,514 22,381,977 1,005,340 U.S. Department of Housing and Urban Development Small Area Fair Market Rent Demonstration Evaluation 14.RD - 6,827 Abt Associates, Inc. 45117 6,827 - Strong Cities Strong Communities (SC2) National Resource Network 14.RD - 1,272 Enterprise Community Partners 13-7172 1,272 - - 8,099 8,099 - Third Sector Capitol Partners - Planning Phase of Evaluation 14.235 - 14,513 Third Sector Capital Partners, Inc. N/A 14,513 - - 14,513 14,513 - NY-RISE: New York Research Institute for Storm Emergencies 14.269 - 30,727 Research Foundation of SUNY 67784-1-1117044 30,727 71,505 - 30,727 30,727 71,505 General Research and Technology Activity 14.506 3,847 - 3,847 - 3,847 - 3,847 - Total U.S. Department of Housing and Urban Development 3,847 53,339 57,186 71,505

The accompanying notes are an integral part of this schedule. 58 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Department of Justice An In-depth Examination of Batterer Intervention and Alternative Treatment Approaches for Domestic Violence Offenders 16.RD 153,859 - 153,859 10,686 Area 2: Reducing Crime for Girls in the Juvenile Justice System through Researcher-Practitioner Partnerships 16.RD 163,247 - 163,247 - Longitudinal Cohort Study of Interpersonal Violence Among College-Aged Women and Men: Planning Phase 16.RD - 109,787 Westat 6467-S001 109,787 - 317,106 109,787 426,893 10,686 An Impact Evaluation of the Safe Public Spaces Program in NYC Schools 16.560 - 100,827 American Institutes for Research 0395200001 NCE 100,827 - National Institute of Justice Research, Evaluation, and Development Project Grants 16.560 - 203,831 NYC Office of Chief Medical Examiner 816 20171411970 203,831 - National Institute of Justice Research, Evaluation, and Development Project Grants 16.560 - 3,742 NYC Office of Chief Medical Examiner 81615ME0028 3,742 - National Institute of Justice Research, Evaluation, and Development Project Grants 16.560 110,215 - 110,215 - National Institute of Justice Research, Evaluation, and Development Project Grants 16.560 306,388 - 306,388 - 416,603 308,400 725,003 - Edward Byrne Memorial Competitive Grant Program 16.751 400,023 - 400,023 - 400,023 - 400,023 - Innovations in Community-Based Crime Reduction 16.817 221,166 - 221,166 - 221,166 - 221,166 - Total U.S. Department of Justice 1,354,898 418,187 1,773,085 10,686 U.S. Department of State Public Diplomacy Programs 19.040 113 - 113 - 113 - 113 - International Programs to Support Democracy, Human Rights and Labor 19.345 453,300 - 453,300 - 453,300 - 453,300 - Academic Exchange Programs - Scholars 19.401 271,501 - 271,501 450 271,501 - 271,501 450 Counter Narcotics 19.704 46,868 - 46,868 - 46,868 - 46,868 - Total U.S. Department of State 771,782 - 771,782 450 U.S. Department of Transportation Calibration / Development of Safety Performance Functions for New Jersey (2017-01) 20.200 - 121,932 Research Foundation of CUNY 75144-03-28 121,932 16,368 - 121,932 121,932 16,368 Advanced Institute Transportation Education Graduate Scholarship - RF49198-04-28 20.701 - 21,072 Research Foundation of CUNY 49198-04-28 21,072 - Graduate Scholarship (Advanced Institute Transportation Education) 20.701 - 3,363 University Transportation Research Center 49198-04-27 NCE 1 3,363 - Graduate Scholarships (Advanced Institute Transportation Education) 20.701 - 8,278 Research Foundation of CUNY 49198-05-28 8,278 - Pedestrian Fatality & Severe Injury Accidents in New York City 20.701 - (25,527) Research Foundation of CUNY 57863-01-01 (25,527) - Portable and Integrated Multi-Sensor System for Data-Driven Performance Evaluation of Urban Transportation Networks 20.701 - 7,329 Research Foundation of CUNY RF# 49198-41-28 7,329 - Public Transit and Mandatory Evacuations Prior to Extreme Weather Events in New York City 20.701 - 22,893 Research Foundation of CUNY 49198-34-27 22,893 - RECAST 2D: Flexural Performance of Concrete Beams Strengthened using Different Repair Techniques 20.701 - 60,236 Rutgers University 0393 Mod No. 1 60,236 - Research on Concrete Applications for Sustainable Transportation (RE-CAST) 20.701 - 47,554 Rutgers University 5447 - PO# 451707 47,554 - University Transportation Centers Program 20.701 62,897 - 62,897 - University Transportation Centers Program 20.701 1,047,407 - 1,047,407 454,262 1,110,304 145,198 1,255,502 454,262 Total U.S. Department of Transportation 1,110,304 267,130 1,377,434 470,630 National Aeronautics and Space Administration (Pope) Finding Planets around Naked Eye Stars 43.RD - 102,506 NASA Jet Propulsion Laboratory 1592259 Mod1 102,506 - A First Look at the Late Stages of Accretion in Tidal Disruption Flares (Cycle 23) 43.RD - 6,465 Space Telescope Science Institute HST-GO-14255.008-A 6,465 - Enhanced rates of tidal disruptions in E+A galaxies: resolving the central dynamics of post-starburst (Cycle 24) 43.RD - 467 Space Telescope Science Institute HST-GO-14785.009-A 467 - Oceans Melting Greenland-OMG 43.RD - 3,565 NASA Jet Propulsion Laboratory 1541570 Mod 4 3,565 - Titan Submarine SPH Simulations 43.RD 35,169 - 35,169 - 35,169 113,003 148,172 - Open Space: An Engine for Dynamic Visualization of Earth and Space Science for Informal Education and Beyond 43.001 - 214,328 American Museum of Natural History 627-2016-1 Amd 3 214,328 - Science 43.001 225,540 - 225,540 - Science 43.001 934 - 934 - Science 43.001 26,224 - 26,224 - Science 43.001 129,024 - 129,024 29,120 Science 43.001 3,563 - 3,563 - Science 43.001 288,433 - 288,433 108,033 Science 43.001 34,356 - 34,356 - Testing Fundamental Physics With Galaxy Surveys (Leistedt Fellowship) 43.001 - 110,251 Smithsonian Astrophysical Observatory PF6-170154 A05 110,251 - 708,074 324,579 1,032,653 137,153 PACS Observations of Supernova Ejecta and Dust in the Composite Supernova 43.002 - 4,049 NASA Jet Propulsion Laboratory RSA NO. 1479542 4,049 - - 4,049 4,049 - Exploration 43.003 1,031 - 1,031 - Exploration 43.003 20,321 - 20,321 - 21,352 - 21,352 - Space Operations 43.007 102,916 - 102,916 - 102,916 - 102,916 - NASA / New York Space Grant Consortium: National Space Grant College and Fellowship Program 2015-2018 43.008 - 22,388 Cornell University 76156-10488 Amd 4 22,388 - - 22,388 22,388 -

The accompanying notes are an integral part of this schedule. 59 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Aeronautics and Space Administration (continued) Space Technology 43.012 10,221 - 10,221 - Space Technology 43.012 59,510 - 59,510 - 69,731 - 69,731 - Total National Aeronautics and Space Administration 937,242 464,019 1,401,261 137,153 National Endowment for the Humanities Promotion of the Arts Grants to Organizations and Individuals 45.024 30,000 - 30,000 - 30,000 - 30,000 - Promotion of the Humanities Division of Preservation and Access 45.149 92,689 - 92,689 - 92,689 - 92,689 - Promotion of the Humanities Research 45.161 13,340 - 13,340 - Promotion of the Humanities Research 45.161 44,661 - 44,661 - 58,001 - 58,001 - Promotion of the Humanities Office of Digital Humanities 45.169 30,400 - 30,400 23,836 30,400 - 30,400 23,836 Total National Endowment for the Humanities 211,090 - 211,090 23,836 National Science Foundation NCWIT Extension Services Mini Grant 47.RD - 518 Stevens Institute of Technology N/A 518 - - 518 518 - E2CDA: Type I: Antiferromagnetic Magneto-electric Memory and Logic 47.041 - 65,418 University of Nebraska N/A 65,418 - EFRI - ODISSEI: Foldable Self-Replicating DNA Nanostructures for Organization of Functional Nanomaterials and 3D Meta 47.041 - 44,444 California Institute of Technology S385012 A06 44,444 - EFRI - ODISSEI: Foldable Self-Replicating DNA Nanostructures for Organization of Functional Nanomaterials and 3D Meta 47.041 - 39,984 California Institute of Technology S385012 A06 39,984 - EFRI - ODISSEI: Foldable Self-Replicating DNA Nanostructures for Organization of Functional Nanomaterials and 3D Meta 47.041 - 58,743 California Institute of Technology S385012 A06 58,743 - Engineering Grants 47.041 48,294 - 48,294 - Engineering Grants 47.041 75,420 - 75,420 30,489 Engineering Grants 47.041 15,546 - 15,546 - Engineering Grants 47.041 15,543 - 15,543 - Engineering Grants 47.041 103,340 - 103,340 - Engineering Grants 47.041 26,849 - 26,849 - Engineering Grants 47.041 1,152 - 1,152 - Engineering Grants 47.041 (3,203) - (3,203) - Engineering Grants 47.041 43,000 - 43,000 - Engineering Grants 47.041 99,688 - 99,688 - Engineering Grants 47.041 36,738 - 36,738 - Engineering Grants 47.041 99,499 - 99,499 31,410 Engineering Grants 47.041 108,094 - 108,094 23,326 Engineering Grants 47.041 49,725 - 49,725 - Engineering Grants 47.041 60,944 - 60,944 - Engineering Grants 47.041 225,692 - 225,692 - Engineering Grants 47.041 46,538 - 46,538 - Engineering Grants 47.041 79,130 - 79,130 - Engineering Grants 47.041 79,809 - 79,809 - Engineering Grants 47.041 3 - 3 - Engineering Grants 47.041 68,205 - 68,205 - Engineering Grants 47.041 6,714 - 6,714 - Engineering Grants 47.041 88,861 - 88,861 - Engineering Grants 47.041 980 - 980 - Engineering Grants 47.041 78,597 - 78,597 - Engineering Grants 47.041 12,189 - 12,189 - Engineering Grants 47.041 89,520 - 89,520 - Engineering Grants 47.041 9,285 - 9,285 - Engineering Grants 47.041 36,609 - 36,609 - Engineering Grants 47.041 1,508 - 1,508 - Engineering Grants 47.041 76,073 - 76,073 - Engineering Grants 47.041 17,232 - 17,232 - Engineering Grants 47.041 70,878 - 70,878 - Engineering Grants 47.041 15,838 - 15,838 - Engineering Grants 47.041 34,538 - 34,538 - Engineering Grants 47.041 73,690 - 73,690 - Engineering Grants 47.041 33,236 - 33,236 - Engineering Grants 47.041 63,837 - 63,837 - Engineering Grants 47.041 166,162 - 166,162 - Engineering Grants 47.041 91,073 - 91,073 - Engineering Grants 47.041 48,927 - 48,927 - Engineering Grants 47.041 10,001 - 10,001 - Engineering Grants 47.041 363,013 - 363,013 - Multi-scale Infrastructure Interactions with Intermittent Disruptions: Coastal Flood Protection, Transportation and Governan 47.041 - 116,296 University Of California, Berkeley 9168 116,296 - Expanding Open Innovation Methods to Complex Engineered Systems 47.041 - 54,691 George Washington University 15-S30-Mod #1 54,691 - I-Corps Node (Track 2): New York City Regional Innovation Node (NYCRIN) 47.041 - 172,442 Research Foundation of CUNY CM00001895-00 Amd 1 172,442 -

The accompanying notes are an integral part of this schedule. 60 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Science Foundation (continued) Mathematical and Physical Sciences 47.049 156,857 - 156,857 - Mathematical and Physical Sciences 47.049 140,748 - 140,748 - Mathematical and Physical Sciences 47.049 133,652 - 133,652 - Mathematical and Physical Sciences 47.049 124,481 - 124,481 - Mathematical and Physical Sciences 47.049 81,996 - 81,996 - Mathematical and Physical Sciences 47.049 77,965 - 77,965 - Mathematical and Physical Sciences 47.049 192,926 - 192,926 - Mathematical and Physical Sciences 47.049 91,302 - 91,302 - Mathematical and Physical Sciences 47.049 1,119 - 1,119 - Mathematical and Physical Sciences 47.049 159,748 - 159,748 - Mathematical and Physical Sciences 47.049 82,680 - 82,680 - Mathematical and Physical Sciences 47.049 179,521 - 179,521 - Mathematical and Physical Sciences 47.049 30,016 - 30,016 - Mathematical and Physical Sciences 47.049 (894) - (894) - Mathematical and Physical Sciences 47.049 20,481 - 20,481 - Mathematical and Physical Sciences 47.049 99,083 - 99,083 - Mathematical and Physical Sciences 47.049 38,839 - 38,839 - Mathematical and Physical Sciences 47.049 (243) - (243) - Mathematical and Physical Sciences 47.049 84,496 - 84,496 - Mathematical and Physical Sciences 47.049 21,823 - 21,823 - Mathematical and Physical Sciences 47.049 79,195 - 79,195 - Mathematical and Physical Sciences 47.049 54,054 - 54,054 - Mathematical and Physical Sciences 47.049 77,364 - 77,364 - Mathematical and Physical Sciences 47.049 157,904 - 157,904 - Mathematical and Physical Sciences 47.049 173,185 - 173,185 - Mathematical and Physical Sciences 47.049 1,976 - 1,976 - Mathematical and Physical Sciences 47.049 96,147 - 96,147 - Mathematical and Physical Sciences 47.049 66,203 - 66,203 - Mathematical and Physical Sciences 47.049 147,154 - 147,154 - Mathematical and Physical Sciences 47.049 58,992 - 58,992 - Mathematical and Physical Sciences 47.049 867 - 867 - Mathematical and Physical Sciences 47.049 32,343 - 32,343 - Mathematical and Physical Sciences 47.049 60,598 - 60,598 - Mathematical and Physical Sciences 47.049 8,461 - 8,461 - Mathematical and Physical Sciences 47.049 124,003 - 124,003 Mathematical and Physical Sciences 47.049 68,158 - 68,158 - Mathematical and Physical Sciences 47.049 77,345 - 77,345 - Mathematical and Physical Sciences 47.049 122,625 - 122,625 - MRSEC: Genetically Engineered Polypeptides for Inorganics 47.049 - 3,959 University of Washington 164935 3,959 - 12,286,013 128,860 12,414,873 76,838 Geosciences 47.050 129,794 - 129,794 - Geosciences 47.050 53,890 - 53,890 - Geosciences 47.050 (154) - (154) - Geosciences 47.050 33,148 - 33,148 - Geosciences 47.050 22,093 - 22,093 - 238,771 - 238,771 - ASCENT: Advancing Computer Science Careers through Enhanced Networking and Training 47.070 - 57,524 Computing Research Association POSTDOC005 57,524 - CIF21 DIBBs: EI: Vizier Streamlined Data Curation 47.070 - 134,959 University At Buffalo R1045441 (Amd 1) 134,959 - EAGER:Collaborative:Ewitness-Preserve and Prove Forensic Soundness of Digital Evidence 47.070 15,196 - 15,196 - Computer and Information Science and Engineering 47.070 123,907 - 123,907 - Computer and Information Science and Engineering 47.070 55,621 - 55,621 31,573 Computer and Information Science and Engineering 47.070 109,292 - 109,292 - Computer and Information Science and Engineering 47.070 10,306 - 10,306 - Computer and Information Science and Engineering 47.070 (5,823) - (5,823) - Computer and Information Science and Engineering 47.070 136,729 - 136,729 - Computer and Information Science and Engineering 47.070 (1,456) - (1,456) - Computer and Information Science and Engineering 47.070 (171) - (171) - Computer and Information Science and Engineering 47.070 98,022 - 98,022 - Computer and Information Science and Engineering 47.070 2,662 - 2,662 - Computer and Information Science and Engineering 47.070 34,368 - 34,368 - Computer and Information Science and Engineering 47.070 2,860 - 2,860 - Computer and Information Science and Engineering 47.070 39,453 - 39,453 40,999 Computer and Information Science and Engineering 47.070 6,741 - 6,741 - Computer and Information Science and Engineering 47.070 464,323 - 464,323 - Computer and Information Science and Engineering 47.070 74,993 - 74,993 - Computer and Information Science and Engineering 47.070 84,526 - 84,526 - Computer and Information Science and Engineering 47.070 4,265 - 4,265 - Computer and Information Science and Engineering 47.070 9,658 - 9,658 - Computer and Information Science and Engineering 47.070 123,990 - 123,990 -

The accompanying notes are an integral part of this schedule. 61 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Science Foundation (continued) Computer and Information Science and Engineering 47.070 17,385 - 17,385 - Computer and Information Science and Engineering 47.070 242,448 - 242,448 - Computer and Information Science and Engineering 47.070 174,511 - 174,511 - Computer and Information Science and Engineering 47.070 96,247 - 96,247 - Computer and Information Science and Engineering 47.070 39,825 - 39,825 - Computer and Information Science and Engineering 47.070 79,747 - 79,747 - Computer and Information Science and Engineering 47.070 161,369 - 161,369 - Computer and Information Science and Engineering 47.070 176,679 - 176,679 - Computer and Information Science and Engineering 47.070 101,580 - 101,580 - Computer and Information Science and Engineering 47.070 74,759 - 74,759 39,964 Computer and Information Science and Engineering 47.070 74,645 - 74,645 - Computer and Information Science and Engineering 47.070 188,973 - 188,973 - Computer and Information Science and Engineering 47.070 875 - 875 - Computer and Information Science and Engineering 47.070 49,756 - 49,756 - Computer and Information Science and Engineering 47.070 1,855 - 1,855 - Computer and Information Science and Engineering 47.070 181,050 - 181,050 - Computer and Information Science and Engineering 47.070 156,070 - 156,070 - Computer and Information Science and Engineering 47.070 309,859 - 309,859 165,075 Computer and Information Science and Engineering 47.070 (882) - (882) - Computer and Information Science and Engineering 47.070 29,431 - 29,431 - Computer and Information Science and Engineering 47.070 (246) - (246) - Computer and Information Science and Engineering 47.070 199,543 - 199,543 - Computer and Information Science and Engineering 47.070 134,641 - 134,641 83,989 Computer and Information Science and Engineering 47.070 7,021 - 7,021 - Computer and Information Science and Engineering 47.070 (4,606) - (4,606) - Computer and Information Science and Engineering 47.070 87 - 87 - Computer and Information Science and Engineering 47.070 89,526 - 89,526 - Computer and Information Science and Engineering 47.070 68,637 - 68,637 - Computer and Information Science and Engineering 47.070 129,035 - 129,035 - Computer and Information Science and Engineering 47.070 1,609 - 1,609 - Computer and Information Science and Engineering 47.070 67,154 - 67,154 - Computer and Information Science and Engineering 47.070 121,000 - 121,000 - Computer and Information Science and Engineering 47.070 140,195 - 140,195 - Computer and Information Science and Engineering 47.070 366,996 - 366,996 - Computer and Information Science and Engineering 47.070 3,503 - 3,503 - Computer and Information Science and Engineering 47.070 (494) - (494) - Computer and Information Science and Engineering 47.070 143,271 - 143,271 66,821 Computer and Information Science and Engineering 47.070 45,797 - 45,797 - Computer and Information Science and Engineering 47.070 149,636 - 149,636 - Computer and Information Science and Engineering 47.070 39,976 - 39,976 - Computer and Information Science and Engineering 47.070 2,519 - 2,519 - Computer and Information Science and Engineering 47.070 115,889 - 115,889 - Computer and Information Science and Engineering 47.070 (1,565) - (1,565) - Computer and Information Science and Engineering 47.070 97,189 - 97,189 - Computer and Information Science and Engineering 47.070 160,700 - 160,700 67,629 Computer and Information Science and Engineering 47.070 83,235 - 83,235 - Computer and Information Science and Engineering 47.070 44,387 - 44,387 - Computer and Information Science and Engineering 47.070 20,415 - 20,415 - Computer and Information Science and Engineering 47.070 63,257 - 63,257 - Computer and Information Science and Engineering 47.070 418,705 - 418,705 - Computer and Information Science and Engineering 47.070 100,759 - 100,759 - Computer and Information Science and Engineering 47.070 83,672 - 83,672 39,622 Computer and Information Science and Engineering 47.070 52,646 - 52,646 - Computer and Information Science and Engineering 47.070 40,493 - 40,493 - Computer and Information Science and Engineering 47.070 74,585 - 74,585 - Computer and Information Science and Engineering 47.070 25,819 - 25,819 - Computer and Information Science and Engineering 47.070 80,000 - 80,000 - Computer and Information Science and Engineering 47.070 151,685 - 151,685 - Computer and Information Science and Engineering 47.070 75,097 - 75,097 - Computer and Information Science and Engineering 47.070 32,148 - 32,148 - Computer and Information Science and Engineering 47.070 40,884 - 40,884 - Computer and Information Science and Engineering 47.070 97,209 - 97,209 - Computer and Information Science and Engineering 47.070 11,870 - 11,870 - Computer and Information Science and Engineering 47.070 121,012 - 121,012 - Computer and Information Science and Engineering 47.070 45,809 - 45,809 - Computer and Information Science and Engineering 47.070 91,066 - 91,066 -

The accompanying notes are an integral part of this schedule. 62 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Science Foundation (continued) Computer and Information Science and Engineering 47.070 21,274 - 21,274 - Computer and Information Science and Engineering 47.070 152,218 - 152,218 - Computer and Information Science and Engineering 47.070 44,154 - 44,154 - Computer and Information Science and Engineering 47.070 302 - 302 - Computer and Information Science and Engineering 47.070 75,402 - 75,402 - Computer and Information Science and Engineering 47.070 68,657 - 68,657 - Computer and Information Science and Engineering 47.070 28,526 - 28,526 - Computer and Information Science and Engineering 47.070 17,314 - 17,314 - Computer and Information Science and Engineering 47.070 5,000 - 5,000 - COSMOS: Cloud-Enhanced Open Software-Defined Mobile-Wireless Testbed 47.070 - 39,208 Rutgers University 0424 - PO #842619 39,208 - 7,790,257 231,691 8,021,948 535,672 Biological Sciences 47.074 12,507 - 12,507 - Biological Sciences 47.074 204,401 - 204,401 - Biological Sciences 47.074 119,332 - 119,332 - Biological Sciences 47.074 496,995 - 496,995 321,835 Biological Sciences 47.074 302,371 - 302,371 - Biological Sciences 47.074 169,442 - 169,442 - Biological Sciences 47.074 4,456 - 4,456 - Biological Sciences 47.074 153,793 - 153,793 - Biological Sciences 47.074 977,831 - 977,831 175,863 Biological Sciences 47.074 31,760 - 31,760 - Biological Sciences 47.074 54,040 - 54,040 - Biological Sciences 47.074 62,380 - 62,380 - Biological Sciences 47.074 102 - 102 - Biological Sciences 47.074 357,946 - 357,946 - Biological Sciences 47.074 85,939 - 85,939 - Biological Sciences 47.074 241 - 241 - Biological Sciences 47.074 476,618 - 476,618 - Biological Sciences 47.074 - 70,137 University of Michigan 3004704725 70,137 - Biological Sciences 47.074 543 - 543 - Biological Sciences 47.074 (1,321) - (1,321) - MaizeCode - An Initial Analysis of Functional Elements in the Maize Genome 47.074 - 190,958 Cold Spring Harbor Laboratory 52560318 A03 190,958 - 3,509,376 261,095 3,770,471 497,698 Carnegie-NYU-Rochester Conference on Public Policy 47.075 - 4,267 Carnegie Mellon University 1122174-378726 4,267 - Econometrics of Asymmetric Information Models with Applications to Nonlinear Pricing, Insurance and Compensation 47.075 3,257 - 3,257 - Social, Behavioral, and Economic Sciences 47.075 63,983 - 63,983 - Social, Behavioral, and Economic Sciences 47.075 (524) - (524) - Social, Behavioral, and Economic Sciences 47.075 431,454 - 431,454 110,864 Social, Behavioral, and Economic Sciences 47.075 121,473 - 121,473 - Social, Behavioral, and Economic Sciences 47.075 193,037 - 193,037 - Social, Behavioral, and Economic Sciences 47.075 106,097 - 106,097 - Social, Behavioral, and Economic Sciences 47.075 11,104 - 11,104 - Social, Behavioral, and Economic Sciences 47.075 21,959 - 21,959 - Social, Behavioral, and Economic Sciences 47.075 2,646 - 2,646 - Social, Behavioral, and Economic Sciences 47.075 95,765 - 95,765 - Social, Behavioral, and Economic Sciences 47.075 134,426 - 134,426 34,157 Social, Behavioral, and Economic Sciences 47.075 280,910 - 280,910 - Social, Behavioral, and Economic Sciences 47.075 2,104 - 2,104 - Social, Behavioral, and Economic Sciences 47.075 124,384 - 124,384 - Social, Behavioral, and Economic Sciences 47.075 125,412 - 125,412 - Social, Behavioral, and Economic Sciences 47.075 38,522 - 38,522 - Social, Behavioral, and Economic Sciences 47.075 14,571 - 14,571 - Social, Behavioral, and Economic Sciences 47.075 13,764 - 13,764 - Social, Behavioral, and Economic Sciences 47.075 74,556 - 74,556 - Social, Behavioral, and Economic Sciences 47.075 5,667 - 5,667 - Social, Behavioral, and Economic Sciences 47.075 3,155 - 3,155 - Social, Behavioral, and Economic Sciences 47.075 85,481 - 85,481 - Social, Behavioral, and Economic Sciences 47.075 80,112 - 80,112 - Social, Behavioral, and Economic Sciences 47.075 77,629 - 77,629 - Social, Behavioral, and Economic Sciences 47.075 114,040 - 114,040 - Social, Behavioral, and Economic Sciences 47.075 437 - 437 - Social, Behavioral, and Economic Sciences 47.075 24,839 - 24,839 - Social, Behavioral, and Economic Sciences 47.075 27,191 - 27,191 - Social, Behavioral, and Economic Sciences 47.075 10,324 - 10,324 - Social, Behavioral, and Economic Sciences 47.075 138,305 - 138,305 - Social, Behavioral, and Economic Sciences 47.075 93,645 - 93,645 - Social, Behavioral, and Economic Sciences 47.075 82,593 - 82,593 - Social, Behavioral, and Economic Sciences 47.075 44,019 - 44,019 - Social, Behavioral, and Economic Sciences 47.075 1,585 - 1,585 - Social, Behavioral, and Economic Sciences 47.075 23,504 - 23,504 - Social, Behavioral, and Economic Sciences 47.075 (19,013) - (19,013) - Social, Behavioral, and Economic Sciences 47.075 13,341 - 13,341 -

The accompanying notes are an integral part of this schedule. 63 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Science Foundation (continued) Social, Behavioral, and Economic Sciences 47.075 26,918 - 26,918 - Social, Behavioral, and Economic Sciences 47.075 14,210 - 14,210 - Social, Behavioral, and Economic Sciences 47.075 2,842 - 2,842 - Social, Behavioral, and Economic Sciences 47.075 4,188 - 4,188 - Social, Behavioral, and Economic Sciences 47.075 1,319 - 1,319 - Social, Behavioral, and Economic Sciences 47.075 122,595 - 122,595 - Social, Behavioral, and Economic Sciences 47.075 39,780 - 39,780 - Social, Behavioral, and Economic Sciences 47.075 3,592 - 3,592 - Social, Behavioral, and Economic Sciences 47.075 5,863 - 5,863 - Social, Behavioral, and Economic Sciences 47.075 2,898 - 2,898 - Social, Behavioral, and Economic Sciences 47.075 18,614 - 18,614 - Social, Behavioral, and Economic Sciences 47.075 25,061 - 25,061 - Social, Behavioral, and Economic Sciences 47.075 575 - 575 - Social, Behavioral, and Economic Sciences 47.075 64,543 - 64,543 - Social, Behavioral, and Economic Sciences 47.075 59,563 - 59,563 - Social, Behavioral, and Economic Sciences 47.075 141,526 - 141,526 - Social, Behavioral, and Economic Sciences 47.075 2,651 - 2,651 - Social, Behavioral, and Economic Sciences 47.075 23,775 - 23,775 - Social, Behavioral, and Economic Sciences 47.075 15,723 - 15,723 - Social, Behavioral, and Economic Sciences 47.075 (72) - (72) - Social, Behavioral, and Economic Sciences 47.075 61,779 - 61,779 - Social, Behavioral, and Economic Sciences 47.075 36,308 - 36,308 - Social, Behavioral, and Economic Sciences 47.075 13,586 - 13,586 - Social, Behavioral, and Economic Sciences 47.075 19,285 - 19,285 - Social, Behavioral, and Economic Sciences 47.075 901 - 901 - Social, Behavioral, and Economic Sciences 47.075 39,729 - 39,729 - Social, Behavioral, and Economic Sciences 47.075 199,461 - 199,461 - Social, Behavioral, and Economic Sciences 47.075 60,418 - 60,418 - Social, Behavioral, and Economic Sciences 47.075 76,125 - 76,125 - Social, Behavioral, and Economic Sciences 47.075 8,912 - 8,912 - Social, Behavioral, and Economic Sciences 47.075 (409) - (409) - Social, Behavioral, and Economic Sciences 47.075 2,110 - 2,110 - Social, Behavioral, and Economic Sciences 47.075 5,253 - 5,253 - Social, Behavioral, and Economic Sciences 47.075 4,295 - 4,295 - Social, Behavioral, and Economic Sciences 47.075 13,218 - 13,218 - Social, Behavioral, and Economic Sciences 47.075 103,026 - 103,026 - Social, Behavioral, and Economic Sciences 47.075 40 - 40 - Social, Behavioral, and Economic Sciences 47.075 78,217 - 78,217 - Social, Behavioral, and Economic Sciences 47.075 21,770 - 21,770 - Social, Behavioral, and Economic Sciences 47.075 50,434 - 50,434 - Social, Behavioral, and Economic Sciences 47.075 68,311 - 68,311 - Traditional Cradling Practices and Short and Long Terms Effects on Infants Development 47.075 - 97,478 Research Foundation of CUNY 40F31-B Amd. 2 97,478 - Urban Resilience to Extreme Weather Related Events Sustainability Research Network (UREx SRN) 47.075 - 48,091 Arizona State University 16-795 Amd 03 48,091 - 4,104,687 149,836 4,254,523 145,021 An Innovative Approach to Earth Science Teacher Preparation: Uniting Science, Informal Science Education, and Schools 47.076 - 1,125 American Museum of Natural History 7-2011 1,125 - Collaborative Research: STEM Training, Employment in Industry & Entrepreneurship 47.076 - 222,790 Ohio State University 60048778-NYU ORG Code Change 222,790 13,716 Collaborative Research: Improving the Implementation of Rigorous Instructional Materials in Middle-Grades Mathematics: 47.076 - 63,428 University of Washington UWSC9582 Amd 2; PO: BPO20403 63,428 - Education and Human Resources 47.076 58,410 - 58,410 - Education and Human Resources 47.076 81,634 - 81,634 - Education and Human Resources 47.076 46,000 - 46,000 - Education and Human Resources 47.076 - (1,016) University of California San Diego 44115522 (1,016) - Education and Human Resources 47.076 124,856 - 124,856 - Education and Human Resources 47.076 1,558,518 - 1,558,518 - Education and Human Resources 47.076 113,548 - 113,548 - Education and Human Resources 47.076 19,806 - 19,806 - Education and Human Resources 47.076 77,069 - 77,069 62,444 Education and Human Resources 47.076 292,951 - 292,951 - Education and Human Resources 47.076 591,405 - 591,405 273,490 Education and Human Resources 47.076 132,609 - 132,609 - Education and Human Resources 47.076 58,834 - 58,834 - Education and Human Resources 47.076 1,484 - 1,484 - Education and Human Resources 47.076 126,642 - 126,642 - Education and Human Resources 47.076 1,043,727 - 1,043,727 - Education and Human Resources 47.076 81,045 - 81,045 - Education and Human Resources 47.076 94,400 - 94,400 - Education and Human Resources 47.076 485,551 - 485,551 - Education and Human Resources 47.076 89,728 - 89,728 - Education and Human Resources 47.076 842 - 842 - Education and Human Resources 47.076 12,672 - 12,672 - Education and Human Resources 47.076 (5,682) - (5,682) - Education and Human Resources 47.076 552,451 - 552,451 -

The accompanying notes are an integral part of this schedule. 64 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster National Science Foundation (continued) Education and Human Resources 47.076 274,589 - 274,589 - Education and Human Resources 47.076 175,214 - 175,214 100,449 Education and Human Resources 47.076 2,928 - 2,928 - Education and Human Resources 47.076 (116) - (116) - Education and Human Resources 47.076 435,254 - 435,254 - Helping Parents to See Mathematics Ability as Malleable: Implications for Children's Mathematics Learning 47.076 - 12,771 University of Illinois, Urbana-champaign 079340-16174 Amd 01 12,771 - IDEAS: Inventing, Designing, and Engineering on the Autism Spectrum 47.076 - 59,523 Education Development Center 12041 Amd 2 59,523 - IDEAS: Inventing, Designing, and Engineering on the Autism Spectrum 47.076 - 44,566 Education Development Center 12041 Amd 2 44,566 - Improving Math Identity for Underrepresented Populations: An Implementation and Impact Study of the After-School Math 47.076 - 30,961 Impaq International 1515586-2578 mod # 4 30,961 - Mercy Intensive STEM Teacher Initiative (MISTI) 47.076 - 6,325 Mercy College 1339951-SA1 6,325 - NRT-IGE: Information Infrastructure for Society: Integrating Data Science and Social Science in Graduate Education and W 47.076 - 49,780 University of Maryland, College Park 42176-Z4801002 Amd B 49,780 - Stereotype-based contagion in Problem Based Learning Contexts and STEM Identification 47.076 - 175,897 University of Delaware 41387 175,897 - Understanding & Improving Learning from Online Mathematics Classroom Videos 47.076 - 45,360 University of Illinois, Urbana-champaign 083755-16481 45,360 - 6,526,369 711,510 7,237,879 450,099 Office of International Science and Engineering 47.079 25,595 - 25,595 - PIRE: Advanced Artificial Muscles for International and Globally Competitive Research and Education in Soft Robotics 47.079 - 93,425 University of Nevada, Las Vegas 71415560A 93,425 - 25,595 93,425 119,020 - NYC Regional Innovation Node (NYCRIN) 47.080 - 59,370 Research Foundation of CUNY 40D14-C NCE 3 59,370 - - 59,370 59,370 - Office of Integrative Activities 47.083 - 181,292 University of Michigan 3003847460 181,292 - - 181,292 181,292 - Total National Science Foundation 37,149,835 2,510,601 39,660,436 1,790,553 Department of Veterans Affairs IPA Agreement for Pamela Cabahug - PI Alesha Castillo 64.RD 6,508- PO#630C75345 6,508 - VA Medical Center 64.RD 31,486 - CAN #: 8326458 31,486 - VA Medical Center 64.RD 7,491 - VA240-13-D-0049 7,491 - VA Medical Center 64.RD 11,319 - VA242-17-R-0306 11,319 - VA Medical Center 64.RD 88,934 - 16-012IPA, 16-013IPA 88,934 - VA Medical Center 64.RD 13,578 - 18-017IPA 13,578 - VA Medical Center 64.RD 19,407 - 14-016IPA 19,407 - VA Medical Center 64.RD 788,345 - 14-015IPA, 15-005IPA, 16-001IPA, 16-004IPA, 16-006IPA 788,345 - 967,068 - 967,068 - Total Department of Veterans Affairs 967,068 - 967,068 - U.S. Environmental Protection Agency (EPA) Science To Achieve Results (STAR) Research Program 66.509 - 42,800 Research Foundation of SUNY 1132005-2-74711 42,800 - Science To Achieve Results (STAR) Research Program 66.509 - 105,631 American Heart Association FX-ATRAC-NYU-05 105,631 - - 148,431 148,431 - Science To Achieve Results (STAR) Fellowship Program 66.514 20,850- FP-91779201 20,850 - 20,850 - 20,850 - Total U.S. Environmental Protection Agency (EPA) 20,850 148,431 169,281 - U.S. Department of Energy Visual Analytics (AIM Project) 81.RD - 7,993 Pacific Northwest National Laboratory 324753 Modification No. 1 7,993 - Ice Sheet Model Optimization and Uncertainty Quantification 81.RD - 3,002 Triad National Security LLC Triad National Security / 458494 3,002 - - 10,995 10,995 - Center for Bio-Inspired Energy Science (CBES) 81.049 - 200,191 Northwestern University SP0027267-PROJ0007140 200,191 - Immobilized Molecular Catalysts: From Basic Design Principles to Cascade Reactions 81.049 - 226,779 Georgia Institute of Technology E-19-ZE4-G2 A13 226,779 - Office of Science Financial Assistance Program 81.049 164,961 - 164,961 - Office of Science Financial Assistance Program 81.049 137,537 - 137,537 - Office of Science Financial Assistance Program 81.049 171,189 - 171,189 - Office of Science Financial Assistance Program 81.049 1,594 - 1,594- Office of Science Financial Assistance Program 81.049 91,994 - 91,994 - Office of Science Financial Assistance Program 81.049 121,314 - 121,314 - Office of Science Financial Assistance Program 81.049 155,856 - 155,856 - Office of Science Financial Assistance Program 81.049 391,384 - 391,384 - Office of Science Financial Assistance Program 81.049 6,924 - 6,924- Office of Science Financial Assistance Program 81.049 168,873 - 168,873 - Office of Science Financial Assistance Program 81.049 482,477 - 482,477 - Office of Science Financial Assistance Program 81.049 1,017,692 - 1,017,692 797,009 Photothermal Solar Cell 81.049 - 6,704 Aquaneers Inc N/A 6,704 - SBIR: Photothermal Solar Cell 81.049 - 73,729 Aquaneers Inc Phase II: Agreement Dated 2018-04-30 73,729 - 2,911,795 507,403 3,419,198 797,009 Support for Reactor Operators in Case of Cyber-Security Threats 81.121 - 15,232 Ohio State University 60054137 Mod 2 15,232 - - 15,232 15,232 - Advanced Research Projects Agency - Energy 81.135 373,932 - 373,932 - 373,932 - 373,932 - Total U.S. Department of Energy 3,285,727 533,630 3,819,357 797,009

The accompanying notes are an integral part of this schedule. 65 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Department of Education (FLAS) Title VI National Resource Center and Foreign Language and Area Studies Fellowships Program 84.015 - (6,317) Columbia University 1(GG009722-03) (6,317) - National Resource Centers Program for Foreign Language and Area Studies or Foreign Language and International Studie 84.015 306,204 - 306,204 8,300 National Resource Centers Program for Foreign Language and Area Studies or Foreign Language and International Studie 84.015 267,723 - 267,723 59,813 573,927 (6,317) 567,610 68,113 Overseas Programs - Doctoral Dissertation Research Abroad 84.022 68,130 - 68,130 - Overseas Programs - Doctoral Dissertation Research Abroad 84.022 52,150 - 52,150 - 120,280 - 120,280 - Graduate Assistance in Areas of National Need 84.200 27,298 - 27,298 - Graduate Assistance in Areas of National Need 84.200 483,987 - 483,987 - 511,285 - 511,285 - Between Home and School: Distance School Buses and Student Outcomes 84.305 - 112,357 Syracuse University 29267-04675-S01 Mod #1 112,357 - Blended Learning at Scale- Implementation and Analysis of Student Achievement in District of Columbia Public Schools Pr 84.305 - 162,924 United States Department of Education R305H160071-3 162,924 - Developing a Model for Delivering School-Based Mentoring to Students in Military Families 84.305 - 35,729 University of Arkansas R305A140285-17 AMD 4 35,729 - Education Research, Development and Dissemination 84.305 - 36,888 The Children's Hospital of Philadelphia 3272530622 36,888 - Education Research, Development and Dissemination 84.305 32,101 - 32,101 - Education Research, Development and Dissemination 84.305 - 117,712 University of Texas UTA13-000970 117,712 - Education Research, Development and Dissemination 84.305 430,968 - 430,968 26,860 Education Research, Development and Dissemination 84.305 266,682 - 266,682 - Education Research, Development and Dissemination 84.305 197,658 - 197,658 112,006 Education Research, Development and Dissemination 84.305 122,747 - 122,747 45,466 Education Research, Development and Dissemination 84.305 (123) - (123) - Education Research, Development and Dissemination 84.305 614,595 - 614,595 130,735 Education Research, Development and Dissemination 84.305 366,605 - 366,605 35,279 Education Research, Development and Dissemination 84.305 575,862 - 575,862 89,352 Education Research, Development and Dissemination 84.305 1,058,192- 1,058,192 - Education Research, Development and Dissemination 84.305 63,021 - 63,021 - Focused Computer Games that Promote Specific Cognitive Skills 84.305 - 119,841 University of California Santa Barbara KK1605 Amd 04 119,841 - Sustaining the Boost: Longitudinal Impacts of the Boston Prekindergarten Program and Variation in Impacts 84.305 - 36,039 University of Michigan 300336935 Amd 04 36,039 - 3,728,308 621,490 4,349,798 439,698 Reading Apprenticeship Across the Disciples: Effective Secondary Teaching and Learning through Literacy Leadership pro 84.367 - 46,371 Impaq International 2597 mod #4 46,371 - - 46,371 46,371 - Design2Learn 84.411 - 130,556 Expanded Schools N/A 130,556 - - 130,556 130,556 - Total U.S. Department of Education 4,933,800 792,100 5,725,900 507,811 US Department of Health and Human Services HIV Oral Testing Infographic Experiment (HOTIE) 93.RD - 9,936 Yale University GR102086 (CON-80001149) 9,936 - Keeping Pace: Tracking Physical Activity Together - Phase 1 93.RD 5,000 - 5,000 - Dynamic Socioeconomic Disadvantage: Children in Family and School contexts 93.RD - 21,242 University of Michigan 3001006156 21,242 - Population Assessment of Tobacco and Health (PATH) Study I 93.RD - 163,978 Westat 8954 163,978 - Mother and Infant Home Visiting Program Evaluation - Strong Start 93.RD - 15,218 MDRC N/A 15,218 - 5,000 210,374 215,374 - Training in General, Pediatric, and Public Health Dentistry 93.059 362,919 - 362,919 - 362,919 - 362,919 - Chronic Diseases: Research, Control, and Prevention 93.068 - 29,041 Weill Cornell Medical College 170524 29,041 - Chronic Diseases: Research, Control, and Prevention 93.068 456,381 - 456,381 (17,830) 456,381 29,041 485,422 (17,830) Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science 93.077 - 135,896 Westat 6260-S04 (prime 5U54CA189222-05) 135,896 - Family Smoking Prevention and Tobacco Control Act Regulatory Research 93.077 - 56,904 American Heart Association FX-ATRAC-NYU-05 56,904 - Family Smoking Prevention and Tobacco Control Act Regulatory Research 93.077 176,196 - 176,196 - 176,196 192,800 368,996 - Research of the Responsible Conduct of Research (RCR) 93.085 24,296 - 24,296 - 24,296 - 24,296 - Pre-and-Post-Release Multimodal Interventions for Incarcerated Fathers Targeting Parenting Economic Stability and Healt 93.086 - 53,354 University of Oregon 290160A 53,354 - - 53,354 53,354 - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (6) - (6) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (188) - (188) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (72) - (72) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (79) - (79) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (330) - (330) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (144) - (144) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (864) - (864) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (119) - (119) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (689) - (689) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (489) - (489) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (194) - (194) - HHS Programs for Disaster Relief Appropriations Act - Non Construction 93.095 (208) - (208) -

The accompanying notes are an integral part of this schedule. 66 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 67 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 68 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (continued) Research Related to Deafness and Communication Disorders 93.173 170,196 - 170,196 - Research Related to Deafness and Communication Disorders 93.173 26,592 - 26,592 - Research Related to Deafness and Communication Disorders 93.173 430,453 - 430,453 - Research Related to Deafness and Communication Disorders 93.173 55,560 - 55,560 - Research Related to Deafness and Communication Disorders 93.173 590,713 - 590,713 - STTR Phase I: staRt: Enhancing speech intervention with smartphone-delivered biofeedback 93.173 - 9,637 Girlfriends Labs LLC N/A 9,637 - 5,619,897 173,657 5,793,554 461,977 National Research Service Award in Primary Care Medicine 93.186 388,937 - 388,937 - National Research Service Award in Primary Care Medicine 93.186 (173) - (173) - 388,764 - 388,764 - Research and Training in Complementary and Alternative Medicine 93.213 - 103,331 Mount Sinai Medical Center of Florida Inc. AT009149103,331- Research and Training in Complementary and Alternative Medicine 93.213 179,415 - 179,415 - Research and Training in Complementary and Alternative Medicine 93.213 94,567 - 94,567 - Research and Training in Complementary and Alternative Medicine 93.213 259,718 - 259,718 93,216 Research and Training in Complementary and Alternative Medicine 93.213 93,798 - 93,798 (8,799) 627,498 103,331 730,829 84,417 Research on Healthcare Costs, Quality and Outcomes 93.226 - 17,178 Albert Einstein College of Medicine 311229 17,178 - Research on Healthcare Costs, Quality and Outcomes 93.226 - 90,253 National Committee for Quality Assurance 4040-0001 90,253 - Research on Healthcare Costs, Quality and Outcomes 93.226 159,782 - 159,782 - Research on Healthcare Costs, Quality and Outcomes 93.226 983,544 - 983,544 - Research on Healthcare Costs, Quality and Outcomes 93.226 210,078 - 210,078 85,450 Research on Healthcare Costs, Quality and Outcomes 93.226 3,761,344 - 3,761,344 2,338,412 Research on Healthcare Costs, Quality and Outcomes 93.226 249,641 - 249,641 - Research on Healthcare Costs, Quality and Outcomes 93.226 194,562 - 194,562 58,803 Research on Healthcare Costs, Quality and Outcomes 93.226 84,380 - 84,380 80,050 5,643,331 107,431 5,750,762 2,562,715 National Center on Sleep Disorders Research 93.233 252,729 - 252,729 - National Center on Sleep Disorders Research 93.233 263,259 - 263,259 6,400 National Center on Sleep Disorders Research 93.233 97,165 - 97,165 6,201 613,153 - 613,153 12,601 (Jaiswal) Research Education Institute for Diverse Scholars (REIDS) 93.242 - 2,863 Yale University GR103600 (CON-80001319) 2,863 - Developing Centers for Innovation in Services and Intervention Research 93.242 - (12,347) University of Chicago 5P20MH078458-05 (12,347) - Developing Centers for Innovation in Services and Intervention Research 93.242 - (16,495) University of Illinois At Chicago 492157 E5449 (16,495) - Development of an online intervention to increase parent communication about sex with their gay and bisexual sons 93.242 - 14,188 George Washington University 17-M65 A01 14,188 - Mental Health Research Grants 93.242 - 41,823 Mount Sinai Medical Center 0255-4091-4609 41,823 - Mental Health Research Grants 93.242 - 77,643 Research Foundation for Mental Hygiene Inc. 1011155-2-25784 77,643 - Mental Health Research Grants 93.242 - 156,883 Research Foundation for Mental Hygiene Inc. 1012489 3 25521 156,883 - Mental Health Research Grants 93.242 - (9,887) Research Foundation of SUNY 1129280-71487 (9,887) - Mental Health Research Grants 93.242 - 169,539 Harvard University 114202-5095074 169,539 - Mental Health Research Grants 93.242 - 225,535 Weill Cornell Medical College 15081421 225,535 - Mental Health Research Grants 93.242 - 13,955 University of Connecticut 180942 13,955 - Mental Health Research Grants 93.242 - 53,599 Weill Cornell Medical College 182213-2 53,599 - Mental Health Research Grants 93.242 384,248 - 384,248 20,885 Mental Health Research Grants 93.242 - (551) Johns Hopkins University 2002896481 (551) - Mental Health Research Grants 93.242 - 529,808 Johns Hopkins University 2002986208 529,808 - Mental Health Research Grants 93.242 - 14,814 City College of New York (CCNY) 41861-B 14,814 - Mental Health Research Grants 93.242 - 47,636 Research Foundation of CUNY 41964-D 47,636 - Mental Health Research Grants 93.242 (368) - (368) - Mental Health Research Grants 93.242 - 110,069 University Medical Center Utrecht 5R01MH111417-02-2110,069- Mental Health Research Grants 93.242 - 15,126 Standford University 61109400-121247 15,126 - Mental Health Research Grants 93.242 - 78,942 Rand Corporation 9920150001 78,942 - Mental Health Research Grants 93.242 - 20,898 Rand Corporation 9920160098 20,898 - Mental Health Research Grants 93.242 - (525) Palo Alto Veterans Institute for Research & Education CLO0001-09 (525) - Mental Health Research Grants 93.242 - 196,371 Research Foundation of CUNY CM00000384 196,371 - Mental Health Research Grants 93.242 29,332 - 29,332 - Mental Health Research Grants 93.242 38,421 - 38,421 - Mental Health Research Grants 93.242 37,093 - 37,093 (1,989) Mental Health Research Grants 93.242 46,250 - 46,250 - Mental Health Research Grants 93.242 55,694 - 55,694 - Mental Health Research Grants 93.242 - 21,647 Fordham University FORD0032 21,647 - Mental Health Research Grants 93.242 - 21 Columbia University GG004695 21 - Mental Health Research Grants 93.242 91,025 - 91,025 - Mental Health Research Grants 93.242 143,193 - 143,193 - Mental Health Research Grants 93.242 69,778 - 69,778 - Mental Health Research Grants 93.242 86,752 - 86,752 - Mental Health Research Grants 93.242 - 32,283 Yale University M17A12650 (A11004) 32,283 -

The accompanying notes are an integral part of this schedule. 69 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 70 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Bridging the Gap Program 93.243 - 60,311 Jewish Board of Family and Children's Services N/A 60,311 - BTC MAT Project Evaluation 93.243 - 23,808 New York State Unified Court System C250599 Amendment 1 23,808 - Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 - 2,793 Fordham University FORD00232,793- Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 (4,045) - (4,045) - Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 414,856 - 414,856 - Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 - 40,582 University of Connecticut UCHC7-95386076-A1 40,582 - Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 - 50,516 University of Connecticut UCHC7-95398742-A1 50,516 - Substance Abuse and Mental Health Services_Projects of Regional and National Significance 93.243 - 124,501 OHEL Children's Home and Family Services 15-A0-00-004643 124,501 - Substance Abuse and Mental Health Services Projects of Regional and National Significance 93.243 1,342 - 1,342 - Substance Abuse and Mental Health Services Projects of Regional and National Significance 93.243 9,346 - 9,346 - 421,499 302,511 724,010 - Advanced Nursing Education Workforce Grant Program 93.247 70,948 - 70,948 - Advanced Nursing Education Workforce Grant Program 93.247 9,470 - 9,470 - Advanced Nursing Education Workforce Grant Program 93.247 595,523 - 595,523 33,251 Advanced Nursing Education Workforce Grant Program 93.247 67,368 - 67,368 82,958 743,309 - 743,309 116,209 NIOSH (Region ll) Education Resources Center 93.262 - 6,951 Icahn School of Medicine At Mount Sinai 0253-6538-4609 Amendment 2 6,951 - Occupational Safety and Health Program 93.262 3,351,913 - 3,351,913 - Occupational Safety and Health Program 93.262 - 122,612 University of Pittsburgh 0053367 (130139-1) 122,612 - Occupational Safety and Health Program 93.262 - 107,239 Mount Sinai School of Medicine 0253-6536-4509 107,239 - Occupational Safety and Health Program 93.262 - 810 Mount Sinai School of Medicine 0254-5754-4609 810 - Occupational Safety and Health Program 93.262 - (53,406) UMDNJ 8017 (53,406) - Occupational Safety and Health Program 93.262 723,986 - 723,986 29,897 Occupational Safety and Health Program 93.262 (8,999) - (8,999) - Occupational Safety and Health Program 93.262 (34,101) - (34,101) - Occupational Safety and Health Program 93.262 (25,459) - (25,459) - Occupational Safety and Health Program 93.262 (3,035) - (3,035) - Occupational Safety and Health Program 93.262 58,937 - 58,937 - Occupational Safety and Health Program 93.262 336,163 - 336,163 207,052 Occupational Safety and Health Program 93.262 516,142 - 516,142 26,188 Occupational Safety and Health Program 93.262 600,581 - 600,581 107,424 Occupational Safety and Health Program 93.262 390,078 - 390,078 - Occupational Safety and Health Program 93.262 529,144 - 529,144 - OEHN Phd Training Program 93.262 - 7,102 Icahn School of Medicine at Mount Sinai N/A 7,102 - OEHN PhD training program 93.262 - 148,678 Icahn School of Medicine at Mount Sinai 0253-6537-4609 Amendment No.2 148,678 - 6,435,350 339,986 6,775,336 370,561 Alcohol Research Programs 93.273 - 136,187 State University of New York Downstate 100-1009153-68005 136,187 - Alcohol Research Programs 93.273 230,004 - 230,004 - Alcohol Research Programs 93.273 184,339 - 184,339 - Alcohol Research Programs 93.273 816,504 - 816,504 - Alcohol Research Programs 93.273 711,135 - 711,135 48,349 Alcohol Research Programs 93.273 38,644 - 38,644 - Alcohol Research Programs 93.273 110,202 - 110,202 - Alcohol Research Programs 93.273 103,741 - 103,741 - Alcohol Research Programs 93.273 199,425 - 199,425 51,589 Alcohol Research Programs 93.273 172,986 - 172,986 27,702 Alcohol Research Programs 93.273 - (8,725) University of Connecticut Health Center UCHC6-49877151 (8,725) - Alcohol Research Programs 93.273 443,390 - 443,390 - Detecting Youth Drinking and Associations with Alcohol Policies via Social Media 93.273 - (46,469) Children's Hospital Boston RSTFD0000659240 (46,469) - TYPE C: Calibrated Agent Simulations for Combined Analysis of Drinking Etiologies (CASCADE) 93.273 - 38,531 University of Sheffield R01AA024443-01A1 SUB02 NYU 38,531 - 3,010,370 119,524 3,129,894 127,640 Cocaine and Material Behavior: Effects in trajectory of infant brain development 93.279 - 140,022 University of North Carolina, Chapel Hill 5104776 Amd No. 3 140,022 - Drug Abuse and Addiction Research Programs 93.279 - 55,938 Mount Sinai School of Medicine 0255-7641-4609 55,938 - Drug Abuse and Addiction Research Programs 93.279 - 24,890 Rutgers University 0258 24,890 - Drug Abuse and Addiction Research Programs 93.279 - 43,262 Research Foundation for Mental Hygiene Inc. 10117541-1-25987 43,262 - Drug Abuse and Addiction Research Programs 93.279 - 109,076 Nathan S. Kline Institute for Psychiatric Research 26746 109,076 - Drug Abuse and Addiction Research Programs 93.279 - 130,678 Children's Research Institute 30003671-02 130,678 - Drug Abuse and Addiction Research Programs 93.279 - 79,730 National Development Research Institute 654A 79,730 - Drug Abuse and Addiction Research Programs 93.279 728,465 - 728,465 14,781 Drug Abuse and Addiction Research Programs 93.279 138,112 - 138,112 - Drug Abuse and Addiction Research Programs 93.279 13,021 - 13,021 - Drug Abuse and Addiction Research Programs 93.279 195,301 - 195,301 - Drug Abuse and Addiction Research Programs 93.279 142,852 - 142,852 - Drug Abuse and Addiction Research Programs 93.279 130,551 - 130,551 - Drug Abuse and Addiction Research Programs 93.279 175,062 - 175,062 - Drug Abuse and Addiction Research Programs 93.279 189,985 - 189,985 - Drug Abuse and Addiction Research Programs 93.279 62,469 - 62,469 - Drug Abuse and Addiction Research Programs 93.279 132,088 - 132,088 - Drug Abuse and Addiction Research Programs 93.279 323,926 - 323,926 - Drug Abuse and Addiction Research Programs 93.279 (99) - (99) -

The accompanying notes are an integral part of this schedule. 71 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Drug Abuse and Addiction Research Programs 93.279 180,746 - 180,746 - Drug Abuse and Addiction Research Programs 93.279 788,583 - 788,583 31,253 Drug Abuse and Addiction Research Programs 93.279 (3,683) - (3,683) - Drug Abuse and Addiction Research Programs 93.279 1,596 - 1,596 - Drug Abuse and Addiction Research Programs 93.279 299,592 - 299,592 83,956 Drug Abuse and Addiction Research Programs 93.279 466,087 - 466,087 262 Drug Abuse and Addiction Research Programs 93.279 348,778 - 348,778 - Drug Abuse and Addiction Research Programs 93.279 604,555 - 604,555 60,982 Drug Abuse and Addiction Research Programs 93.279 174,325 - 174,325 30,988 Drug Abuse and Addiction Research Programs 93.279 121,217 - 121,217 66,206 Drug Abuse and Addiction Research Programs 93.279 (88) - (88) - Drug Abuse and Addiction Research Programs 93.279 313,424 - 313,424 13,253 Drug Abuse and Addiction Research Programs 93.279 (1,388) - (1,388) - Drug Abuse and Addiction Research Programs 93.279 310,931 - 310,931 (716) Drug Abuse and Addiction Research Programs 93.279 - 17,883 Children's Hospital Los Angeles RGF009146-C 17,883 - Drug Abuse and Addiction Research Programs 93.279 453,914 - 453,914 - Drug Abuse and Addiction Research Programs 93.279 4,237,759 - 4,237,759 2,364,077 Drug Abuse and Addiction Research Programs 93.279 80,733 - 80,733 72,838 Drug Abuse and Addiction Research Programs 93.279 121,815 - 121,815 30,927 Drug Abuse and Addiction Research Programs 93.279 175,490 - 175,490 130,696 Drug Abuse and Addiction Research Programs 93.279 82,791 - 82,791 - Drug Abuse and Addiction Research Programs 93.279 100,183 - 100,183 - Drug Abuse and Addiction Research Programs 93.279 (19,466) - (19,466) - Drug Abuse and Addiction Research Programs 93.279 29 - 29 - Drug Abuse and Addiction Research Programs 93.279 147,948 - 147,948 - Drug Abuse and Addiction Research Programs 93.279 56,196 - 56,196 - Drug Abuse and Addiction Research Programs 93.279 262,537 - 262,537 - Drug Abuse and Addiction Research Programs 93.279 538,173 - 538,173 - Drug Abuse and Addiction Research Programs 93.279 (689) - (689) - Drug Abuse and Addiction Research Programs 93.279 77,589 - 77,589 - Drug Abuse and Addiction Research Programs 93.279 38,810 - 38,810 - Drug Abuse and Addiction Research Programs 93.279 497,668 - 497,668 109,266 Drug Abuse and Addiction Research Programs 93.279 339,061 - 339,061 - Drug Abuse and Addiction Research Programs 93.279 822,715 - 822,715 194,506 Drug Abuse and Addiction Research Programs 93.279 56,925 - 56,925 - Drug Abuse and Addiction Research Programs 93.279 387,641 - 387,641 - Drug Abuse and Addiction Research Programs 93.279 116,635 - 116,635 - Drug Abuse and Addiction Research Programs 93.279 480,200 - 480,200 - Drug Abuse and Addiction Research Programs 93.279 1,764,534 - 1,764,534 130,217 Drug Abuse and Addiction Research Programs 93.279 81,773 - 81,773 - Drug Abuse and Addiction Research Programs 93.279 38,914 - 38,914 - Drug Abuse and Addiction Research Programs 93.279 29,612 - 29,612 8,909 Drug Abuse and Addiction Research Programs 93.279 507,473 - 507,473 24,117 Drug Abuse and Addiction Research Programs 93.279 415,033 - 415,033 - Drug Abuse and Addiction Research Programs 93.279 5,298 - 5,298 - Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs 93.279 - 10,525 Weill Medical College of Cornell University 17060914-01 Amd 01 10,525 - HIV/Drug Abuse Prevention Research Ethics Training Institute 93.279 - 20,541 Fordham University FORD0031 Amd 1 20,541 - Host Genetics of HIV: Enhancing Discovery through Study 93.279 - 56,264 RTI International 4-312-0214454-52251L Mod 3 56,264 - Impact of health reform on outpatient substance abuse treatment programs 93.279 - 12,691 Baystate Medical Center, Inc. 15258-NYU-5 12,691 - Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV Risk Behaviors 93.279 - 18,190 National Development and Research Institutes #656A 18,190 - Reducing HIV Transmission by Promoting Sexual health among Drug Users, "Sexual Health" 93.279 - (1,243) National Development and Research Institutes NDRI PROJECT# 146 (1,243) - Syndemic Production in Emergent Adult Men 93.279 - 119,392 Rutgers University 0457 (3R01DA025537-11S1) 119,392 - Syndemic Production in Emergent Adult Men 93.279 - 197,968 Rutgers University 0259 (7R01DA025537-10) 197,968 - Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir 93.279 - 10,329 RTI International 3-312-0216573-65366L 10,329 - 17,733,702 1,046,136 18,779,838 3,366,518 Centers for Disease Control and Prevention_Investigations and Technical Assistance 93.283 - 55 Olive View-UCLA Education & Research Institute 11-01&11-40&11-40(R) 55 - Centers for Disease Control and Prevention_Investigations and Technical Assistance 93.283 (26,120) - (26,120) - Centers for Disease Control and Prevention_Investigations and Technical Assistance 93.283 - (16,902) Rhode Island Hospital 7017137227 (16,902) - CSTE Behavioral Health Measures Proposal 93.283 - 149,996 Council of State and Territorial Epidemiologists General Contract Agreement.V07-09.2017 149,996 - (26,120) 133,149 107,029 - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 237,107 - 237,107 - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 - (11,911) Mount Sinai School of Medicine 0255-9766-4609 (11,911) - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 - (29,957) Vanderbilt University Medical Center 2544-017572 (29,957) - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 - 32,034 University of New Mexico 3RY83 32,034 - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 881,791 - 881,791 111,156 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 - 64,207 Regents of the University of Minnesota N006269303 64,207 - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 - 296,010 Riverside Research Institute NYO.1187.00057.16 296,010 - Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 238,184 - 238,184 14,664 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 517,444 - 517,444 191,796 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286 392,348 - 392,348 -

The accompanying notes are an integral part of this schedule. 72 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 73 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 74 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 75 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 76 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 77 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 78 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Arthritis, Musculoskeletal and Skin Diseases Research 93.846 114 - 114 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 95,239 - 95,239 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 (1,788) - (1,788) - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 85,071 - 85,071 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 46,931 - 46,931 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 222,260 - 222,260 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 257,946 - 257,946 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 221,502 - 221,502 91,538 Arthritis, Musculoskeletal and Skin Diseases Research 93.846 363,999 - 363,999 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 220 - 220 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 117,534 - 117,534 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 219,773 - 219,773 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 1,134,884 - 1,134,884 408,896 Arthritis, Musculoskeletal and Skin Diseases Research 93.846 131,156 - 131,156 48,266 Arthritis, Musculoskeletal and Skin Diseases Research 93.846 - 150 Washington University WU-10-156-MOD-4 150 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 29,460 - 29,460 - Arthritis, Musculoskeletal and Skin Diseases Research 93.846 49 - 49 - 11,503,136 246,368 11,749,504 911,466 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 466,831 - 466,831 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 287,676 - 287,676 83,652 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 728 - 728 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 55,806 Oregon HLT & Science University 10111119_NYU 55,806 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 42,120 Johns Hopkins University 2003515917 42,120 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 32,101 University of Michigan 3003289636 32,101 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 15,417 Albert Einstein College of Medicine 31119F 15,417 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 177,355 University of Pennsylvania 562070/564083 177,355 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 31,458 University of Pennsylvania 572700 31,458 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 (3,043) - (3,043) - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 5,120 University of Ghana 9U54DK116913-06 5,120 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 35,664 - 35,664 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 212,380 - 212,380 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 29,270 Mayo Clinic NSM-182824-04 29,270 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 68,513 Mayo Clinic NUM-182824-03 68,513 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 - 129,533 Mayo Clinic NUS-182824-05 129,533 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 (50) - (50) - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 439,502 - 439,502 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 (38,192) - (38,192) - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 457,081 - 457,081 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 (2,691) - (2,691) - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 236,391 - 236,391 11,621 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 227,877 - 227,877 20,800 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 500 - 500 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 119,044 - 119,044 (9,323) Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 586,305 - 586,305 137,101 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 825,069 - 825,069 (427) Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 342,074 - 342,074 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 813,955 - 813,955 (129,918) Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 359,318 - 359,318 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 371,601 - 371,601 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 369,840 - 369,840 23,959 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 327,654 - 327,654 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 822,123 - 822,123 130,672 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 591,771 - 591,771 15,192 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 411,965 - 411,965 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 653,420 - 653,420 47,735 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 705,664 - 705,664 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 (352) - (352) - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 745,038 - 745,038 317,317 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 10,647 - 10,647 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 293,279 - 293,279 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 791,755 - 791,755 10,657 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 248,120 - 248,120 8,822 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 565,228 - 565,228 65,562 Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 15,620 - 15,620 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 95,724 - 95,724 - Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 819,617 - 819,617 378,761 L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystnuria 93.847 - 26,213 Rutgers University 0113 Y05 26,213 - 13,205,133 612,906 13,818,039 1,112,183

The accompanying notes are an integral part of this schedule. 79 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) Supplement 93.853 - 49,193 Mayo Clinic NEW-238655 49,193 - Experience-dependent Modulations of Synaptic Circuits in the Hippocampus 93.853 - 20,029 Downstate Medical Center 100-1123838-70995 A01 20,029 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 165,037 University of Pittsburgh 0042669 (125250-1) 165,037 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 45,238 Columbia University 1(GG011777-01) 45,238 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - (2,128) Columbia University 1(GG012360) (2,128) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 61,687 Columbia University 1(GG012971-01) 61,687 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 35,604 Brigham & Women's Hospital 113266 35,604 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 11,404 - 11,404 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 141,347 University of California, Davis 201602825-01 141,347 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - (89) Massachusetts General Hospital 228591 (89) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 27,805 Massachusetts General Hospital 231373 27,805 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 32,528 Columbia University 3(GG010432) 32,528 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - (3,786) University of Michigan 3003298886 (3,786) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 73,986 Purdue University 4102-71508 73,986 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 359,527 Boston University 4500002585 359,527 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 121,020 University of London 519723 121,020 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 99,005 Massachusetts Institute of Tech 5710004164 99,005 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (532) - (532) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 10,467 - 10,467 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 102,698 Standford Unviersity 61752758-128582 102,698 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - (1,893) The Regents of the University of California 9835sc (1,893) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 323,131 - 323,131 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 31,026 - 31,026 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 40,722 - 40,722 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 6,165 - 6,165 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 41,461 - 41,461 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 10,576 - 10,576 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 36,644 - 36,644 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 10,135 - 10,135 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 45,148 - 45,148 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 4,054 - 4,054 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 211,591 - 211,591 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 182,130 - 182,130 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 3,410 - 3,410 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 11,538 - 11,538 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 9,448 University of Minnesota N004688402 9,448 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 1,088,981 - 1,088,981 204,704 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (15,181) - (15,181) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 83,040 - 83,040 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 187,954 - 187,954 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 157 - 157 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (25,162) - (25,162) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 532,584 - 532,584 27,031 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 123,621 - 123,621 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 262,745 - 262,745 636 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 232,598 - 232,598 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 489,021 - 489,021 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 4,916 - 4,916 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 339,538 - 339,538 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (52,350) - (52,350) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 324,116 - 324,116 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 558 - 558 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 163,069 - 163,069 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 549,754 - 549,754 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (17,348) - (17,348) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 334,638 - 334,638 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 317,060 - 317,060 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 335,860 - 335,860 7,406 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 519,100 - 519,100 28,000 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 387,945 - 387,945 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 484,400 - 484,400 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 122,890 - 122,890 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 15,192 - 15,192 (34,860) Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 291,553 - 291,553 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 23,895 - 23,895 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 432,027 - 432,027 166,053 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 208,188 - 208,188 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 261,118 - 261,118 90,505 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 9,481 - 9,481 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 35,007 - 35,007 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 239 - 239 -

The accompanying notes are an integral part of this schedule. 80 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 106,028 - 106,028 (16,278) Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 163 - 163 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 18,456 - 18,456 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 8,875 - 8,875 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 11,442 - 11,442 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 211,868 - 211,868 (18,957) Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (14,450) - (14,450) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (67) - (67) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 162,128 - 162,128 41,228 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 274,564 - 274,564 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 201,832 - 201,832 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 149,738 New Jersey Institute of Technology R21NS101386 149,738 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 7,210 - 7,210 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 298,190 - 298,190 3,208 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 939,025 - 939,025 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 504,857 - 504,857 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 631,084 - 631,084 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 86,251 Case Western Reserve University RES513485 86,251 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 172,436 - 172,436 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 11,431 Emory University T662050 (Yr4 T472196) 11,431 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 28,141 - 28,141 11,341 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 1,068,231 - 1,068,231 99,893 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 1,110,442 - 1,110,442 415,665 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 27,655 - 27,655 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 309,771 Vanderbilt University Medical Center VUMO56980 309,771 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 61,573 Univ of Massachusetts School of Medicine WA00356659 / OSP2016079 61,573 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - (914) Wayne State University WSU11098 (914) - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 - 650 The Regents of the University of Minnesota 11-01160 650 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 545,893 - 545,893 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 358,436 - 358,436 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 86,074 - 86,074 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 483,647 - 483,647 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 710,576 - 710,576 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 35,604 - 35,604 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 6,082 - 6,082 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 23,376 - 23,376 - Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 36,524 - 36,524 26,371 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 (19,589) - (19,589) (19,031) Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853 152,232 - 152,232 - MEGA: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System 93.853 - 16,303 Gray Matter Research 1U01NS090557-01 16,303 - NYCCRCC, StrokeNet 1U01NS086531 93.853 - 17,792 Icahn School of Medicine at Mount Sinai 0255-6584-4609 17,792 Optimizing flexible, active electrode arrays for chronic, large-scale recording and stimulation on the scale of 100,000 electr 93.853 - 194,866 Duke University 203-6432 194,866 - Optimizing flexible, active electrode arrays for chronic, large-scale recording and stimulation on the scale of 100,000 electr 93.853 - (59) Duke University 203-5814 (59) - 17,217,239 2,183,658 19,400,897 1,032,915 (A1) Functional interplay between Brugia and its Wolbachia symbiont 93.855 - 59,673 New York Blood Center NIH000418 A02 59,673 - Allergy and Infectious Diseases Research 93.855 - 26,631 Mount Sinai School of Medicine 0253-6448-4609 26,631 - Allergy and Infectious Diseases Research 93.855 - 4,917 Columbia University 1(GG013000-01) 4,917 - Allergy and Infectious Diseases Research 93.855 - 19,103 Dana-Farber Cancer Center 1006719 19,103 - Allergy and Infectious Diseases Research 93.855 58 - 58 - Allergy and Infectious Diseases Research 93.855 - 34,933 Johns Hopkins University 2002655897 34,933 - Allergy and Infectious Diseases Research 93.855 - 47,323 Johns Hopkins University 2003746449 47,323 - Allergy and Infectious Diseases Research 93.855 - 440,089 Columbia University 3(GG012754-07) 440,089 - Allergy and Infectious Diseases Research 93.855 - 30,797 Luna, Inc. 3483-NIH-1S NYU 30,797 - Allergy and Infectious Diseases Research 93.855 - 282,933 Rutgers University 8039 282,933 - Allergy and Infectious Diseases Research 93.855 - 16,425 Rutgers University 8230 16,425 - Allergy and Infectious Diseases Research 93.855 - 37,915 Aaron Diamond Aids Research Center A09-200-NYU-Duerr37,915- Allergy and Infectious Diseases Research 93.855 - 81,042 Aaron Diamond Aids Research Center A09-200-NYU-Kong 81,042 - Allergy and Infectious Diseases Research 93.855 8,750 - 8,750 - Allergy and Infectious Diseases Research 93.855 39,285 - 39,285 - Allergy and Infectious Diseases Research 93.855 5,425 - 5,425 - Allergy and Infectious Diseases Research 93.855 - 4,791 Benaroya Research Institute at Virginia FY16ITN041 4,791 - Allergy and Infectious Diseases Research 93.855 1,216,866 - 1,216,866 28,300 Allergy and Infectious Diseases Research 93.855 - (1,662) Indiana University IN-4688381-NYM (1,662) - Allergy and Infectious Diseases Research 93.855 5,474 - 5,474 - Allergy and Infectious Diseases Research 93.855 193,257 - 193,257 - Allergy and Infectious Diseases Research 93.855 201,799 - 201,799 - Allergy and Infectious Diseases Research 93.855 14,915 - 14,915 - Allergy and Infectious Diseases Research 93.855 188,804 - 188,804 7,483 Allergy and Infectious Diseases Research 93.855 2,724,078 - 2,724,078 1,714,880 Allergy and Infectious Diseases Research 93.855 188,424 - 188,424 - Allergy and Infectious Diseases Research 93.855 401,483 - 401,483 - Allergy and Infectious Diseases Research 93.855 577,815 - 577,815 - Allergy and Infectious Diseases Research 93.855 307,354 - 307,354 - Allergy and Infectious Diseases Research 93.855 241,869 - 241,869 -

The accompanying notes are an integral part of this schedule. 81 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 82 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Allergy and Infectious Diseases Research 93.855 766 - 766 747 Effects of M. tuberculosis infection on lung microbiome in macaques 93.855 - 12,973 University of Pittsburgh 00483150 (127229-1) A01 12,973 - Film Anitretroviral Microbicide Evaluation 93.855 - 2,739 Magee-women's Research Institute & Foundation 4667 2,739 - Film Antiretroviral Microbicide Evaluation 93.855 - 90,456 Magee-women's Research Institute & Foundation 4677 year 3 90,456 - Film Antiretroviral Microbicide Evaluation 93.855 - 42,684 Magee-women's Research Institute & Foundation 4685_NYU 42,684 - The Connie Wofsy Women's HIV Study 93.855 - 170,116 The Regents of the University of California 8845SC 170,116 - The Connie Wofsy Women's HIV Study 93.855 - 277,359 The University of California, San Francisco 8845sc Amendment 8 277,359 - Virus Dynamics and Multiple Infection of Cells: Computational and Experimental Analysis 93.855 - 238 University of California, Irvine 2011-2702 238 - 25,969,135 2,208,712 28,177,847 5,714,548 (R25 BP-ENDURE) Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education 93.859 - 114,311 Research Foundation of CUNY CM00001407 114,311 - Approaches to Computing Diffusion Rates in Proteins Using Transition Path Theory 93.859 - (170) Drexel University 232505 (170) - Biomedical Research and Research Training 93.859 - 103,882 The President and Fellows of Harvard Col 152719.5101604.0004 103,882 - Biomedical Research and Research Training 93.859 - 31,813 University of Mississippi 19-07-006 31,813 - Biomedical Research and Research Training 93.859 - 50,089 Rockefeller University 1R01GM126170-01 50,089 - Biomedical Research and Research Training 93.859 - 47,968 University of Delaware 41230 47,968 - Biomedical Research and Research Training 93.859 - 127,285 Rockefeller University 5P41GM109824-05 127,285 - Biomedical Research and Research Training 93.859 - 88,057 Rockefeller University 5P4GM109824-04 88,057 - Biomedical Research and Research Training 93.859 (42) - (42) - Biomedical Research and Research Training 93.859 (136) - (136) - Biomedical Research and Research Training 93.859 36,616 - 36,616 - Biomedical Research and Research Training 93.859 51,400 - 51,400 - Biomedical Research and Research Training 93.859 45,613 - 45,613 - Biomedical Research and Research Training 93.859 - 59 NY Structural Biology Center NYSBCG02003-2 59 - Biomedical Research and Research Training 93.859 1,518,166 - 1,518,166 769,708 Biomedical Research and Research Training 93.859 413,468 - 413,468 - Biomedical Research and Research Training 93.859 420,953 - 420,953 - Biomedical Research and Research Training 93.859 497,628 - 497,628 68,860 Biomedical Research and Research Training 93.859 352,454 - 352,454 - Biomedical Research and Research Training 93.859 138,536 - 138,536 - Biomedical Research and Research Training 93.859 240 - 240 - Biomedical Research and Research Training 93.859 603,766 - 603,766 - Biomedical Research and Research Training 93.859 (2,264) - (2,264) - Biomedical Research and Research Training 93.859 (1,078) - (1,078) - Biomedical Research and Research Training 93.859 188,917 - 188,917 - Biomedical Research and Research Training 93.859 64,771 - 64,771 - Biomedical Research and Research Training 93.859 20,781 - 20,781 - Biomedical Research and Research Training 93.859 29,581 - 29,581 - Biomedical Research and Research Training 93.859 328,730 - 328,730 - Biomedical Research and Research Training 93.859 405,737 - 405,737 - Biomedical Research and Research Training 93.859 119,473 - 119,473 - Biomedical Research and Research Training 93.859 238,960 - 238,960 - Biomedical Research and Research Training 93.859 257,028 - 257,028 - Biomedical Research and Research Training 93.859 249,890 - 249,890 - Biomedical Research and Research Training 93.859 (52,747) - (52,747) 4,029 Biomedical Research and Research Training 93.859 266,135 - 266,135 - Biomedical Research and Research Training 93.859 217,868 - 217,868 - Biomedical Research and Research Training 93.859 308,136 - 308,136 (10,900) Biomedical Research and Research Training 93.859 374,500 - 374,500 - Biomedical Research and Research Training 93.859 395,091 - 395,091 - Biomedical Research and Research Training 93.859 598,458 - 598,458 104,168 Biomedical Research and Research Training 93.859 351,733 - 351,733 - Biomedical Research and Research Training 93.859 360,684 - 360,684 - Biomedical Research and Research Training 93.859 442,140 - 442,140 38,932 Biomedical Research and Research Training 93.859 118,145 - 118,145 - Biomedical Research and Research Training 93.859 99,363 - 99,363 - Biomedical Research and Research Training 93.859 37,187 - 37,187 - Biomedical Research and Research Training 93.859 316,313 - 316,313 - Biomedical Research and Research Training 93.859 46,440 - 46,440 - Biomedical Research and Research Training 93.859 663,504 - 663,504 - Biomedical Research and Research Training 93.859 443,420 - 443,420 - Biomedical Research and Research Training 93.859 726,200 - 726,200 (18,695) Biomedical Research and Research Training 93.859 294,923 - 294,923 - Biomedical Research and Research Training 93.859 19,134 - 19,134 - Biomedical Research and Research Training 93.859 1,607,364 - 1,607,364 - Biomedical Research and Research Training 93.859 222,451 - 222,451 - Biomedical Research and Research Training 93.859 162,190 - 162,190 - Biomedical Research and Research Training 93.859 189,555 - 189,555 - Biomedical Research and Research Training 93.859 - 90,955 Pharmaseq. Inc 17-A1-00-007252 90,955 - Biomedical Research and Research Training 93.859 - 93,181 Protein Metrics Inc. 17-A1-00-007274 & 15-A0-00-004162 93,181 -

The accompanying notes are an integral part of this schedule. 83 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 84 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster US Department of Health and Human Services (Continued) Child Health and Human Development Extramural Research 93.865 128,375 - 128,375 - Child Health and Human Development Extramural Research 93.865 124,684 - 124,684 - Child Health and Human Development Extramural Research 93.865 (569) - (569) - Child Health and Human Development Extramural Research 93.865 491,729 - 491,729 17,296 Child Health and Human Development Extramural Research 93.865 338,911 - 338,911 138,706 Child Health and Human Development Extramural Research 93.865 468,835 - 468,835 - Child Health and Human Development Extramural Research 93.865 281,976 - 281,976 18,741 Child Health and Human Development Extramural Research 93.865 327,341 - 327,341 87,480 Child Health and Human Development Extramural Research 93.865 106,042 - 106,042 - Child Health and Human Development Extramural Research 93.865 13,251 - 13,251 - Child Health and Human Development Extramural Research 93.865 (977) - (977) - Child Health and Human Development Extramural Research 93.865 39,612 - 39,612 - Child Health and Human Development Extramural Research 93.865 59,526 - 59,526 - Child Health and Human Development Extramural Research 93.865 169,919 - 169,919 - Child Health and Human Development Extramural Research 93.865 159,845 - 159,845 - Child Health and Human Development Extramural Research 93.865 89,422 - 89,422 - Child Health and Human Development Extramural Research 93.865 26,633 - 26,633 - Child Health and Human Development Extramural Research 93.865 255,728 - 255,728 - Child Health and Human Development Extramural Research 93.865 129,598 - 129,598 - Child Health and Human Development Extramural Research 93.865 263,888 - 263,888 - Child Health and Human Development Extramural Research 93.865 462,872 - 462,872 208,607 Child Health and Human Development Extramural Research 93.865 - 66,927 Princeton University SUB0000200 66,927 - Child Health and Human Development Extramural Research 93.865 156,860 - 156,860 10,162 Child Health and Human Development Extramural Research 93.865 - 197,104 Vanderbilt Medical Center VUMC 35299 197,104 - Child Health and Human Development Extramural Research 93.865 (228) - (228) - Child Health and Human Development Extramural Research 93.865 138,935 - 138,935 - Child Health and Human Development Extramural Research 93.865 339,144 - 339,144 293,141 Child Health and Human Development Extramural Research 93.865 (33)- (33) - Child Health and Human Development Extramural Research 93.865 (49)- (49) - Child Health and Human Development Extramural Research 93.865 38,764 - 38,764 - Child Health and Human Development Extramural Research 93.865 (9,168) - (9,168) - Child Health and Human Development Extramural Research 93.865 (5,955) - (5,955) - Child Health and Human Development Extramural Research 93.865 17,591 - 17,591 - Child Health and Human Development Extramural Research 93.865 339,481 - 339,481 58,653 Child Health and Human Development Extramural Research 93.865 (268) - (268) - Child Health and Human Development Extramural Research 93.865 (196) - (196) - Child Health and Human Development Extramural Research 93.865 58,044 - 58,044 - Child Health and Human Development Extramural Research 93.865 228,284 - 228,284 - Child Health and Human Development Extramural Research 93.865 1,236,987 - 1,236,987 576,633 Child Health and Human Development Extramural Research 93.865 1,257,398 - 1,257,398 873,701 Child Health and Human Development Extramural Research 93.865 423,760 - 423,760 226,345 Child Health and Human Development Extramural Research 93.865 647,585 - 647,585 49,450 Child Health and Human Development Extramural Research 93.865 234,534 - 234,534 - Child Health and Human Development Extramural Research 93.865 16,278 - 16,278 - Child Health and Human Development Extramural Research 93.865 426,088 - 426,088 33,035 Child Health and Human Development Extramural Research 93.865 294,969 - 294,969 43,921 Child Health and Human Development Extramural Research 93.865 7,114 - 7,114 - Child Health and Human Development Extramural Research 93.865 10,200 - 10,200 - Child Health and Human Development Extramural Research 93.865 21,541 - 21,541 - Child Health and Human Development Extramural Research 93.865 7,988 - 7,988 - Demographic and Health Disparities in Recovery from Hurricane Katrina: KATRINA@10 93.865 - 40,312 Tulane University TUL-HSC-554775-16/17 (RP-2 AMD 1) 40,312 17,715 Demographic and Health Disparities in Recovery from Hurricane Katrina: KATRINA@10 93.865 - 273,917 Tulane University TUL-HSC-555501-17/18 (RP-2 Yr3) 273,917 55,197 Demographic and Health Disparities in Recovery from Hurricane Katrina: KATRINA@10 93.865 - 3,989 Tulane University TUL-HSC-556511-18/19-CoreB) 3,989 - Demographic and Health Disparities in Recovery from Hurricane Katrina: KATRINA@10 93.865 - 8,208 Tulane University TUL-HSC-556512-18/19 8,208 - Demographic and Health Disparities in Recovery from Hurricane Katrina: KATRINA@10 93.865 - 477,782 Tulane University TUL-HSC-555500-17/18 (CoreB) 477,782 - Household Income and Child Development in the First Three Years of Life 93.865 - 13,448 The Regents of the University of California 2017-3510 Amd 01 13,448 - MEGA: Rescuing the Fragile X Syndrome by resetting translational homeostasis 93.865 - 249,733 University of Massachusetts, Worcester OSP2017009 A01 249,733 - Rescuing the Fragile X Syndrome by Resetting Translational Homeostasis - Core C 93.865 - 2,997 University of Massachusetts, Worcester WA00441542/OSP2017010 2,997 - Rescuing the Fragile X Syndrome by Resetting Translational Homeostasis - Core C 93.865 - 68,680 University of Massachusetts, Worcester OSP2017010 A01 68,680 - Rescuing the Fragile X Syndrome by Resetting Translational Homeostasis - Project 3 93.865 - 486 University of Massachusetts, Worcester WA00441544/OSP2017009 486 - Temporal connectomics for infant brain: neurodevelopment modulated by pathology 93.865 - 16,418 University of Pennsylvania 571036 Amd 1 16,418 - Temporal connectomics for infant brain: neurodevelopment modulated by pathology 93.865 - 3,035 University of Pennsylvania 571036 3,035 - 10,406,873 2,397,684 12,804,557 2,789,479 Aging Research 93.866 97,766 - 97,766 - Aging Research 93.866 408,588 - 408,588 78,745 Aging Research 93.866 43,138 - 43,138 - Aging Research 93.866 42,128 - 42,128 739 Aging Research 93.866 16,325 - 16,325 - Aging Research 93.866 - 391,778 Brown University 00000974 391,778 - Aging Research 93.866 - 34,515 Mount Sinai School of Medicine 0255-3651-4609 34,515 - Aging Research 93.866 - 1,831 Columbia University 1(GG011968-01) 1,831 - Aging Research 93.866 - 172,388 St. Joseph's Hospital & Medical Center 1023114-NYUMC 172,388 - Aging Research 93.866 - 207,220 St. Joseph's Hospital & Medical Center 1032146-NYUMC 207,220 50,023 Aging Research 93.866 - 131,405 Healthcare Interactive, Inc. 20121030 131,405 - Aging Research 93.866 - 74,667 Healthcare Interactive, Inc. 20151119 74,667 - Aging Research 93.866 - 43,015 University of California Irvina 2018-3569 43,015 - Aging Research 93.866 - 126,136 Massachusetts General Hospital 227350 126,136 - Aging Research 93.866 (47) - 5P3AG008051 (47) - The accompanying notes are an integral part of this schedule. 85 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 86 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

The accompanying notes are an integral part of this schedule. 87 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Research and Development Cluster U.S. Agency for International Development A computational model to detect illegal wildlife sales online 98.001 - 11,626 Integra Government Services International LLC FAA1/NYU/2016 11,626 - China Rule of Law - Criminal Law 98.001 - 877 American Bar Association CONTRACT LOG #9409 877 - USAID Foreign Assistance for Programs Overseas 98.001 1,358,732 - 1,358,732 (36,800) 1,358,732 12,503 1,371,235 (36,800) (Type A): Assets & Market Access Collaborative Research Support Program 98.RD - 154,874 University of California, Davis 201121454-27 Amd 03 154,874 54,670 - 154,874 154,874 54,670 Total U.S. Agency for International Development 1,358,732 167,377 1,526,109 17,870 Total Research and Development Cluster 387,700,936 38,991,587 426,692,523 50,859,689 Highway Planning and Construction Cluster U.S. Department of Transportation CIDNY Task 2: Develop a Multi-agency/Multimodal Construction Management Tool to Enhance Coordination Projects City- 20.205 - 29,293 City College (CUNY) RF# 57315-01-28 29,293 CIDNY Task 7: Research on Pedestrian Safety Using ITS Technology in NYC Year 2 20.205 - 60,017 City College (CUNY) RF# 573015-03-28 60,017 - September 11th Memorial Program for Regional Transportation Planning 20.205 - 25,000 University Transportation Research Center 55606-07-28 (C030794) 25,000 - - 114,310 114,310 - Total U.S. Department of Transportation - 114,310 114,310 - Total Highway Planning and Construction Cluster - 114,310 114,310 - TRIO Cluster U.S. Department of Education TRIO Student Support Services 84.042 392,282 - 392,282 - 392,282 - 392,282 - TRIO Upward Bound 84.047 (79) - (79) - (79) - (79) - Total U.S. Department of Education 392,203 - 392,203 - Total TRIO Cluster 392,203 - 392,203 - Student Financial Aid Cluster U.S. Department of Education Federal Supplemental Educational Opportunity Grants Federal Supplemental Educational Opportunity Grants 84.007 1,960,000 - 1,960,000 - Federal Supplemental Educational Opportunity Grants 84.007 719,617- 719,617 - Total Federal Supplemental Educational Opportunity Grants 2,679,617 - 2,679,617 - Federal Work-Study Program Federal Work-Study Program 84.033 624,937 - 624,937 - Federal Work-Study Program 84.033 38,786 - 38,786 - Federal Work-Study Program 84.033 5,005,111 - 5,005,111 - Total Federal Work-Study Program 5,668,834 - 5,668,834 - Teacher Education Assistance for College and Higher Education Grants (TEACH Grants) Teacher Education Assistance for College and Higher Education Grants (TEACH Grants) 84.379 (3,728) - (3,728) - Teacher Education Assistance for College and Higher Education Grants (TEACH Grants) 84.379 131,066 - 131,066 - Total Teacher Education Assistance for College and Higher Education Grants (TEACH Grants) 127,338 - 127,338 - Federal Direct Loan Program Federal Direct Student Loans 84.268 617,662,801 - 617,662,801 - Total Federal Direct Student Loans 617,662,801 - 617,662,801 - Federal Pell Grant Program Federal Pell Grant Program 84.063 27,316,038 - 27,316,038 - Total Federal Pell Grant Program 27,316,038 - 27,316,038 - Federal Perkins Loan Program 84.038 Outstanding loans at September 1, 2017 96,948,574 - 96,948,574 New loans issued during fiscal year 2018 7,052,351 - 7,052,351 - Total Federal Perkins Loan Program 104,000,925 - 104,000,925 - Total U.S Department of Education 757,455,553 - 757,455,553 - U.S. Department of Health and Human Services Health Professions Student Loan Program Health Professions Student Loan Program/Loans to Disadvantaged Students 93.342 Outstanding loans at September 1, 2017 6,701,248 - 6,701,248 - New loans issued during fiscal year 2018 3,372,627 - 3,372,627 - Total Health Professions Student Loan Program 10,073,875 - 10,073,875 - Nursing Student Loans Undergraduate Nursing Student Loans 93.364 Outstanding loans at September 1, 2017 1,538,381 - 1,538,381 - New loans issued during fiscal year 2018 304,314 - 304,314 - Total Nursing Student Loan Program 1,842,695 - 1,842,695 - Graduate Nursing Student Loans 93.364 Outstanding loans at September 1, 2017 171,862 - 171,862 - New loans issued during fiscal year 2018 -- -- Total Graduate Nursing Loan Program 171,862 - 171,862 -

The accompanying notes are an integral part of this schedule. 88 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Student Financial Aid Cluster (continued) Graduate Nursing Student Loans (continued) Faculty Nursing Student Loans 93.264 Outstanding loans at September 1, 2017 1,226,178 - 1,226,178 - New loans issued during fiscal year 2018 108,000 - 108,000 - Total Nursing Faculty Loans 1,334,178 - 1,334,178 - Total U.S. Department of Health and Human Services 13,422,610 - 13,422,610 - Total Student Financial Aid Cluster 770,878,163 - 770,878,163 - Other Programs U.S. Department of Commerce Science, Technology, Business and/or Education Outreach 11.620 9,037 - 9,037 - 9,037 - 9,037 - Marine Debris Program 11.U01 831,096 - 0094-FY16-PAY-005 831,096 465,359 Project Management on PatentsView IV 11.U01 - 22,691 American Institutes for Research (AIR) D141010702 MOD1 22,691 - 831,096 22,691 853,787 465,359 Total U.S. Department of Commerce 840,133 22,691 862,824 465,359 U.S. Department of Defense Basic Scientific Research 12.431 10,000 - 10,000 - 10,000 - 10,000 - Language Grant Program 12.900 48,394 - 48,394 - Language Grant Program 12.900 31,480 - 31,480 18,174 79,874 - 79,874 18,174 CyberSecurity Core Curriculum 12.905 125,307 - 125,307 - 125,307 - 125,307 - Total U.S. Department of Defense 215,181 - 215,181 18,174 U.S. Department of Justice Creating Juvenile Drug Court Communities of Practice 16.585 - 35,978 National Council of Juvenile and Family Court Judges 32516 -SVU Amendment No.1 35,978 - - 35,978 35,978 - Implementing Task Force Data Collection Recommendations in California 16.710 - 26,110 State of California Office of the Attorney General 16-K016C 26,110 - - 26,110 26,110 - Edward Byrne Memorial Competitive Grant Program 16.751 2,280 - 2,280 - 2,280 - 2,280 - Evaluation of the New York State Permanent Judicial Commission on Justice for Children 16.830 - 187,681 New York State Unified Court System NCE to 9-30-2019 187,681 - - 187,681 187,681 - Total U.S. Department of Justice 2,280 249,769 252,049 - U.S. Department of State Iraq Assistance Program 19.016 (1,017) - (1,017) (1,018) (1,017) - (1,017) (1,018) Intersections in American and Arab Art 19.022 9,800 - 9,800 - Intersections in American and Arab Literature 19.022 9,801 - 9,801 - 19,601 - 19,601 - International Programs to Support Democracy, Human Rights and Labor 19.345 3,507 - 3,507 - International Programs to Support Democracy, Human Rights and Labor 19.345 334 - 334 - Protecting Academic Freedom and Freedom of Thought 19.345 - 194,439 National Endowment for Democracy 2017-1378 194,439 - Scholars at Risk: Monitoring Attacks on Academic Freedom 19.345 - 250 National Endowment for Democracy 2015-1360 250 - Scholars at Risk: Protecting Academic Freedom and Freedom of Thought 19.345 - 71,569 National Endowment for Democracy 2016-1444.1 71,569 - 3,841 266,258 270,099 - Academic Exchange Programs - Scholars 19.401 (460) - (460) - (460) - (460) - Total U.S. Department of State 21,965 266,258 288,223 (1,018)

U.S. Department of Transportation Engineering Design and Inspection Services Citywide for intelligent Transportation (ITS) Related and Planning Projects 20.200 - 13,371 City College (CUNY) 70025-01-28 NCE No. 2 13,371 - - 13,371 13,371 - Highway Training and Education 20.215 5,000 - 5,000 - 5,000 - 5,000 - Total U.S. Department of Transportation 5,000 13,371 18,371 - National Endowment for the Arts Promotion of the Arts Grants to Organizations and Individuals 45.024 6,023 - 6,023 - Promotion of the Arts Grants to Organizations and Individuals 45.024 20,000 - 20,000 - Promotion of the Arts Grants to Organizations and Individuals 45.024 300 - 300 - Promotion of the Arts Grants to Organizations and Individuals 45.024 19,993 - 19,993 - Promotion of the Arts Grants to Organizations and Individuals 45.024 30,000 - 30,000 - Promotion of the Arts Grants to Organizations and Individuals 45.024 10,000 - 10,000 - 86,316 - 86,316 - Glucksman Ireland House NYU Public Events and Lecture Series 45.129 - (1,249) New York Council for the Humanities 6146 (1,249) - Skirball Talks 45.129 - 5,001 Humanities New York 3086715 5,001 - - 3,752 3,752 - Total National Endowment for the Arts 86,316 3,752 90,068 - The accompanying notes are an integral part of this schedule. 89 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients Other Programs (continued) Institute of Museum and Library Services National Leadership Grants 45.312 1,179 - 1,179- 1,179 - 1,179- Laura Bush 21st Century Librarian Program 45.313 76,208 - 76,208 56,455 76,208 - 76,208 56,455 Total Institute of Museum and Library Services 77,387 - 77,387 56,455 National Endowment for the Humanities Promotion of the Humanities Division of Preservation and Access 45.149 28,462 - 28,462 - Promotion of the Humanities Division of Preservation and Access 45.149 19,633 - 19,633 - Promotion of the Humanities Division of Preservation and Access 45.149 102,356 - 102,356 - Promotion of the Humanities Division of Preservation and Access 45.149 19,382 - 19,382 - Promotion of the Humanities Division of Preservation and Access 45.149 86,000 - 86,000 - 255,833 - 255,833 - Promotion of the Humanities Office of Digital Humanities 45.169 34,632 - 34,632 - 34,632 - 34,632 - Total National Endowment for the Humanities 290,465 - 290,465 -

Department of Veterans Affairs IPA Agreement for Chao Liu - PI Alesha Castillo 64.U01 51,377 - 51,377 - A multi-modal physician-centered intervention to improve guideline-concordant prostate cancer imaging 64.U01 12,323 - 12,323 - IPA Agreement - Cinyee Cai 64.U01 21,716 - 21,716 - Testing the efficacy of a technology-assisted intervention to improve weight management of obese patients within Patient A 64.U01 11,619 - 11,619 - 97,035 - 97,035 - Total Department of Veterans Affairs 97,035 - 97,035 - U.S. Department of Energy Department of Energy 81.049 - 31,995 Battelle Memorial Institute,Pacific Northwest Division 354461 31,995 - - 31,995 31,995 - Total U.S. Department of Energy - 31,995 31,995 - U.S. Department of Education (NRC) National Resource Center Program 84.015 - 113,928 Columbia University 1(GG009734-04) Amd 01 113,928 - (NRC) Title VI National Resource Center and Foreign Language and Area Studies Fellowships Program 84.015 - 332 Columbia University 1(GG009734-03) 332 - 84.015B (FLAS) Foreign Language and Area Studies Fellowships 84.015 - 192,483 Columbia University 1(GG009722-04) Amd 01 192,483 - - 306,743 306,743 - Research and Data Support for MDRC'S PTECH Study 84.305 - 29,016 MDRC Agreement recvd 05-07-2018 29,016 - - 29,016 29,016 - Partnership for Innovation in Compensation for Charter Schools (PICCS) 84.374 - 17,834 Center for Educational Innovation - Public Education Association N/A 17,834 - Partnership for Innovation in Compensation for Charter Schools (PICCS) 84.374 - 211 Center for Educational Innovation - Public Education Association N/A 211 - Partnership for Innovation in Compensation for Charter Schools (PICCS) 84.374 - 5,008 Center for Educational Innovation - Public Education Association N/A 5,008 - - 23,053 23,053 - ARRA - Support and Enhance Activities for Teacher and School Building Leader Program 84.U01 - 24 Commission on Independent Colleges and Universities N/A 24 - ARRA - Professional Development Services 84.U01 - 5,959 New York City Department of Education QC510AE ARRA 5,959 - New York State UPK Expansion: Authentic Assessment Training & Coaching Project 84.U01 - 53,638 Research Foundation of CUNY 50137-B Amd 2 53,638 - Wisconsin PROMISE 84.U01 - 28,996 University of Wisconsin, Madison 809K034 28,996 - Wisconsin PROMISE 84.U01 - 10,109 University of Wisconsin, Madison 752K264 10,109 - - 98,726 98,726 - Total U.S. Department of Education - 457,538 457,538 - US Department of Health and Human Services Training in General, Pediatric, and Public Health Dentistry 93.059 149,217 - 149,217 - Training in General, Pediatric, and Public Health Dentistry 93.059 3,702 - 3,702 - 152,919 - 152,919 - Healthy Marriage and Relationship Education Grants 93.086 - 53,717 Phoenix House HHS-2015-ACF-OFA-FM-0985 53,717 - - 53,717 53,717 - Hazardous Materials Worker Health and Safety Training (U45) Cooperative Agreement 93.142 - 101,199 Rutgers University 8356 AMD 2 (5U45ES006179-26 and 26 Revised) 101,199 - Hazardous Materials Worker Health and Safety Training (U45) Cooperative Agreement 93.142 - 8,799 Rutgers University 0600 (5U45ES006179-27 8,799 - - 109,998 109,998 - Type A: Resilient and Responsive Health Systems (RRHS) Initiative 93.266 - 199,476 Brigham and Women's Hospital 116337 Amendment 2 199,476 - Type A: Resilient and Responsive Health Systems (RRHS) Initiative 93.266 - 137,239 Brigham and Women's Hospital 116337 Amendment 1 137,239 - - 336,715 336,715 - PROJECT AsAP-NY!: A Campaign to End Health Inequity and Invisibility in the Asian American Community 93.310 - 18,395 American Association of Colleges of Nursing N/A 18,395 - - 18,395 18,395 - Topology of Cancer Evolution and Heterogeneity 93.397 - (21,205) Columbia University 1(GG010188-10) (21,205) - -(21,205) (21,205) - Child Health and Human Development Extramural Research 93.865 6,000 - 6,000 - 6,000 - 6,000 - Grants for Primary Care Training and Enhancement 93.884 32,981 - 32,981 - 32,981 - 32,981 - PPHF Geriatric Education Centers 93.969 421,426 - 421,426 80,213 421,426 - 421,426 80,213 Senior Policy Advisor for Early Childhood Policy in the Division of Children and Youth Policy, Office of Human Services Pol 93.U01 (21,528) - (21,528) - (21,528) - (21,528) - Total US Department of Health and Human Services 591,798 497,620 1,089,418 80,213 The accompanying notes are an integral part of this schedule. 90 New York University Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

Pass-Through Entity Sponsor Number / Contract Total Passed to Sub- Federal Program CFDA Direct Pass-Through Pass-Through Entity Award Number Expenditures Recipients

Other Programs (continued) Corporation For National and Community Service AmeriCorps Program 94.006 - 823 Jumpstart for Young Children, Inc 790200 823 - - 823 823 - Evaluation and Research Services Relating to the Connections to Care Initiative 94.019 - 207,001 Rand Corporation MFANYC_09.01.15 207,001 - Evaluation of the Corporation for Supportive Housing's Social Innovation Fund Initiative 94.019 - 68,092 Corporation for Supportive Housing Social Innovation 12-042-C 68,092 Social Innovation Fund Pathways Fund 94.019 - (11) New Profit Inc. N/A (11) - - 275,082 275,082 - Total Corporation for National and Community Service - 275,905 275,905 - Department of Homeland Security Capped Grant 97.036 - 59,726,481 NYS Division of Homeland Security and Emergency Management PW 04005 59,726,481 -

Project Worksheets 97.036 - 28,137,729 NYS Division of Homeland Security and Emergency Management PW 00004, PW 00006, PW 00007, PW 04619 28,137,729 -

- 87,864,210 87,864,210 - Total U.S. Department of Homeland Security - 87,864,210 87,864,210 - Department of Homeland Security Assistance to Firefighters Grant 97.044 369,371 - 369,371 - Assistance to Firefighters Grant 97.044 65,455 - 65,455 (32,396) Assistance to Firefighters Grant 97.044 152,627 - 152,627 (35,370) 587,453 - 587,453 (67,766) Total Department of Homeland Security 587,453 - 587,453 (67,766) Total Other Programs 2,815,013 89,683,109 92,498,122 551,417 Total Expenditures of Federal Awards $ 1,161,786,315 $ 128,789,006 $ 1,290,575,321 $ 51,411,106

The accompanying notes are an integral part of this schedule. 91 New York University Notes to Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

1. Basis of Presentation

The accompanying schedule of expenditures of federal awards (“the Schedule”) presents the federal grant activity of New York University (“NYU”) and is presented on the accrual basis of accounting.

The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) and therefore, some amounts may differ from amounts presented in, or used in the preparation of NYU’s consolidated financial statements. Negative amounts represent adjustments or credits to amounts reported as expenditures in prior years arising out of the normal course of business. CFDA numbers and pass- through numbers are provided when available.

NYU’s consolidated financial statements include the operations of NYU School of Medicine (“NYUSoM”) and NYU Langone Health System (“the Health System”) (collectively referred to as “NYU Langone Health”) as described in Note 1 to the accompanying consolidated financial statements. The Schedule does not include the expenditures of the Health System, which received $40,975,219 in federal awards for the year ended August 31, 2018 because those component entities of NYU obtain separate audits of federal award programs in accordance with OMB Uniform Guidance.

The research expenditures for direct costs are recognized using the cost accounting principles contained in OMB Circular A-21, Cost Principles for Educational Institutions, and OMB Uniform Guidance, where applicable. Under those cost principles, certain types of expenditures are not allowed for reimbursement. In addition, expenditures include a portion of costs associated with general School activities (facilities and administrative) which are allocated to federal awards under negotiated formulas commonly referred to as facilities and administrative rates (also under the provisions of OMB Circular A-21 and OMB Uniform Guidance, where applicable).

NYU does not use the 10% de-minimis indirect cost rate for sponsored programs.

2. Superstorm Sandy

As described in Note 2 to the accompanying consolidated financial statements, as a result of Superstorm Sandy, NYU Langone Health sustained widespread damage to the main campus facilities including NYU Langone Hospital’s inpatient and outpatient facilities and the NYUSoM research, faculty group clinical practice and education facilities all of which were temporarily closed. Under Federal Emergency Management Agency (“FEMA”) regulations, NYU Langone Health qualified for funding as a private non-profit facility that supplies critical services to the community. For Superstorm Sandy, FEMA (through the U.S. Department of Homeland Security) reimburses eligible entities at 90% of all eligible costs awarded.

In 2014, FEMA awarded NYU Langone Health a fixed, capped Public Assistance Grant (“Capped Grant”) totaling $1,091,635,575, which is to be spent over a 7 year performance period for activities covered in the agreed upon scopes of work. The $1,091,635,575 will be subject to offset for future commercial insurance recoveries related to property damage. All reimbursement under the Capped Grant is passed through from New York State to the University, to NYU Langone Health. Included in the Schedule are $59,726,481 of NYUSoM expenditures under the Capped Grant. The Health System’s expenditures under the Capped Grant are excluded from the Schedule and included in its separate schedule of expenditures of federal awards.

92 New York University Notes to Schedule of Expenditures of Federal Awards Year Ended August 31, 2018

In 2013, NYU Langone Health received $179,394,000 of expedited funding under their initial FEMA Project Worksheet applications, which is separate funding from the FEMA Capped Grant. These Project Worksheets are subject to review and finalization by FEMA. The expenses associated with these Project Worksheets are included in the Schedule in the year incurred. Included in the schedule are $28,137,729 of NYUSoM expenditures related to these Project Worksheets. The Health System’s expenditures under Project Worksheets are excluded from the Schedule and included in its separate schedule of expenditures of federal awards.

3. Facilities and Administrative Cost Rates

The University had predetermined facilities and administrative cost rates for the fiscal year ended 2018, under a rate agreement with the Department of Health and Human Services (“DHHS”), the University’s federal cognizant agency. The base rate for on-campus research was 58.5% for fiscal 2018. The base rate for off-campus research was 26% for fiscal 2018.

NYUSoM had predetermined facilities and administrative cost rates for the fiscal year ended 2018, under a rate agreement with the DHHS, NYUSoM’s federal cognizant agency. The base rate for on-campus research was 69.5% for fiscal 2018. The base rate for off-campus research was 26% for fiscal 2018.

4. Federal Student Loan Programs

NYU administers and accounts for all aspects of the campus-based student loan programs. Accordingly, NYU’s consolidated financial statements include all activity related to these programs. The amount of loans outstanding under each of these programs at August 31, 2018 are presented below. Amount Outstanding at August 31, Program CFDA 2018

Federal Perkins Loan 84.038$ 68,257,306 Health Professions Student Loans - Loans to Disadvantaged Students 93.342 2,128,165 Health Professions Student Loans 93.342 13,931,898 Nursing Student Loans 93.364 1,250,012 Graduate Nursing Loans 93.364 63,016 Nursing Faculty Loans 93.264 927,344 Nursing Faculty Loans - ARRA 93.264 83,812 Totals$ 86,641,553

With respect to the Federal Direct Loan Program, NYU is only responsible for the performance of certain administrative duties. Therefore, the transactions and the balances of loans outstanding related to this program are not included in NYU’s consolidated financial statements. The Schedule includes the loans issued to NYU students during the year ended August 31, 2018.

The administrative cost allowance for the Pell Grant Program of $28,220 has been included in the schedule of expenditures of federal awards.

NYU did not receive an administrative cost allowance from the Perkins Loan Program (CFDA #84.038) for the year ended August 31, 2018.

Part III Reports on Internal Control and Compliance

To The Board of Trustees New York University

We have audited in accordance with auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards issued by the Comptroller General of the United States, the consolidated financial statements of New York University and its subsidiaries (NYU), which comprise the consolidated balance sheets as of August 31, 2018, and the related consolidated statements of activities and of cash flows for the year then ended, and the related notes to the financial statements, and have issued our report thereon dated December 7, 2018.

Internal Control Over Financial Reporting In planning and performing our audit of the financial statements, we considered NYU’s internal control over financial reporting (internal control) to determine the audit procedures that are appropriate in the circumstances for the purpose of expressing our opinion on the financial statements, but not for the purpose of expressing an opinion on the effectiveness of NYU’s internal control. Accordingly, we do not express an opinion on the effectiveness of NYU’s internal control.

A deficiency in internal control exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct, misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control such that there is a reasonable possibility that a material misstatement of the entity’s financial statements will not be prevented, or detected and corrected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control that is less severe than a material weakness, yet important enough to merit attention by those charged with governance.

Our consideration of internal control was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control that might be material weaknesses or significant deficiencies. Given these limitations, during our audit we did not identify any deficiencies in internal control that we consider to be material weaknesses. However, material weaknesses may exist that have not been identified.

Compliance and Other Matters As part of obtaining reasonable assurance about whether NYU’s financial statements are free from material misstatement, we performed tests of its compliance with certain provisions of laws, regulations, contracts and grant agreements, noncompliance with which could have a direct and material effect on the determination of financial statement amounts. However, providing an opinion on compliance with those provisions was not an objective of our audit, and accordingly, we do not express such an opinion. The results of our tests disclosed no instances of noncompliance or other matters that are required to be reported under Government Auditing Standards.

PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, New York 10017 T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us

Purpose of this Report The purpose of this report is solely to describe the scope of our testing of internal control and compliance and the results of that testing, and not to provide an opinion on the effectiveness of the entity’s internal control or on compliance. This report is an integral part of an audit performed in accordance with Government Auditing Standards in considering the entity’s internal control and compliance. Accordingly, this communication is not suitable for any other purpose.

December 7, 2018, except for certain information in Note 16, for which the date is March 6, 2019 New York, New York

To The Board of Trustees New York University

Report on Compliance for Each Major Federal Program We have audited New York University and its subsidiaries’ (NYU) compliance, except for NYU Langone Health System, with the types of compliance requirements described in the OMB Compliance Supplement that could have a direct and material effect on each of NYU’s major federal programs for the year ended August 31, 2018. NYU’s major federal programs are identified in the summary of auditor’s results section of the accompanying schedule of findings and questioned costs.

NYU’s consolidated financial statements include the operations of NYU Langone Health System, which received $40,975,219 in federal awards which is not included in NYU’s schedule of expenditures of federal awards during the year ended August 31, 2018. Our audit, described below, did not include the operations of NYU Langone Health System, because those component entities of NYU obtain separate audits of federal award programs in accordance with the Uniform Guidance.

Management’s Responsibility Management is responsible for compliance with federal statutes, regulations and the terms and conditions of its federal awards applicable to its federal programs.

Auditor’s Responsibility Our responsibility is to express an opinion on compliance for each of NYU’s major federal programs based on our audit of the types of compliance requirements referred to above. We conducted our audit of compliance in accordance with auditing standards generally accepted in the United States of America; the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States; and the audit requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Those standards and the Uniform Guidance require that we plan and perform the audit to obtain reasonable assurance about whether noncompliance with the types of compliance requirements referred to above that could have a direct and material effect on a major federal program occurred. An audit includes examining, on a test basis, evidence about NYU’s compliance with those requirements and performing such other procedures as we considered necessary in the circumstances.

We believe that our audit provides a reasonable basis for our opinion on compliance for each major federal program. However, our audit does not provide a legal determination of NYU’s compliance.

Opinion on Each Major Federal Program In our opinion, NYU complied, in all material respects, with the types of compliance requirements referred to above that could have a direct and material effect on each of their major federal programs for the year ended August 31, 2018.

PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, New York 10017 T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us

Other Matters The results of our auditing procedures disclosed instances of noncompliance, which are required to be reported in accordance with the Uniform Guidance and which are described in the accompanying schedule of findings and questioned costs as items 2018-001 and 2018-002. Our opinion on each major federal program is not modified with respect to these matters.

NYU’s response to the noncompliance findings identified in our audit is described in the accompanying management’s views and corrective action plan. NYU’s response was not subjected to the auditing procedures applied in the audit of compliance and, accordingly, we express no opinion on the response.

Report on Internal Control Over Compliance Management of NYU is responsible for establishing and maintaining effective internal control over compliance with the types of compliance requirements referred to above. In planning and performing our audit of compliance, we considered NYU’s internal control over compliance with the types of requirements that could have a direct and material effect on each major federal program to determine the auditing procedures that are appropriate in the circumstances for the purpose of expressing an opinion on compliance for each major federal program and to test and report on internal control over compliance in accordance with the Uniform Guidance, but not for the purpose of expressing an opinion on the effectiveness of internal control over compliance. Accordingly, we do not express an opinion on the effectiveness of NYU’s internal control over compliance.

A deficiency in internal control over compliance exists when the design or operation of a control over compliance does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct, noncompliance with a type of compliance requirement of a federal program on a timely basis. A material weakness in internal control over compliance is a deficiency, or combination of deficiencies, in internal control over compliance, such that there is a reasonable possibility that material noncompliance with a type of compliance requirement of a federal program will not be prevented, or detected and corrected, on a timely basis. A significant deficiency in internal control over compliance is a deficiency, or a combination of deficiencies, in internal control over compliance with a type of compliance requirement of a federal program that is less severe than a material weakness in internal control over compliance, yet important enough to merit attention by those charged with governance.

Our consideration of internal control over compliance was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control over compliance that might be material weaknesses or significant deficiencies. We did not identify any deficiencies in internal control over compliance that we consider to be material weaknesses. However, material weaknesses may exist that have not been identified.

The purpose of this report on internal control over compliance is solely to describe the scope of our testing of internal control over compliance and the results of that testing based on the requirements of the Uniform Guidance. Accordingly, this report is not suitable for any other purpose.

March 6, 2019 New York, New York

Part IV Findings

New York University Schedule of Findings and Questioned Costs August 31, 2018

Section I – Summary of Auditor’s Results

Financial Statements Type of auditor’s report issued: Unmodified

Internal control over financial reporting:

x Material weakness(es) identified? ___ Yes X No x Significant deficiency(ies) identified that are not considered to be material weaknesses? ___ Yes X None reported x Noncompliance material to financial statements noted? ___ Yes X No

Federal Awards Internal control over major programs:

x Material weakness(es) identified? ____ Yes X No x Significant deficiency(ies) identified that are not considered to be material weaknesses? ____ Yes X None reported

Type of auditor’s report issued on compliance for major programs: Unmodified Any audit findings disclosed that are required to be reported in accordance with 2 CFR 200.516(a)? X Yes No

Identification of major programs:

CFDA Number(s) Name of Federal Program or Cluster Various Student Financial Assistance Cluster Various Research and Development Cluster

Dollar threshold used to distinguish between type A and type B programs: $3,871,726

Auditee qualified as low-risk auditee? X Yes ____ No

98 New York University Schedule of Findings and Questioned Costs August 31, 2018

Section II - Financial Statement Findings As a result of our audit, no instances of noncompliance related to the financial statements that are required to be reported in accordance with Government Auditing Standards were identified.

Section III - Federal Award Findings and Questioned Costs

2018-001: Federal Work Study Program Disbursements

Federal Agency: Department of Education

Program: Student Financial Aid Cluster

CFDA #: 84.033

Criteria In accordance with 34 CFR section 675.19(b)(2)(i), an institution must establish and maintain Federal Work Study (FWS) program and fiscal records that include a certification by the student’s supervisor that each student has worked and earned the amount being paid. The certification must include or be supported by, for students paid on an hourly basis, a time record showing the hours each student worked in clock time sequence, or the total hours worked per day.

Condition The University’s timekeeping and payroll systems are configured such that if a supervisor does not approve a student’s timesheet by the date that payroll disbursements are set to occur, the timesheet automatically “locks” and calculates the amount to be disbursed to the student based on the submitted hours and the student’s pay rate in order to ensure the student is paid timely. The amount is then disbursed to the student utilizing FWS funds without this approval, and the timesheets may, but are not required to be retroactively certified by the supervisor. 6 of the 25 timesheets tested were not approved by a supervisor prior to disbursement of FWS funds, nor were they retroactively reviewed subsequent to the disbursement.

Cause As a result of the ability for the payroll system to automatically disburse funds to students, timesheets were not properly reviewed and certified. A formal policy exists which states that FWS timesheets must be approved, however, this policy was circumvented by the capability within the system for these automated disbursements to occur.

Effect Timesheets that are not reviewed and approved by a responsible official prior to disbursement of FWS funds could result in inaccurate and/or unearned disbursements, causing a misallocation of Federal funds.

Questioned Costs The questioned cost associated with this finding is $1,492, which represents the amount of FWS funds disbursed from the six unapproved timesheets tested.

Recommendation We recommend the University remove the ability for timesheets to automatically be paid prior to approval, and implement a formal control such that FWS funds are not disbursed to students prior to certification by a student’s supervisor, and if timesheets are not approved, institutional funds are instead utilized to pay the student rather than FWS funds.

99 New York University Schedule of Findings and Questioned Costs August 31, 2018

Management’s Views and Corrective Action Plan Refer to Management’s Views and Corrective Action Plan at the end of the report.

2018-002: Omission of Expenditures from the 2013-2017 Schedules of Expenditures of Federal Awards

Federal Agency: All

Program: All

CFDA #: All

Award #: All

Criteria OMB Uniform Guidance 2 CFR 200.510(b)(3) requires that the auditee provide the Federal awards expended for each individual Federal Program and the CFDA number or other identifying number when the CFDA information is not available on the Schedule of Expenditure of Federal Awards (SEFA).

Condition The SEFA and Data Collection Form (DCF) for fiscal years 2013-2017 did not include the $1,759,939 of federal expenditures incurred under the awards listed below. There was no impact on our audit scoping given these awards either fall under the Research and Development Cluster, which already exceeded the Type A threshold for each respective fiscal year, or are non-research awards that did not individually exceed our Type B threshold for the year from which they were omitted.

Federal Agency Award CFDA # Amount Department of Agriculture Agriculture and Food Research Initiative (AFRI) 10.310$ 127,523 Department of Defense Basic, Applied, and Advanced Research in Science and Engineering 12.431 197,767 Department of Defense Air Force Defense Research Sciences Program 12.800 18,661 Department of State Intersections in American and Arab Art 19.022 9,800 Department of State Intersections in American and Arab Literature 19.022 9,800 National Aeronautics and Space Administration Science 43.001 36,364 National Aeronautics and Space Administration Science 43.001 20,812 National Aeronautics and Space Administration PACS Observations of Supernova Ejecta and Dust in the Composite Supernova 43.002 4,050 National Science Foundation Engineering Grants 47.041 12,099 National Science Foundation Engineering Grants 47.041 275,898 National Science Foundation Mathematical and Physical Sciences 47.049 122,625 National Science Foundation Computer and Information Science and Engineering 47.070 67,786 National Science Foundation Social, Behavioral, and Economic Sciences 47.075 63,982 Department of Health and Human Services Neural Dynamics of Human Working Memory Networks 93.242 26,638 Department of Health and Human Services Alcohol Research Programs 93.273 309,426 Department of Health and Human Services Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 414,995 Department of Homeland Security Text-Enabled CVE Gatekeeper Intervention Help-Line & Referral System 97.RD 41,713 $ 1,759,939

Cause The awards are administered by personnel at the University’s Abu Dhabi campus, rather than central Sponsored Programs Administration (SPA), and are recorded to a different fund number in the University’s general ledger than federal programs administered by SPA. As a result, the awards were incorrectly excluded from the SEFA and DCF.

100 New York University Schedule of Findings and Questioned Costs August 31, 2018

Effect The 2013-2017 SEFA and DCF were understated by $1,759,939. Audit scoping was not impacted, but could have been if the awards did not fall into a pre-existing cluster that already exceeded the Type A threshold or individually exceeded the Type B threshold for awards outside of this cluster.

Questioned Costs None.

Recommendation The University should implement controls to ensure all Federal awards are reported on the SEFA and DCF.

Management’s Views and Correction Action Plan Refer to Management’s Views and Correction Action Plan at the end of the report.

101 New York University Summary Schedule of Prior Audit Findings August 31, 2018

There were no prior year findings that require an update in this report.

102